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Abstract 
I piccoli RNA sono corte sequenze di RNA non codificante che regolano l’espressione di numerosi 
elementi coinvolti nella virulenza di batteri patogeni, in particolar modo quelli coinvolti 
nell’interazione con l’ospite. In Pseudomonas aeruginosa, patogeno opportunista che causa 
infezioni potenzialmente mortali in soggetti immunodepressi ed in pazienti affetti da fibrosi cistica, 
i piccoli RNA rivestono un ruolo di grande interesse nello scenario dei regolatori post-trascrizionali, 
modulando importanti meccanismi regolativi alla base della patogenesi di questo microrganismo. 
Il progetto di ricerca discusso in questa tesi di dottorato ha come obiettivo la caratterizzazione di 
due piccoli RNA di P. aeruginosa, denominati ErsA e PesA, conservati sia in ceppi clinici che 
ambientali.  
Come descritto in Ferrara et al. 2015, l’espressione di ErsA è sotto il controllo del fattore sigma 
“alternativo” σ22 (AlgT/U), implicato nella patogenesi in risposta a diversi stress ambientali, e 
l’espressione di ErsA viene modulata da segnali connessi con la transizione ambiente esterno-
ospite, cambiamenti della temperatura oppure modulazione dei livelli di ossigeno, Nel ceppo 
standard di laboratorio PAO1, ErsA regola negativamente a livello post-trascrizionale l’RNA 
messaggero (mRNA) di AlgC codificante per un enzima cruciale nella sintesi degli zuccheri 
utilizzati nella produzione di esopolisaccaridi, componente principale della matrice del biofilm 
batterico. Partendo da questo scenario, abbiamo usato diverse strategie sperimentali per delineare in 
modo più dettagliato il contributo di ErsA nella formazione di biofilm come analisi in silico, in vivo 
ed in vitro, corroborate da studi fenotipici e genetici (RNA-sequencing) eseguiti su un ceppo di 
PAO1 deleto del gene codificante per ErsA (PAO1 ΔersA).  
I risultati ottenuti dall’analisi fenotipica, suggeriscono un’influenza positiva di ErsA sul corretto 
sviluppo del biofilm di P. aeruginosa, presumibilmente modulando a livello post-trascrizionale 
l’espressione di AmrZ, identificato come nuovo target diretto di ErsA. AmrZ è un regolatore 
trascrizionale che controlla l’espressione di numerosi geni coinvolti nella produzione di strutture 
necessarie allo sviluppo del biofilm batterico, alcuni dei quali risultano essere deregolati in assenza 
di ErsA come emerso dall’analisi del profilo trascrizionale del ceppo PAO1 ΔersA. 
In parallelo allo studio su ErsA, abbiamo caratterizzato anche un secondo piccolo RNA, PesA, 
codificato dall’isola di patogenicità PAPI-1 del ceppo PA14. I nostri risultati mostrano che la 
delezione di pesA in PA14 (PA14 ΔpesA) determina una minore virulenza del ceppo rispetto al suo 
corrispondente wild-type, come evidenziato dall’alta percentuale di sopravvivenza delle cellule 
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epiteliali bronchiali derivate da pazienti affetti da fibrosi cistica in seguito all’infezione con il ceppo 
PA14ΔpesA. Inoltre, abbiamo evidenziato una regolazione positiva che PesA esercita sull’operone 
pyoS3A-I deputato alla produzione di piocine S3, batteriocine importanti per la virulenza e la 
colonizzazione di nuove nicchie ecologiche. Infine, la mancanza di PesA contribuisce alla maggiore 
sensibilità all’antibiotico fluorochinolone ciprofloxacina e al trattamento con raggi UV suggerendo 
un potenziale coinvolgimento delle piocine S3 nella riparazione dei danni al DNA.  
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Abstract 
In bacterial pathogens, small RNAs (sRNAs) are involved in the coordinate expression of the 
virulence factors underlying the interaction with host. Several sRNAs have been described in the 
human pathogen Pseudomonas aeruginosa, as integral part of the complex and intricate regulatory 
networks that represent the bedrock of its pathogenicity. This PhD project aimed to expand the 
knowledge about the recently described sRNA ErsA and to functional characterize the novel sRNA 
PesA which is transcribed within the pathogenicity island PAPI-1 of P. aeruginosa PA14 strain. 
ErsA is expressed in all the P. aeruginosa sequenced genomes, and in PAO1 it is responsive to 
infection-relevant host stimuli such as oxygen availability and temperature shift and its transcription 
is under the control of the alternative sigma factor σ22 (AlgT/U), a mediator of the stress response 
implicated in the bacterium pathogenicity. In addition, ErsA has been suggested to directly exert a 
negative post-transcriptional regulation on the virulence-associated algC gene encoding for the 
bifunctional enzyme AlgC implicated in alginate and exopolysaccharides biosynthesis for biofilm 
formation. Here, we investigated the multiple aspects of ErsA regulation in AlgC-related pathways, 
in particular biofilm formation, using a strategy based on in silico, in vivo and in vitro analyses, 
RNA-seq and phenotypic assays. Our combinatorial approach shows an interesting positive 
contribution of ErsA in biofilm development, likely by regulating at post-transcriptional level the 
AmrZ transcriptional regulator and resulting in altered transcriptional levels of genes belonging to 
the AmrZ regulon and crucial in biofilm formation as algD, and pel genes.  
In this study we characterized also a novel sRNA of P. aeruginosa PA14 named PesA. We show 
that PesA, which is transcribed within the pathogenicity island PAPI-1 of P. aeruginosa strain 
PA14, contributes to P. aeruginosa PA14 virulence and pathogenesis. Specifically, pesA gene 
deletion results in a less pathogenic strain, showing higher survival of cystic fibrosis human 
bronchial epithelial cells after infection compared to PA14 wildtype. Furthermore, ΔpesA is more 
sensitive to fluoroquinolone antibiotic ciprofloxacin and UV irradiation, this last is comparable to 
that of a strain deleted for pyoS3A-I. The pyoS3A-I locus encodes for pyocin S3 and we show that 
PesA influences the production of these bacteriocins positively regulating at post-transcriptional 
level the pyoS3A-I operon. On the whole, our results suggest a positive contribution of PesA in P. 
aeruginosa virulence and niche establishment. Furthermore, we suggest a potential involvement of 
pyocin S3 in DNA damage repair, introducing a link between DNA damage and repair modulated 
by PesA that has to be elucidated.  
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State of the art 
1. Pseudomonas aeruginosa 
In the genus of Pseudomonas, characterized by roughly 200 species widespread in the environment 
as soil, water, plants and animals, Pseudomonas aeruginosa is the type species of the genus, most 
frequently associated to human infection (Coggan and Wolfgang, 2012). 
P. aeruginosa is a Gram-negative, motile and aerobic microorganism, characterized by high 
metabolic versatility and a remarkable tolerance to a wide variety of physico-chemical conditions, 
including temperature, high concentrations of salts and dyes, weak antiseptics, and many commonly 
used antibiotics. Indeed, the emergence of P. aeruginosa as a human pathogen in the past century is 
considered associated to a massive use of antibiotics and disinfectants to eradicate “old” pathogens 
which caused the availability of new niches (Bjarnsholt and Givskov, 2007). 
P. aeruginosa is classified as a human opportunistic pathogen, since not normally part of the 
microbiota, which can establishes acute and chronic infections in hospitalized patients and immuno-
compromised individuals, settling in a multitude of sites and tissues, including: lungs (Fig.1), burns, 
wounds, eyes, ears, and abiotic surfaces (i.e. catheters and ventilators) (Driscoll et al., 2007). 
 
 
Figure 1 Coloured scanning electron micrograph (SEM) Pseudomonas aeruginosa 
bacteria (blue) in the lung of a burns patient. Photo credit: Steve 
Gschmeissner/Science photo library, www.sciencephoto.com. 
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P. aeruginosa has been recognized as one of the most encountered bacteria and the predominant 
cause of mortality in cystic fibrosis (CF) patients (Folkesson et al., 2012). Cystic fibrosis is a 
genetic disorder caused by a defect in the cystic fibrosis conductance regulator (CFTR) that mainly 
affects the physiological activity of secretory districts as lungs, digestive and reproductive systems 
(Kreda et al., 2012). According to the Cystic Fibrosis Foundation Patient Registry, more than 
70.000 people are affected by cystic fibrosis worldwide, approximately 1.000 new cases of CF are 
diagnosed each year and more than 75 percent of people with CF are diagnosed by age 2. 
Alteration in CFTR channel in the lungs results in sticky and thick sputum which interfere with the 
epithelial clearance and innate immune system protection. As a consequence, inflammatory 
conditions and microbial infections provoke the lung function collapse which is associated to the 
high mortality rate of CF patients (Folkesson et al., 2012; Ratjen, 2009). The presence and 
persistence of P. aeruginosa in CF airways reflects its versatile metabolic capacity and broad 
potential for adaptation to fluctuating environmental conditions. Indeed, the optimum temperature 
for P. aeruginosa growth is 37° C; however, it is able to tolerate temperatures as high as 50°C. 
Furthermore, the environment in CF lungs is considered microaerophilic or anaerobic and P. 
aeruginosa is capable of growing under both aerobic as well as anaerobic conditions using 
preferentially nitrate as a terminal electron acceptor (Hassett et al., 2002, 2009; Schobert and Jahn, 
2010). 
All these extraordinary features are provided by the large genome (from 6.22 to 6.91 Mb) and a 
notable number of regulatory genes (10% of the genome) to control the P. aeruginosa virulence 
(Olson et al., 2000). Almost the totality of the genome is characterized by highly conserved 
sequences. The small percentage of diversity (0.5-0.7%) is similar in the core genome, except for 
some genes involved in virulence and immunogenicity, as pyoverdine synthesis and uptake, flagella 
and O-antigen fraction in LPS (lipopolysaccharide) composition, which are under diversifying 
selection in patients (Klockgether et al., 2011; Smith et al., 2006) 
P. aeruginosa strains display a huge variability in virulence, ranging from very moderate to highly 
virulent strains. PAO1 is a moderate virulent strain, isolated the first time from a wound over 50 
years ago. In contrast, PA14 is a highly virulent isolate and in laboratory conditions is used as a 
model for clinical isolates (He et al., 2004; Wiehlmann et al., 2007). Although PA14 and PAO1 
present a high degree of genome identity, the PA14 genome is slightly bigger than PAO1 genome 
and contains two pathogenicity islands that are absent in PAO1, that carry several genes implicated 
in virulence, as exotoxin gene exoU and the Rcs/Pvr two-component systems that control the cupD 
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fimbrial cluster (Mikkelsen et al., 2009; Nicastro et al., 2009). Furthermore the pathogenicity island 
is involved also in the pathogenicity of P.aeruginosa in murine models, although is not possible to 
predict the precise number of genes involved in this process (Harrison et al., 2010a). 
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2. P. aeruginosa virulence and pathogenesis 
The pathogenesis of P. aeruginosa is a multifactorial process and characterized by a number of 
virulence properties that lead to P. aeruginosa to colonize, resist and persist in the host. According 
to Pollack (Pollack, 2000) there are three stages of infection: i) bacterial attachment and 
colonization, ii) local infection, and iii) bloodstream dissemination and systemic disease. In the first 
step, flagella, type IV pili and LPS lead the attachment of bacteria to host-cells by binding epithelial 
gangliosides, asialoGM1 and asialoGM2. All these features are immunogenic and cause the 
response of the innate immune system and early inflammation state. Then, the invasion of the 
bacteria is modulated by the type III secretion system (T3SS), which is involved in the injection of 
cytotoxins into the host cell, and by several proteases which disrupt the epithelial junctions.  
The attachment and invasion are also supported by swarming, swimming and twitching bacterial 
movements that are important to form P. aeruginosa microcolonies which develop in mature 
biofilm. The exopolysaccharide matrix composing biofilm protects the bacterium from the host 
immune system components and antibiotics treatment, leading the chronic infection in the lung. 
Furthermore, alginate that represents the main component of P. aeruginosa biofilm, provides an 
additional or alternative adhesin which attaches to the tracheobronchial mucin (N-
acetylglucosamine) conferring the mucoid phenotype typical of P. aeruginosa clinical strains 
isolated from the lung of CF patients during chronic infection (Fig. 2) 
 
 
Figure 2. A mucoid phenotype expressed by a P. aeruginosa clinical strain isolated 
from CF sputum sample on Pseudomonas isolation agar (PIA). 
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Once disseminated, P. aeruginosa produces pyocyanin and pyoverdine, blue and green pigments 
respectively, to interfere with host cell electron transport pathways and to captures iron in order to 
avoid iron starvation during the competition for the niche.  
Blood stream invasion and dissemination of Pseudomonas is probably due to the same factors 
involved in local settlement and infection. The resistance of P. aeruginosa to phagocytosis and 
serum bactericidal response is due to its mucoid capsule and LPS. Moreover, the lipidic component 
of LPS (lipid A, endotoxin) mediates the usual pathologic aspects of Gram-negative septicemia, e.g. 
fever, hypotension and intravascular coagulation. The virulence mechanism of P. aeruginosa is 
summarized in Fig.3. 
 
 
 
Figure 3. Virulence mechanisms employed during P. aeruginosa infections. Modified from Lee and Zhang, 2015. 
 
P. aeruginosa acute infections often spread rapidly and can cause tissue damage and sepsis with 
high mortality rates; chronic infections can persist for weeks, months, or years in the face of 
intensive clinical intervention. As mentioned before, acute infections are characterized by the 
expression of a plethora of secreted and cell-associated virulence factors which worsen the clinical 
status of immunocompromised patients and are clearly recognizable. Chronic infections are 
characterized by a permanent inflammatory state due to the recurrent, intermittent bacterial 
infection. The main example for chronic infection is induced by P. aeruginosa in CF lung which is 
highly different compared to the strains isolated from acute infection site. Indeed, clinical isolates 
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from chronic infection site accumulated mutations and loss of function in genes involved for 
example in acute infection traits, as pili, flagella, quorum sensing adopting a more sessile mode of 
life (Fig. 4) (Gellatly and Hancock, 2013; Smith et al., 2006). The acquisition of the mucoid 
phenotype is also the result of the accumulation of a mutation, specifically in mucA gene, involved 
in the negative control of the alternative sigma factor AlgU which is activated in stress condition 
and regulates a number of genes associated to central metabolism, virulence and motility (Ciofu et 
al., 2010; Jones et al., 2010; Yu et al., 1995). Sigma factors are global regulators of transcription 
initiation in bacteria, which allow the RNA polymerase binding to a specific promoter. They 
regulate the expression of a number of genes simultaneously, connected to virulence and stress 
response. 
 
 
Figure 4. Graphic representation of P. aeruginosa changes during infection in CF airways. During the early infection P. aeruginosa 
produces cell-associated virulence factors and secreted factors, and is still antibiotic sensitive. In chronic infection stage P. 
aeruginosa accumulates mutations to be fully adapted to CF environment and is characterized by overproduction of alginate, loss of 
the appendages and show more resistance to antibiotics. Modified from (Sousa and Pereira, 2014) 
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2.1 P. aeruginosa sigma factors 
In P. aeruginosa, transcription initiation is the major event in regulation of target genes orchestrated 
by sigma factors, which confers to the bacterium adaptability and versatily to several environmental 
conditions, including human host. 
Flexible changes in the transcriptional profile of P. aeruginosa are crucial in the switch between 
acute and chronic infections and in modulating all the phenotypes connected to this event, as 
biofilm formation (Oliver et al., 2000; Sadikot et al., 2005). Alternative sigma factors and extra-
cytoplasmatic function factors (ECF) are known to provide fast regulation of gene expression in 
challenging environmental conditions. P.aeruginosa produces 25 sigma factors, including one 
strain-specific (encoded from PA14_27690 gene in PA14 strain) and 21 ECF sigma factors (Potvin 
et al., 2008). 
The basic initiation of transcription in bacteria is performed by the multisubunit RNA polymerase 
(RNAP) that binds the sigma factor σ70 (Helmann and Chamberlin, 1988) to detect the promoter 
region. The σ70 proteins bind the positions -10 and -35 and allow the melting of double-stranded 
DNA to interact with the core of the RNAP.  
P. aeruginosa produces a major σ70 named RpoD which recognizes and controls the expression of a 
large number of housekeeping genes. RpoD has extensive homology with σ70 of E. coli (Tanaka and 
Takahashi, 1994) and it exerts is transcriptional activity essentially during the exponential phase of 
growth (Fujita et al., 1994) RpoD is constitutivelty transcribed from PC promoter under steady-state 
and upon heat shock, and transiently transcribed from PHS promoter upon heat-shock (Aramaki and 
Fujita, 1999). RpoD, as all σ70, is characterized by four domains of which domain 2 and 4 are the 
most conserved and involved in the binding to -10 and -30 regions (Harley and Reynolds, 1987; 
Zhou and Gross, 1992). 
P. aeruginosa and E.coli share similarities also for another σ70-like, RpoH, which is 61% identical 
to σH (σ32) of E. coli (Benvenisti et al., 1995). In P. aeruginosa rpoH  transcription is AlgU-
dependent and it is required for positive regulation of heatshock genes as well as for more than 20 
heat-shock proteins (HSPs), including DnaK, DnaJ, GrpE, GroEL and GroES and specific proteases 
(Arsène et al., 2000). Interestingly, the promoter of RpoH was found to be activated in mucoid 
mucA mutants, suggesting a connection between the conversion to mucoid phenotype and the heat-
shock response in P. aeruginosa (Schurr and Deretic, 1997). 
FliA (RpoF or σ28) is an alternative σ factor. The fliA gene of P. aeruginosa shares up to 67% 
similarity with the gene of Salmonella typhimurium and its major function is the control of flagellin 
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biosynthesis, since the insertional inactivation of fliA results in a non-motile P. aeruginosa 
(Starnbach and Lory, 1992). The molecular mechanism that controls the expression of fliA is 
unclear but its transcription seems to be independent of RpoN or other flagellar regulator such as 
FleQ or FleR (Dasgupta et al., 2003). 
RpoS is one of the best-characterized alternative σ70 in P. aeruginosa (Schuster et al., 2004; 
Whiteley et al., 2000) and a homologue of σs in E. coli. RpoS is involved in the regulation of QS via 
the modulation of the transcriptional regulators RhlR and LasR (Latifi et al., 1996)lately affecting 
the formation of biofilm (Davies et al., 1998) as described in the following section of this thesis. 
RpoS is involved in the secretion of extracellular virulence factors such as alginate, exotoxin A, Las 
A and Las B elastases and exoenzyme S (Hogardt et al., 2004; Sonnleitner et al., 2003; Suh et al., 
1999) and its transcription in Pseudomonas implicates four genetic loci psrA, gacA, lasI and rhlI. 
PsrA has a significant role in rpoS transcription during the late-exponential and stationary growth 
phases, Vfr has a probable role in transcriptional repression of RpoS during the exponential phase 
and ClpXP protease is involved in degradation of RpoS during the exponential phase (Bertani et al., 
2003) RpoS has also been reported to be a general stress regulator in P. aeruginosa, P. fluorescens 
and P. putida (Venturi, 2003, 2006). In addition, RpoS is known to be involved in the expression of 
a subset of extracellular toxins that are also regulated by other global regulators in response to cell 
density and to other environmental factors. 
RpoN (σ54 or σN, formerly NtrA) was initially linked to nitrogen assimilation only. However, RpoN 
has been found to play important roles in motility, in the transport of nutrients, in the formation of 
pili, in mucoidy and in cell-to-cell signalling (Dasgupta et al., 2003; Heurlier et al., 2003; Ishimoto 
and Lory, 1989; Mattick et al., 1996; Strom and Lory, 1993; Thompson et al., 2003; Totten et al., 
1990). In addition, there are 22 proteins annotated known to have a binding site for σ54, FleQ and 
FleR involved in the biosynthesis of flagellin in P. aeruginosa (Dasgupta et al., 2003), PilR for pilin 
biosynthesis (Mattick et al., 1996) and AlgB, which regulates alginate exopolysaccharide 
production. RpoN is hence involved in the expression of different virulence determinants of P. 
aeruginosa including cell-to-cell communication pathways (Hendrickson et al., 2001). All RpoN-
regulated genes have the consensus promoter sequence -24(GG)/-12(GC) and their expressions 
required at least one transcriptional activator (Thöny and Hennecke, 1989). 
Alternative σ factors are involved in the regulation of gene expression in response to various 
extracellular changes, and they are designed as σ-ECF. Despite similarities in the genome size of 
Pseudomonas species (6–7 Mbp), only 10 ECF have been identified in the genome of P. syringae; 
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19 ECF in P. aeruginosa and in P. putida, 28 ECF predicted in P. fluorescens Pf-5. Based on their 
sequence conservation and function across bacterial species, ECF are classified as σ70 and the 
consensus sequence recognized is highly conserved. In most cases, the activity is modulated by an 
anti-σ, an inner membrane protein present in both E. coli and in P. aeruginosa. The anti-σ acts as a 
sensor in signalling, allowing an adaptive response to specific environmental changes to co-ordinate 
transcription of a specific regulon. There are three common characteristics shared among all ECFs, 
i) promoter sequence recognized contains an (AAC) motif in the 35 region; ii) ECF is cotranscribed 
with an anti-σ factor having an extracytoplasmic sensory domain and an intracellular inhibitory 
domain; ii) ECF are involved in regulating extracellular pathways as periplasmic stress and 
heatshock (σE ), iron transport (σFecI), metal ion efflux systems (CnrH), alginate secretion (AlgU) 
and synthesis of membrane-localized carotenoids (CarQ) (Raivio and Silhavy, 2001). 
Some ECF have been characterized and have a defined function in P. aeruginosa: AlgU was 
described to be involved in alginate biosynthesis (Schurr et al., 1996). PvdS is implicated in iron 
regulation responsible for the biosynthesis of pyoverdine (Cunliffe et al., 1995). SigX was shown to 
control the expression of the major outer membrane protein OprF (Brinkman et al., 1999) 
AlgU shares a 79% amino acid sequence similarity to the E. coli σE heat-shock produced in 
response to elevated temperatures, suggesting similar functions in response to stress. In P. 
aeruginosa, AlgU has been firstly identified to be linked in the switch betweend non-mucoid to 
mucoid phenotype in cystic fibrosis (CF) patients interacting with the promoter of algD, the key 
enzyme in the alginate biosynthesis pathway (Schurr et al., 1996). AlgU was also described to be 
involved in the regulation of resistance to oxidative and heat-shock stress (Schurr and Deretic, 
1997). AlgU is transcribed, together with its regulators from algTmucABCD operon. MucA 
represses AlgU activity acting as an anti-σ and its inactivation results in constitutive expression of 
the alginate pathway dependent on algU transcription. MucB is another negative regulator of AlgU 
localized in the periplasm, and a deletion of the leader peptide and the cytoplasmic location of 
MucB abrogated its ability to inhibit mucoidy (Schurr et al., 1996). As described in the following 
sections, AlgU is crucial in regulating exopolysaccharide production through the activation of 
transcriptional regulators, as AmrZ, and post-transcriptional regulator as the small RNA ErsA, 
which is one of the main topics of this thesis. 
PvdS controls the production of the siderophore pyoverdine and the expression of two P. 
aeruginosa extracellular virulence factors: the endoprotease PrpL (Wilderman et al., 2001) and 
exotoxin A (Helmann, 2002; Wilson and Lamont, 2000). The regulation of pyoverdine production 
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and uptake depends also to another ECF-σ, FpvI, together with one anti-σ, FpvR. PvdS shows 
considerable similarity to σFecI of E. coli, a positive regulator for transcription of fec implicated in 
ferric citrate transport (Miyazaki et al., 1995). The pvdS gene is expressed only in iron-limiting 
conditions and it is regulated by Fur (Ferric uptake regulator) repressor (Cunliffe et al., 1995). Fur 
interacts with the DNA operator sequences (Fur box) to regulate the expression of a subset of genes 
iron-regulated (Ochsner et al., 1995). It was been described that in the presence of iron, Fur binds 
the pvdS promoter to repress the transcription of pvdS, affecting the expression of pvdA encoding a 
key enzyme in the pyoverdine biosynthetic pathway (Leoni et al., 1996). Exotoxin A is also 
secreted under iron-limiting conditions. The structural gene toxA is regulated at the transcriptional 
level by the products of regAB. The expression of both toxA and regAB is repressed under iron-
deficient conditions, suggesting a role for Fur in the regulation of toxA expression. In addition 
exotoxin A and regA are also positively regulated by PtxR Lys-R-type transcriptional regulator 
(Hamood et al., 1996). PtxR and PvdS were also shown to be implicated in the synthesis of 
pyoverdine via a positive regulation of the pvdABCD operon, which is negatively regulated under 
high-iron conditions (Stintzi et al., 1999). 
SigX is the most recent σ70 ECF with a function demonstrated in P. aeruginosa and it shares 49% 
similarity to σw of Bacillus subtilis induced by alkaline shock, salt, phage infection and antibiotics 
that affect cell-wall biosynthesis (Schöbel et al., 2004). In P. aeruginosa and in P. fluorescence, 
sigX is located upstream of oprF and the disruption of sigX in both affects oprF expression 
(Brinkman et al., 1999). 
  
2.2 Secreted virulence factors 
Secreted virulence factors, as exotoxin A, proteases and pyocyanin determine the peculiar acute 
traits of P. aeruginosa infections and their expression represents the cross point between 
colonization and acute infection establishment (Moradali et al., 2017).  
 
2.2.1 Exotoxins and proteases 
Exotoxin A (ExoA), proteases and elastases are the main cause of local tissue damage, bacterial 
invasion (Woods and Iglewski), alteration of immune system and cell death due to inhibition of 
protein synthesis (Steadman et al., 1993). 
In particular, ExoA is an ADP-ribosyl transferase secreted into the extracellular space, which 
inhibits the elongation factor-2 (EF-2) and it has been shown to depress the host response to 
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infection (Michalska and Wolf, 2015). Furthermore, the injection of ExoA in mice induces 
hepatocyte apoptosis, the release of TNF, IFN-γ, IL-2, and IL-6 into the circulation and an increase 
in plasma transaminase activities (Mühlen et al., 2004). 
The most studied and relevant proteases in P. aeruginosa infection are elastase LasA and LasB, and 
alkaline protease. Alkaline protease, AprA is a type I secreted zinc protease required for 
degradation of host immune system components and host fibronectin (Hong and Ghebrehiwet, 
1992) and is involved also in degrading free flagellin to prevent Toll-Like receptor 5 activation 
(Bardoel et al., 2011). 
LasA and LasB are regulated by the las quorum-sensing system and secreted via Type II secretion 
machinery (De Kievit and Iglewski, 2000). LasA is a 20 kDa serine protease and has been described 
to cleave the pentaglycine bonds in the peptidoglycan of Staphylococcus aureus (Vessillier et al., 
2001). LasB degrades elastin, fibrin, and collagen (Cotar et al., 2010). All these proteases are 
associated to tissue invasion, damage and necrosis and the pathogenic role of alkaline proteases, 
beside lung infections, has been shown also in corneal infections (Galloway, 1991; Guzzo et al., 
1991). Other proteases, classified as endoproteases, cleave lactoferrin and transferrin altering the 
iron-caption in the host (Wilderman et al., 2001). 
P. aeruginosa produces also a number of hemolysins as the phospholipase C, which is secreted in 
the extracellular compartment and contributes to acute infection and inflammation, inducing cell 
death in animal models (Wieland et al., 2002). 
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2.2.2 Pigments 
One of the peculiar traits of P. aeruginosa is the production of pigments that confers different 
colorations associated to precise physiological processes.  
The phenazine-based pyocyanin compound is a non-fluorescent blue pigment, particularly 
interesting for its capability to generate reactive oxygen species (ROS) and thereby its application is 
very common as a redox compound in biosensors (Priyaja et al., 2016). Pyocyanin is present in 
large amount in CF sputum and since it can cross the biological membrane, P. aeruginosa uses this 
compound in oxygen-limited condition, to transport electrons produced by respiration to remote 
electron acceptors (Jennings et al., 2015; Lau et al., 2004). 
Pyoverdine (fluorescins or pseudobactins) and pyochelin are the two small molecules produced by 
P. aeruginosa in iron-limited condition. In the host P. aeruginosa produces pyoverdine and 
pyochelin to chelate extracellular Fe3+ since the iron supply is limited and almost all sequestered in 
heme molecules or combined to lactoferrin and transferrin proteins (Cornelissen and Sparling, 
1994).  
The expression of pyoverdine and pyochelin genes is modulated by the repressor Fur (ferric uptake 
regulator). In normal condition, Fur is complexed with Fe2+ and this conformation is suitable to 
bind DNA region (named Fur box) within promoters of iron uptake genes repressing their 
expression. More than 200 genes are known to be involved in iron metabolism in P. aeruginosa, but 
only a few of them present a Fur box (Cornelis et al., 2009). One example is the sigma factor PvdS 
which regulates a number of genes in iron-deplete conditions, including those encoding for 
pyoverdine, but is known to be also involved indirectly or directly in virulence factors production, 
such as exotoxin A (Leoni et al., 2000; Wilderman et al., 2001). 
However, beyond the role of siderophores, pyoverdine and pyochelin are both involved in acute and 
chronic infections, increasing inflammation and causing tissue damages as shown in a burned 
mouse model or in case of mouse pulmonary infections (Cornelis et al., 2013; Lyczak et al., 2002; 
Meyer et al., 1996; Takase et al., 2000)  
 
2.2.3 Type III and type VI secretion system 
The injection of toxic compounds into the host cell cytosol, or their secretion in the extracellular 
compartment, is provided by a number of secretion systems. Type III secretion system is a complex 
machinery attached to the bacterial surface which is designated to deliver toxic proteins, named 
 17 
 
effectors, directly in the host cell through a pore formed in the membrane. So far, four effectors 
have been described in P. aeruginosa, ExoY, ExoS, ExoT, ExoU (Galle et al., 2012; Hauser, 2009).  
ExoS and ExoT are bifunctional, with GTPase activating protein (GAP) and ADP-ribosyltransferase 
activity, while ExoY is an adenylate cyclase. The pathological role of these exotoxins is to disrupt 
epithelial junctions, to alter the cytoskeletal organization and to modify the host cell membrane 
permeability in the lung leading to the symptoms of bacterial pneumonia (Hauser, 2009). 
Type VI secretion system (T6SS) is most recent in characterization compared to T3SS. Its function 
is to inject virulence factors, as Hcp1 and VgrG proteins in the host cell lumen by a needle-like 
structure and the Hcp1 protein can be recovered directly from the CF sputum with P. aeruginosa 
infection (Filloux, 2011). P. aeruginosa encodes three T6SS clusters, H1, H2 and H3-T6SS. As 
recently described in Allsopp et al. (Allsopp et al., 2017), the T6SS is fine tune regulated at both 
transcriptional and post-transcriptional levels, by the pleiotropic transcriptional regulator AmrZ and 
by the small RNA RsmA. This regulation is pivotal for P. aeruginosa since the T6SS is built to kill 
bacterial competitors during the settlement of the infection and prevail in specific niches.  
 
2.2.4 Pyocins 
Pyocins were described for the first time by François Jacob as bacteriocins produced by P. 
aeruginosa when treated with a mutagen agent as ultraviolet irradiation. These inducible 
compounds when absorbed by the cell surface of other bacteria cause their death. 
After this first evidence, other studies increased the knowledge about pyocins and in particular the 
classification in R-pyocins, F-pyocins and S-pyocins (Michel-Briand and Baysse, 2002; Takeya et 
al., 1967). 
Although almost all the P. aeruginosa strains can produce pyocins, the spontaneous production 
level is low and could increase if induced by mutagen agents. The mechanism of action of pyocins 
is based on a hit mechanism to kill the target (Kuroda and Kageyama, 1979; Okawa et al., 1973). 
However, not all the pyocins secreted are active, but one of them is enough to exert the killing 
activity in the host. Furthermore, strains producing pyocins are insensitive to their own pyocins, 
although one exception has been reported (Goodwin et al., 1972). 
Three types of pyocins have been described as produced by P. aeruginosa. The first pyocin 
identified and called R1, is synthetized in rod-like particles, and is nuclease and protease resistant 
(Takeya et al., 1967)  
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The second type of pyocin is called F-pyocin and occurs as a flexuous rod-like structure, and is 
usually produced associated to R-type pyocins. R‐type pyocins are contractile but non flexible, 
while the F‐type pyocins are flexible but non contractile (Govan, 1974). The R-pyocins are 
characterized by a double hollow cylinder, constituted by a sheath and a core. The sheath is the 
contractile unit; the core is located in the sheath and is composed by ≈180 subunits. The distal 
portion of the pyocin particle is accompanied by six tail fibers constituted by a subunit protein in 
which the subgroup specificity could be located at the C-terminal end (five subgroups: R1–R5) (Yui 
Furihata, 1972). These structural features share similarities with bacteriophage tail (Fig. 5).  
The fibers are basically recognized by the LPS of Gram negative bacteria and several strains are 
sensitive to the R-type pyocin of P. aeruginosa, such as Neisseria gonorrhea, Neisseria 
meningitides, Haemophilus ducreyi, and Haemophilus influenzae (Andersen et al., 1995; Blackwell 
et al., 1979; Filiatrault et al., 2001; Levin and Stein, 1996). 
After the interaction with the receptor, the contraction of the R-pyocin sheath allows the penetration 
of the core in the outer membrane for the killing activity. The release of intracellular material is 
followed by cell death for depolarization of the cytoplasmic membrane within 20 min (Uratani and 
Hoshino, 1984; Yui Furihata, 1972).  
Concerning F-type pyocins, the structure is composed by one squared end and the other with a 
fiber-like structure which resemble flexible phage tails (Kuroda and Kageyama, 1979; Takeya et al., 
1967). 
 
 
Figure 5. Structure of pyocin. (A) The structure consists of a rigid tube (orange subunits), contractible sheath (blue subunits), 
lipopolysaccharide(LPS)-targeting tail fibers (red) attached to the baseplate (gray), and spike (black) connected via the baseplate hub 
(pale yellow) to the central tube. (B) Tail-tube architecture of pyocin R2 in extended conformation. Modified from (Ghequire and De 
Mot, 2015). 
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Another large group of pyocins are the protease‐sensitive “soluble” (S‐type) pyocin. The first S1-
pyocin was identified treating a strain producing R-type pyocin by an anti-R serum. Other S-type 
pyocins as Sa and S3, were been isolated from a P. aeruginosa strain isolated from cystic fibrosis 
patient sputum. Two other soluble pyocins, S4 and S5, have been predicted bioinformatically in 
2000 and they have a tRNase structure and a pore-forming activity, respectively (Duport et al., 
1995; Elfarash et al., 2012, 2014; Parret and De Mot, 2000). 
S-type pyocins AP41, S1, S2, and S3 are constituted of two protein components in which the large 
component carries an endonuclease C-terminal domain responsible for the killing activity that 
causes cell death by DNA cleavage (Sano et al., 1993; Sano and Kageyama, 1984).  
The activity of S-type pyocins is also based on the interaction with the outer membrane of Gram-
negative bacteria. The N-terminal portion of the larger protein corresponds to the receptor binding 
domain (domain I). The second domain is not present in S2 and its role is not completely 
understood. The third domain (domain III) is involved in the translocation across the outer 
membrane, and the C-terminal end (domain IV) is crucial for the DNase activity (Michel-Briand 
and Baysse, 2002). 
Furthermore, a majority of S‐type pyocins have been found to invade the cells using a TonB‐
dependent outer membrane receptor involved in ferri‐siderophore uptake. In particular, S2 and S4 
use the ferripyoverdine receptor FpvAI (Denayer et al., 2007; Elfarash et al., 2012), pyocin S3 
targets FpvAII (Baysse et al., 1999) (Baysse et al., 1999), while pyocin S5 recognizes the FptA 
ferripyochelin receptor (Elfarash et al., 2014). 
AP41 pyocin causes induction of synthesis of other pyocins (R2 and S2 pyocins), in the sensitive 
target cell PAO1 and the receptor of AP41 pyocin seems to belong to another system where iron is 
involved (Michel-Briand and Baysse, 2002).  
Other pyocin families, comparable in size to the S pyocins, are M‐type and L‐type pyocins. M‐type 
pyocins provides a module that cleaves lipid II peptidoglycan precursors (Barreteau et al., 2009). L‐
type pyocins have two mannose‐binding lectin domains which kill target cells via an unknown 
mechanism (Ghequire et al., 2013, 2014; McCaughey et al., 2014). 
Recently, bacterial bacteriocins are considered a valid alternative therapeutic strategy to treat both 
multidrug-resistant and chronic bacterial infections (Behrens et al., 2017). The use of bacteriocins 
could target a particular microorganism closely related to the bacteriocin-producers, not affecting 
the rest of microflora (Francino, 2016). In addition, the “selective killing action” strongly reduces 
the selective pressure for resistance among strains sharing the same niches. In vitro studies have 
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already demonstrated the activity of bacteriocins against both planktonic and biofilm-bacteria 
(Smith et al., 2012). Furthermore they have also key properties in vivo, as specificity and high 
activity that suggest they may be excellent candidates for further therapeutic development (Behrens 
et al., 2017). 
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2.3 Cell surface virulence factor 
The first stages of P. aeruginosa infections rely on both attachment and adhesion to the host-cell 
surface. The expression of pili and flagella, as well as LPS, is pivotal for the human pathogen to 
find a niche and colonize the host inducing at once the inflammatory and immunogenic response 
typical of P. aeruginosa acute infection. 
 
2.3.1 Type IV pili and flagella 
Several bacteria, characterized by motile phenotype, use either flagella or type IV pili (TFP) to 
spread in the environment. P. aeruginosa possess and uses both of these motile appendage types 
implementing multiple motile styles as swarming, swimming, twitching, crawling, and walking 
(Kazmierczak et al., 2015). Type IV pili are long, thin (5–8 nm diameter) appendages present also 
on archaeal cell surfaces (Makarova et al., 2016). They are involved not only in bacterial motility, 
but also in cell-cell interaction and adhesion. Indeed, mutations in TFP production, result in less 
virulent strains, since lacking of colonization machinery (Bradley, 1980; Burrows, 2005; Mattick, 
2002; Pelicic, 2008).  
Two major TFP families have been described in P. aeruginosa, type IVa and Type IVb both 
characterized by high dynamicity. The retraction and extension movements of TFP in combination 
with other appendages, confer the force for the different types of locomotion, in particular for 
twitching motility (Gibiansky et al., 2010; Mattick, 2002). 
However, the main structure for swimming and swarming motilities is flagellum. P. aeruginosa 
possess a single polar flagellum which, through a rotating motion, contributes to swimming motility 
in aqueous environment and swarming on semi-solid surface (Kazmierczak et al., 2015; Kohler et 
al., 2000). The structural protein forming the body of flagellum is the called flagellin and the 
flagellar biosynthesis is based on the hierarchical expression of specific genes: i) fleQ gene, ii) 
basal-body genes and iii) flagellin and chemotaxis gene. All these genes are fine regulated by fleQ 
and the stationary-phase sigma factor rpoS (Dasgupta et al., 2004; Garrett et al., 1999; Wolfgang et 
al., 2004). The flagellar master regulator FleQ is inhibited by c-di-GMP binding or by sequestration 
from FleN which also modulates swarming motility regulating the flagella number (Dasgupta et al., 
2000; Dasgupta and Ramphal, 2001; Hickman and Harwood, 2008). In addition, the transcriptional 
regulator AmrZ is known to regulate flagellar expression repressing fleQ and inhibiting flagellar-
dependent motility (Tart et al., 2006).  
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Clinical isolates from CF lungs are non-motile due to the high production of mucin secreted in the 
airways of CF patients and the suppression of motility results in enhanced biofilm formation 
(Landry et al., 2006). The molecular reason for the inhibition of motility is that FliD flagellar cap 
protein is attached to the mucin and their interaction interferes with the rotation of the flagellar 
machinery (Arora et al., 1998; Landry et al., 2006). The genetic reason is the mutation in the mucA 
gene present in CF clinical isolates, which reduces flagellar expression and promotes biofilm 
formation (Poschet et al., 2001). The mucA mutation causes a cascade effect (Fig. 6), starting with 
the unadjusted expression of AlgU which triggers the expression of alginate genes and AmrZ (Tart 
et al., 2005). As mentioned before, the transcriptional regulator AmrZ inhibits the flagellar 
expression repressing FleQ (Garrett et al., 1999; Tart et al., 2005, 2006). FleQ represses also pel 
operon expression, thus its inactivation results in more Pel production and consequently more 
biofilm production (Hickman and Harwood, 2008). In latest biofilm stages of maturation, the 
motility is important to permit cell dispersal. Thus, swimming motility is re-activated. Biofilm 
dispersal is associated to the release of a chemical signal, cis-2-decenoic acid (Davies and Marques, 
2009), but its role in activating motility is unknown. 
 
Figure 6. P. aeruginosa biofilm-related motility regulation. Transcriptional regulation is labeled in blue, functional regulation 
labeled in red, and the biofilm matrix products in purple. Modified from (Guttenplan and Kearns, 2013) 
 
AmrZ 
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The rotator movement is provided by the rotor component of the flagellum, while the attachment to 
the membrane of P. aeruginosa is allocated in the static component named stator. The rotor is 
composed by 25 copies of FliG, 34 of FliM, >100 of FliN proteins all arranged in a C-ring structure, 
while the stator proteins Mot-A,B,C,D,Y are associated in two sets to facilitate the flagellar 
movement (Fig. 7). 
The flagellum is also highly immunogenic, due to the flagellin which causes the release of 
cytokines and neutrophils in the infection site (Hayashi et al., 2001; Smith et al., 2003). 
Interestingly, CF clinical isolates show the absence of appendages during chronic infection, 
suggesting a strategy to escape from immune system response (Wolfgang et al., 2004). 
The inverse relation biofilm-flagellar motility rely also in the repression of flagellar genes during 
the last stages of biofilm maturation (O’Toole and Kolter, 1998; Sauer et al., 2002; Wolfgang et al., 
2004) 
Considering the important role of flagella and pili in P. aeruginosa virulence, they are studied as 
main components of new vaccines in burned mouse model (Korpi et al., 2016) and in the recent era 
of increased drug resistance for the majority pathogenic human bugs, including P. aeruginosa, the 
immunotherapy’s field is representing a valid alternative to antibiotics to prevent and fight bacterial 
infection. 
 
Figure 7. Flagellar structure. Simplified diagram showing the main components of the flagellum of Gram negative (left side) 
bacteria: the basal body, hook, and flagellar filament. The motor is composed of the stator (MotA and MotB proteins) and the rotor 
(C ring, composed of FliG, FliM, and FliN).. Modified from (Belas, 2014) 
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2.3.2 Swarming and twitching motility regulation 
As previously described, swarming in P. aeruginosa requires a complete flagellum and twitching is 
a type IV pili-dependent movement. Interestingly, the presence of type IV pili has been described as 
important for swarming motility in P. aeruginosa PAO1 strain (Kohler et al., 2000), in addition to 
rhamnolipids (RLs) and 3-(3-hydroxyalkanoyloxy) alkanoic acids (HAAs), which act as wetting 
agents and chemotactic-like stimuli (Caiazza et al., 2007; Tremblay et al., 2007). 
P. aeruginosa can synthesize maximum two flagella, thus the retractable type IV pili could provide 
and additional feature in viscous surface propagation. 
Swarming motility is characterized by a fast migration of bacteria and occurs in presence of viscous 
surface and in laboratory condition is generally used a range of 0.5-0.8% of agar concentration.  
Several genes connected to P. aeruginosa virulence are differentially expressed in swarming 
condition, including type III secretion system genes, protease and iron transport (Wang et al., 2014). 
Furthermore, swarming cells have been described as more resistant to some antibiotics, as 
gentamicin, polymyxin B and ciprofloxin compared to strains with a planktonic lifestyle 
(Gooderham et al., 2008).  
The presence of rhamnolipids is a clear evidence of the involvement of cell to cell signaling in 
swarming motility regulation. In particular, mutant in rhl system are unable to swarm since 
deficient in flagellum production, pilus assembly and rhamnolipid production. Moreover, the 
production of rhamnolipids is also reduced in the lasI and lasR mutants, which if mutated show a 
delayed swarming behavior (Shrout et al., 2006).  
Several roles have been attributed to rhamnolipids in Pseudomonas genus (Soberón-Chávez et al., 
2005). Beside the main role of these biosurfactants in solubilizing and promoting the uptake of 
hydrophobic substrates, P. aeruginosa produces rhamnolipids as toxic compounds against both 
Gram positives and Gram negatives microorganism to prevail in niche colonization (El-Sheshtawy 
and Doheim, 2014). In addition, the production of rhamnolipids in swarming motility has been 
shown to contribute to the correct shaping of biofilm development (Lequette and Greenberg, 2005).  
Due to their pleiotropic role in P. aeruginosa pathogenicity, as hemolytic, phospholipidic and 
immunogenic activity, rhamnolipids are considered secreted virulence factor (Reis et al., 2011), 
however the biological meaning in vivo has not been fully understood. 
Twitching motility occurs on solid or with moderate viscosity surface, equivalent to a media with 
1% agar. Retraction and rotating movement given by TFP, allow to bacterial cells a fast migration 
along a surface from the initial point of adhesion. This movement impact on cells disposition in 
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biofilm differentiation, and help cells to escape when necessary during host colonization (Alarcon et 
al., 2009). The regulation of twitching motility is basically associated to the expression of pilin 
subunit, PilA, controlled by the sigma factor RpoN (σ54) and the two component system PilR-PilS 
(Mikkelsen et al., 2011b; Strom and Lory, 1993). The autophosphorylation of the sensor kinase PilS 
and the subsequent phosphorylation of its response regulator PilR, trigger the PilA expression 
which is sensed as a signal from PilS in the inner membrane in a feed-forward manner (Giltner et 
al., 2011). 
A minor pilin operon, controlled by AlgR-FimS system and the alternative sigma factor AlgU 
(σ22/AlgT), has been described as an indirect regulator of twitching motility controlling the 
expression of lectin LecB, which triggers the PilJ expression, important for pilus biogenesis 
(Nguyen et al., 2015a, 2015b).  
 
2.3.3. Lipopolysaccharide 
Lipopolysaccharide is one of the main components of the virulence factors arsenal in P. aeruginosa. 
It is composed by a glycolipid matrix and three different regions: LipidA, anchored to the 
membrane, the oligosaccharide core divided into the inner and outer core, and the highly variable 
O-specific polysaccharide region (named also O- antigen) (King et al., 2009). 
Lipid A backbone is composed by diglucosamine biphosphate anchored to the bacterial membrane 
by O- and N-linked primary and secondary fatty acids. Lipid A induces endocytotoxicity in the host 
but the inflammatory response induced by lipid A of P. aeruginosa is less than other enterobacteria. 
This is probably the reason why clinical isolates from CF patients present mutated form of lipid A 
in particular in acyl chains composition. These changes result in more severe inflammatory 
response to lipid A, contributing to increase the lung damage. Furthermore, modifications in lipid A 
are associated also to environmental changes, conferring more resistance to antibiotics treatment 
and immune system (Lam et al., 2011; Maeshima and Fernandez, 2013). 
Bound to the lipid A there is the inner-core structure which contains two D-manno-oct-2-ulosonic 
acid residues and two L-glycero-D-manno-heptose residues. The outer core of the P. aeruginosa 
LPS is usually present in 2 different isoforms or glycoforms and the glycoform 2 is the structure to 
which the O-antigen is attached (Bystrova et al., 2003).  
The O-polysaccharide region is the hydrophilic and immunogenic portion of LPS characterized by 
polysaccharide repeated units that protrude from the core to the exterior of the bacterial surface. The 
O-antigen portion confers the serogroup specificity of P. aeruginosa and is recognized by the innate 
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immune response by antibodies specific for each variants of the O-antigen. There are at least 11 O- 
antigen structural variants (Pier, 2007) with minor differences among related structures in properties 
such as side-group substituents, linkages between sugars or conformations of different 
monosaccharide. The sugar composition of P. aeruginosa O-side chains is strain dependent and in 
P. aeruginosa is basically composed by rhamnose (Bystrova et al., 2006; Knirel et al., 2006). 
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2.4 Quorum sensing 
Multiple virulence factors and pathogenesis traits in P. aeruginosa are regulated by cell to cell 
signaling mechanism known as quorum sensing (QS). It is a widespread communication network 
based on sensing and exchanging of small signal molecules which provide information about the 
entire dynamic of population in that particular timeframe and environment. The concentration of the 
signal molecule is cell density-dependent and only when a certain threshold is reached the signal 
molecule binds and activates a cognate receptor (Papenfort and Bassler, 2016) . 
Currently, three inter-linked QS systems have been characterized in P. aeruginosa: las, rhl and pqs 
(Papenfort and Bassler, 2016; Rampioni et al., 2016). A fourth molecule, IQS, was recently 
proposed to work as and additional communication system active during phosphate limiting 
conditions (Lee et al., 2013; Papenfort and Bassler, 2016). In contrast, however, other works 
suggested that IQS is aeruginaldehyde, a byproduct produced during pyochelin siderophore 
biosynthesis both in P. aeruginosa and P. fluorescens, rather than a bona fide QS system (Murcia et 
al., 2015; Ye et al., 2014).   
The las and rhl systems are based on N-acylhomoserine lactones, while pqs employs 2-alkyl-4-
quinolones (AQs) as QS signal molecules. Briefly, as schematized in Fig.8, the las system produces 
by LasI synthase the N-3-oxo-dodecanoyl-homoserin lactone (3-oxo-C12-HSL) signal molecule 
(Lee and Zhang, 2015; Smith and Iglewski, 2003). When the cell density increases and 3-oxo-C12 
reaches the critical threshold, it binds to the transcriptional regulator LasR, encoded by lasR gene. 
The 3-oxo-C12-HSL–LasR complex binds to the promoter regions of multiple genes, activating or 
repressing their transcription. Among the genes upregulated there is lasI, to increase the production 
of 3-oxo-C12-HSL with an auto-induction effect, and rhlR, which increases the production of the 
rhl response regulator RhlR, activating the second QS system (de Kievit et al., 2002).   
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Figure 8. Las and rhl inter-linked QS systems. The activation of las system by 3-oxo-C12 triggers the 
expression of the transcriptional regulator RhlR involved in the activation of rhl QS system. Genes controlled 
by each Qs system are listed on the left side.  Modified from (Jimenez et al., 2012). 
The transcriptional unit for the third QS system pqs is composed by the pqsABCDE-phnAB operon 
and the pqsR gene. The pqsABCDE-phnAB operon synthesizes proteins (or enzymes) involved in 
the synthesis of the first signal molecule 2-heptyl-4-quinolone (HHQ), precursor of 2-heptyl-3-
hydroxy-4-quinolone (also known as Pseudomonas Quinolone Signal, PQS), and 2-heptyl-4-
hydroxyquinoline-N-oxide (HQNO).  
The first four genes of pqsABCDE operon are involved only in signal molecules production, while 
pqsE is known to be an important effector involved in P. aeruginosa virulence (Deziel et al., 2004).  
The pqs system is the most complex P. aeruginosa QS system and the physiological role of its 
component has been recently addressed (Rampioni et al., 2016). As summarized in Fig. 9, both 
HHQ and PQS binds to and activates the PqsR transcriptional regulator; indeed, the PqsR-
HHQ/PQS complex promotes the expression of pqsABCDE modulating the activity of pqsA 
promoter, thus increasing HHQ and PqsE levels. HHQ is involved only in PqsR-dependent PpqsA 
regulation, while the authors show that PQS exerts its regulatory role also in a PqsR-independent 
manner affecting the transcriptional levels of genes coding for virulence factors such as pyoverdine, 
ExoS toxin and AprX protease. In addition, PqsR-independent PQS regulation is linked to its iron 
chelator activity involved in iron starvation response and PQS may work as an ion-trap (Diggle et 
al., 2007). However, the regulation of PQS on PpqsA not dependent to PqsR is unrelated to iron 
starvation response but inhibited in high-iron concentration.  
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Notably, PqsE down-regulates PpqsA activity, AQs production and the expression of genes 
involved in denitrification and T6SS. Conversely, PqsE upregulates genes involved in biofilm 
formation, virulence factors production and antibiotic resistance. 
HQNO, synthesized by the contribution of other two genes pqsH and pqsL, does not affect the P. 
aeruginosa transcriptome, and its role seems to be linked to environmental competition due to its 
cytochrome inhibitory activity.  
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3. Biofilm in bacteria 
Biofilms have been defined as microbial communities, aggregated and embedded in a self-produced 
extracellular matrix. The matrix is basically composed by exopolysaccharide polymers which allow 
cell to cell contact and the attachment to a surface. The term “aggregate” refers to groups of bacteria 
adherent to each other and disposed in layers which compose the complex architecture of mature 
biofilms (Hall-Stoodley et al., 2004). 
Biofilm formation relies on both social and physical organization into bacterial communities and it 
represents without any doubt the most spread and coordinated microbial lifestyle in nature 
(Vlamakis et al., 2013). Interestingly, despite biofilm grown in lab condition are characterized by a 
single microbial species, natural biofilms present polymicrobial communities organized in stable 
bacterial consortia (Flemming et al., 2007; Vlamakis et al., 2013). The spatial distribution of the 
species in biofilm is also driven by oxygen concentration, with decrease from the external structure 
into the biofilm center until is completely depleted. Thus, microorganisms with aerobic metabolism 
are located in the upper layers of the biofilm, while anaerobic bacteria find favorable niches deeply 
in the biofilm (Schramm et al., 1996). 
In addition, biofilms drive a number of biogeochemical processes in different environments, as soil 
and water, earning an important position in biotechnological applications, as the production of fine 
chemicals and the degradation of wastewater and solid waste (McDougald et al., 2011). However, 
biofilm developed on abiotic surface, as medical devices or implants, leads the propagation of 
bacterial infection in humans contributing to the outbreak of resistant bacteria in nosocomial 
environments.  
Biofilm formation is a vantage for the bacteria population in terms of resistance to antibiotic 
treatment and environmental stress (Stewart, 2014) and a common mechanism that occurs in 
biofilm is the acquisition of resistance genes by horizontal transfer, which is facilitated by the high 
cell density and mobile genetic elements into the matrix (Mah, 2012). The horizontal transfer take 
place in several ways, for example by plasmid conjugation, as the case of P. putida and Escherichia 
coli (Van Meervenne et al., 2014), or using type IV secretion system as occur in Vibrio cholerae 
biofilm (Borgeaud et al., 2015). 
In addition, in biofilm structures, bacteria develop complex interaction between individual cells, 
providing a coordinate strategy to survive in disadvantageous conditions, for example nutrients 
limitation, in oxygen-limiting conditions or low pH (Rinaudi and Giordano, 2010). Thus, several 
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environmental and intracellular signals are important for biofilm development, as well as 
transcriptional and post-transcriptional regulators. 
For example, products of primary and secondary metabolism function are considered intracellular 
signals, as in the case of indole, which if accumulated into the cells promotes biofilm formation in a 
number of microorganism, as E.coli, Klebsiella oxytoca, Providencia stuartii, Citrobacter koseri, 
Morganella morganii, and Haemophilus influenzae (Hu et al., 2010).  
Oxygen is one of the most described environmental cues that influence cellular adhesion and 
biofilm formation. In oxygen-starvation P. aeruginosa produces more biofilm, with increased 
antibiotic tolerance and alginate biosynthesis (Schobert and Tielen, 2010). However, E. coli 
adherence is reduced in a microaerophilic environment (Landini and Zehnder, 2002).  
Iron is another essential nutrient for bacteria but difficult to trace since most of the iron in the 
environment is stable in inorganic complexes or tightly bound to siderophores (Miethke and 
Marahiel, 2007). The effect of iron as environmental cue on biofilm formation varies in different 
bacteria. In P. aeruginosa, for example, high concentrations of iron induce expression of adhesion 
factors, while poor iron in the environment inhibit biofilm formation process (Bollinger et al., 2001) 
and this is also the case of V. cholerae biofilm formation which is reduced upon iron-limiting 
conditions (Mey et al., 2005). 
Temperature is another crucial signal, especially for pathogens or commensal bacteria, since the 
host-colonization relies on temperature switches, usually from lower to higher temperature. 
Concerning E. coli, temperatures higher than 32°C, typical of the host, inhibit the synthesis of curli 
adhesins (Olsèn et al., 1993), however at the same temperature, curli are stimulated in pathogenic 
enteroinvasive (EIEC) or enteroemorragic (EHEC) strains of E. coli (Cookson et al., 2002). A 
number of regulators are also employed in biofilm development and sigma factors represent one of 
the most common classes. They direct RNA polymerase to specific DNA sequences in gene 
promoter regions, thus allowing correct transcription initiation. RpoS (σS) is the key regulator of 
general stress response and, in E. coli, it also affects the expression of genes involved in biofilm 
formation such as curli fibres and cellulose (Gerstel et al., 2003), and genes connected to the 
biosynthesis of the signal molecule c-di-GMP, which mediates the transition from planktonic to 
sessile communities (Sommerfeldt et al., 2009). In P. aeruginosa, the RpoS expression is related to 
quorum-sensing system. During biofilm formation, expression of RpoS is repressed and rpoS-
deficient mutants form biofilm better than wild type cells (Whiteley et al., 2000).  
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Concerning biofilm post-transcriptional regulation, small noncoding RNAs (sRNAs) are the major 
players. A sRNA can bind and regulate a multitude of target mRNAs and mechanism of action is 
discussed in details in section 4.1 of this thesis. One example of sRNA involved in biofilm 
regulation is MtvR, discovered in the highly epidemic clinical isolates Burkholderia cenocepacia 
J2315, E.coli and P. aeruginosa. MtvR is involved in a number of phenotypes, typical of global 
regulators, related to growth and survival after several stresses, swimming and swarming motility, 
resistance to antibiotics but in particular biofilm formation (Ramos et al., 2014).  
Furthermore, there are sRNAs which modulate the production of other global regulators; for 
example, the DsrA sRNA regulates RpoS and H-NS (heath-stable nucleoid-structuring protein) 
expression, promoting the production of the former and inhibiting the synthesis of the latter (Lease 
and Belfort, 2000), lately affecting biofilm development in E. coli.  
Another interesting group is characterized by sRNAs that bind proteins. The best-studied example 
in E. coli is CsrB, a sRNA that interacts and modulates the activity of the post-transcriptional global 
regulator CsrA. CsrA is a small protein of 61 amino acids that binds to mRNAs and regulates their 
stability and translation. Although it is commonly a repressor, CsrA is a positive regulator of 
flagella biosynthesis (Wei et al., 2001) while it represses c-di-GMP synthesis and 
exopolysaccharide poly-N-acetylglucosamine (PNAG) production, playing a negative role in 
biofilm formation (Jonas et al., 2008; Wang et al., 2005). 
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4. P. aeruginosa biofilm 
P. aeruginosa is considered a model organism to study Gram negative biofilms. This human 
pathogen can form biofilm on biotic and abiotic surface such as the mucus plugs of the CF lung, 
catheters and contact lenses, increasing the severity of infections which result in increased difficulty 
to eradicate the bacterium. 
P. aeruginosa biofilm matrix is composed mainly by EPS, proteins and extracellular DNA (eDNA), 
holding the bacterial cells together and shaping the tridimensional structure necessary for nutrients 
exchanging, protection and resistance (Ghafoor et al., 2011).  
There are several examples about the role of P. aeruginosa biofilm in infectious disease, and these 
include cystic fibrosis pneumonia, chronic wound infections and chronic otitis media. Concerning 
cystic fibrosis, the presence of biofilm in the lung is considered a clear sign of P. aeruginosa 
chronic infection. The characteristic of this biofilm is the presence of polymorphonuclear 
leukocytes (PMNs) surrounding the biofilm structures which causes a constant inflammatory state, 
a massive immune response and tissue damage, ultimately resulting in respiratory failure. However, 
antibiotic treatment and immune response are not enough to disrupt biofilm formations in the CF 
lung. In addition, activated PMNs and hydrogen peroxide contribute to induce mutation in the P. 
aeruginosa genome, in particular in mucA gene causing the conversion in mucoid phenotype and 
the overproduction of alginate is an advantage for the entire population since it protects bacteria 
from phagocytosis and clearance from the lung (Boucher et al., 1997; Mulchay et al., 2014).  
Interestingly, biofilms of chronic wound infections and otitis media are also characterized by an 
excess of PMNs which causes an extreme immune-inflammatory response and tissue damage, but if 
the infection is eradicated and biofilm removed, tissue recovery is possible.  
 
4.1 Biofilm development  
Two models of biofilms development have been described in P. aeruginosa (Fig. 10). The first type 
is based on precise stages and describes the planktonic state in vitro and the initial phases of CF 
lung colonization by P. aeruginosa (Fig. 10A). When the infection switches from acute to chronic, 
and the CF airways are covered by a thick layer of mucus, the biofilm model 2 (Fig. 10B) 
predominates on model 1 (Hall-Stoodley et al., 2004; Lau et al., 2005). 
Based on the first model, the biofilm development in P. aeruginosa follows three main stages which 
are common to other Gram negative bacteria: i) attachment, ii) maturation, iii) dispersion. 
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Figure 10. Models of biofilm formation. A) Biofilm model 1 describing the P. aeruginosa planktonic state B) Biofilm model 2 
occurring in P. aeruginosa chronic infection in CF airways. Modified from (Lau et al., 2005). 
 
In the first step, cells are attached to the surface with a reversible adhesion by Van der Waals 
interactions and are controlled by physiochemical properties as hydrophobicity and electrical charge 
(Hall-Stoodley et al., 2004; Landini et al., 2010; Sauer et al., 2002; Stewart, 2014).  
The initial attachment is followed by population growth and the subpopulations which are 
irreversible attached to the surface start to form the substrate for microcolonies (Stewart, 2014; 
Zhao et al., 2013). Specific genetic programs are now activated and stronger cell-cell interactions 
allow the three-dimensional structures formation, commonly named as “mushrooms”. The surface 
of these structures is composed by bacteria which move using twitching motility, and at this stage 
the differentiation from early biofilm to mature biofilm is determined by the EPS production which 
surrounds the bacterial colonies. In the last stages of biofilm the variety of thickness of the 
tridimensional structures is important to generate specific physiochemical conditions pivotal for the 
survival of the all microbial communities (Hall-Stoodley et al., 2004).  
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In the last step of biofilm life-cycle, a fragmentation of the structure occurs, mainly due to 
environmental changes as accumulation of oxygen, nitrogen reactive species, and loss of nutrients 
(Gjermansen et al., 2010; Sauer et al., 2004). Bacterial dispersal represents and effective way to 
escape from a disadvantageous situation in the host and it relies on the production of enzymes to 
degrade the EPS matrix (Abee et al., 2011; Nijland et al., 2010).  
In biofilm model 2, which describe the cystic fibrosis (CF) airways infected by P. aeruginosa, the 
bacterial cells are embedded in a layer of thickened mucus and rarely come into indirect contact 
with epithelial surface. Bacteria lose flagella and pili, and convert to a mucoidy phenotype with a 
massive production of alginate, forming biofilm macrocolonies. Biofilm structures and thick mucus 
determine a strong protection for P. aeruginosa from clearance by neutrophils and macrophages, 
allowing the establishment of chronic infections (Hassett et al., 2003; Lau et al., 2005). 
 
4.2 Biofilm composition 
Bacteria with a planktonic lifestyle and able to form biofilm, present peculiar traits in gene 
expression and morphology, completely different from motile bacteria (Landini et al., 2010) and as 
well as in other Gram negative bacteria, fundamental is the role played by the self-produced EPS 
matrix which represent the major component (from 50 to 90%) of the biofilm biomass compared to 
microbial cell density. 
The EPS components present intermolecular interactions, which determine also the physiology of 
the population in the biofilm. Moreover, EPS fill the spaces without cells in biofilm resulting in 
more stable structure (Flemming et al., 2007; Ryder et al., 2007).  
P. aeruginosa produces at least three exopolysaccharides: alginate, Psl and Pel, each of them plays 
an important role in biofilm shaping and stability. P. aeruginosa PAO1 strain produces both Pel and 
Psl, while PA14 synthesizes only Pel (Friedman and Kolter, 2004a, 2004b).  
Alginate, which is overproduced by clinical isolates in CF patients, is a linear polyanionic 
exopolysaccharide composed by uronic acids. Alginate production requires a number of enzymes 
and precursor substrates with a fine control on its production. Its production involves 11 operons 
and the algC gene that is located elsewhere in the genome (Gacesa, 1998; Ramsey and Wozniak, 
2005). The coordinated expression of these genes is due to several transcriptional regulators, 
including AlgR, Vfr, AlgB, AlgP (Hp-1), IHF, CysB and AmrZ (Baynham et al., 1999; Leech et al., 
2008; Pritchett et al., 2015; Whitchurch et al., 2005; Wozniak and Ohman, 1994) whose expression 
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is controlled by the alternative sigma factor AlgU which also directs the transcription of the alginate 
biosynthesis operon (Damron and Goldberg, 2012; Jones et al., 2010; Wozniak and Ohman, 1994).  
Although alginate is considered the main component of P. aeruginosa biofilm, the presence of the 
two others important EPS, Pel and Psl, allows to non-mucoid strains lacking alginate biosynthesis 
machinery to form biofilm (Mann and Wozniak, 2012; Wozniak et al., 2003). Pel is a glucose-rich 
polymer synthesized by the pelA-G operon (Jennings et al., 2015) essential for the formation of a 
pellicle at the air-liquid interface and recently it has been described as important for P. aeruginosa 
PA14 biofilm scaffold, in particular in the early stages of formation (Jennings et al., 2015).  
Psl is a mannose and galactose polymer, produced by pslA-O operon, important for cell-cell 
interaction and for cell-surface adhesion in the first stages of biofilm development. It also 
contributes to maintain the stability in mature biofilms, covering the mushroom surfaces (Ma et al., 
2007; Zhao et al., 2013). Furthermore, Psl acts also as a signal to stimulate biofilm formation and in 
non-mucoid strains is the main component which confers stability and promotes cell-cell interaction 
(Colvin et al., 2012; Ghafoor et al., 2011; Ma et al., 2012; Yang et al., 2011).  
Since Psl is known to promote adhesion and cellular aggregation, recent studies suggests its role in 
promoting immune evasion and effectively antibodies generated against Psl can provide protection 
against P. aeruginosa (DiGiandomenico et al., 2012; Mishra et al., 2012). The role of Pel and Psl in 
biofilm formation is strain specific (Ghafoor et al., 2011), since PAO1 biofilm relies mainly on Psl 
(Yang et al., 2011), while Pel is important for mature biofilm in PA14 (Colvin et al., 2011). 
However Pel and Psl are both required to have a proper biofilm development in PAO1 (Colvin et 
al., 2012).  
Beside the important role of EPS, P. aeruginosa produces extracellular DNA that is an important 
biofilm determinant in several bacterial biofilm, for nutrient diffusion, antibiotic resistance and 
structural stability. Indeed, eDNA interacts with psl fibers forming a web which constitute a 
scaffold for the entire biofilm structure (Wang et al., 2015). Furthermore, eDNA facilitates 
twitching motility by maintaining the right cell alignments (Gloag et al., 2013) 
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4.3. Gene regulation in biofilm formation 
Generally, microorganisms form biofilm in response to several factors including nutritional cues 
and biochemical changes or, in some cases, to sub-inhibitory concentrations of antibiotics. The 
switch from planktonic to sessile lifestyle undergoes genetic rearrangement resulting in specific 
phenotypic expression and requires secondary messengers, transcriptional and post-transcriptional 
regulators (Moradali et al., 2017). 
 
C-di-GMP: The secondary messenger c-di-GMP stimulates the biosynthesis of adhesins and 
exopolysaccharide in biofilm formation, negatively affecting the P. aeruginosa motility. This 
regulation contributes to determine the conversion into sessile phenotype.  
C-di-GMP is synthesized from two molecules of GTP by diguanylate cyclases (DGC) and is 
processed by phosphodiesterases (PDE). The regulatory role of c-di-GMP is exerted by its binding 
to effectors (c-di-GMP receptors) (Hengge, 2009). In P. aeruginosa, at least four c-di-GMP 
effectors are present including FleQ, PelD, Alg44, and PilZ (Boyd and O’Toole, 2012).  
FleQ is a c-di-GMP-binding transcription factor, which generally activates flagella biosynthesis but 
it has been described also as a repressor for the transcription of the pel operon in the absence of c-
di-GMP and an activator when is bound to c-di-GMP (Baraquet et al., 2012; Hickman and 
Harwood, 2008; Matsuyama et al., 2016).  
PilZ is described as a c-di-GMP binding protein and is involved in twitching motility regulating 
type IV pili biogenesis (Alm et al., 1996).  
PelD, which belong to PilZ family protein, contributes to Pel biosynthesis in P. aeruginosa. It is 
also described as a c-di-GMP binding protein and it presumably requires activities of DGCs and 
PDEs as a means to ensure the regulated production of Pel (Baker et al., 2016; Ha and O’Toole, 
2015; Yang et al., 2011). 
Alg44 also belongs to the PilZ family protein and is involved in alginate biosynthesis regulation 
(Remminghorst and Rehm, 2006; Whitney et al., 2015).  
P. aeruginosa PAO1 and PA14 strains produce roughly 40 DCGs and PDEs, to modulate the c-di-
GMP levels in the cell and regulate the EPS production during the biofilm formation (Hickman et 
al., 2005; Kuchma et al., 2007; Kulasakara et al., 2006). There are currently several examples of 
DGC and PDE in regulating motility and biofilm formation affecting the local concentration of the 
secondary messenger c-di-GMP, as the DGCs RoeA and SadC. RoeA is involved in biofilm 
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formation regulating the polysaccharides production, SadC is mainly involved in modulation of 
flagellar motility (Bernier et al., 2011; Merritt et al., 2010). 
 
Two-component systems (TCS): Expression of the pel and psl genes for exopolysaccharide 
production in P. aeruginosa can be also regulated by GacA/GacS two-component system (TCS). 
GacA/GacS TCS is a global signal transduction system highly conserved in Gram-negative bacteria 
(Heeb and Haas, 2001). GacS is a sensing transmembrane protein that can respond to environmental 
signals and activate the cognate response regulator GacA by phosphorylation, as reported in Fig. 11 
(Pernestig et al., 2001; Rich et al., 1994). GacA in turn triggers the expression of two small 
regulatory RNA molecules RsmY/RsmZ, which allow the translation of mRNAs target, as those 
involved in biofilm formation, antagonizing the repressors RsmA/RsmE (Lapouge et al., 2007; 
Valverde et al., 2003). Furthermore, RsmA binds pslA in the region spanning the ribosome binding 
site and forming a secondary structure which prevent the ribosome binding (Irie et al., 2010).  
 
 
Figure 11. Schematic diagram of the two-component system regulation of biofilm formation and virulence in P. aeruginosa.  
Unknown environmental cues received by the input domains of the three membrane-associated sensor kinases (GacS, LadS and 
RetS) activate or repress the expression of genes necessary for acute or chronic infection. Modified from (Jimenez et al., 2012) 
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GacA/GacS activity is in turn inversely controlled by the TCS hybrids RetS and LadS (Sonnleitner 
and Haas, 2011a; Ventre et al., 2006; Wolfgang et al., 2004). RetS negatively regulates rsmYZ 
expression and its inactivation results in higher psl expression levels and hyper attachment, and 
suppression of the type III secretion system (TTSS). On the contrary, LadS positively controls 
sRNA levels, and its mutation results in decreased attachment due to reduced Psl production, and 
elevated TTSS expression. These evidences suggest that LadS may function to balance the RetS 
regulatory effect on genes important for P. aeruginosa acute infection (Heeb and Haas, 2001; 
Jimenez et al., 2012; Ventre et al., 2006). 
Two distinct structurally RsmA homologues, named RsmN/RsmF, if expressed in trans could 
complement an rsmA mutant and the relative phenotypes as swarming and pyocyanin production. 
Furthermore, the deletion of rsmA, rsmN, rsmF, results in a massive biofilm production (Marden et 
al., 2013; Morris et al., 2013).  
 
AlgC: Biofilm formation is also metabolically regulated, as for the example by AlgC, a crucial 
enzyme involved in biosynthesis of sugar precursors for Pel, Psl, alginate and LPS production. 
AlgC is a phosphoglucomutase (PGM) which is required for the synthesis of mannose 1-phosphate 
and glucose 1-phosphate (Coyne et al., 1994; Davies and Geesey, 1995; Olvera et al., 1999). AlgC 
is a checkpoint enzyme since the overproduction of one exopolysaccharide precludes the expression 
of the others in particular environmental conditions. Indeed, the expression of algC is under the 
transcriptional control of the alternative sigma factor AlgU (σ22), homologue of the σE in E. coli, 
which drives and coordinates the stress response (Jones et al., 2010; Yu et al., 1995). Furthermore, 
in P. aeruginosa algC gene is regulated at the post-transcriptional level by the sRNA ErsA, one of 
the main topics of this thesis. Specifically in PAO1, as shown in Ferrara et al., 2015, ErsA directly 
exerts a negative post-transcriptional regulation on algC. Furthermore, since ErsA is also 
transcriptionally regulated by AlgU, it has been proposed an incoherent feed forward loop 
implemented by AlgU for the AlgC regulation.  
 
AmrZ: The ribbon-helix-helix transcription factor AmrZ is part of the AlgU regulon and modulates 
several pathways important for biofilm formation. AmrZ is composed by three segments: the 
flexible N-terminal motif (Baynham et al., 1999), the ribbon-helix-helix domain which is involved 
in the interaction AmrZ-DNA (Pryor et al., 2012), and the C-Terminal domain which is essential for 
efficient AmrZ-mediated activation and repression of targets (Xu et al., 2016).  
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AmrZ functions as both an activator and repressor; in particular it activates transcription of the 
alginate biosynthesis operon and represses flagella-mediated motility, Psl production and c-di-GMP 
synthesis (Baynham et al., 2006; Baynham and Wozniak, 1996; Jones et al., 2014; Ramsey and 
Wozniak, 2005; Tart et al., 2006). Conversely, the absence or lower concentration of AmrZ, as in 
non-mucoid strains, P. aeruginosa develops a Psl-based biofilm, enhances the expression of c-di-
GMP and increases the twitching motility by expressing flagellar proteins (Jones et al., 2014; 
Petrova et al., 2014). Although AmrZ has been described as a pleiotropic regulator of biofilm and 
motility, its direct impact on biofilm has not been elucidated yet.  
 
Quorum sensing: Several works highlighted the role of the three QS systems in motility and 
biofilm formation. Specifically, Davies et al. (Davies et al., 1998) have discussed the role of the las 
system, showing that the deletion of lasI results in a flat biofilm and less resistant to sodium 
dodecyl sulfate compared to P. aeruginosa wild-type. Furthermore LasR binds the promoter region 
of psl operon affecting Psl synthesis (Gilbert et al., 2009). The rhl system is also linked to 
exopolysaccharide production since has been reported to enhancing Pel polysaccharide biosynthesis 
(Sakuragi and Kolter, 2007). It controls swarming and twitching motility (Daniels et al., 2004; 
Patriquin et al., 2008), and is essential for rhamnolipids production (Dusane et al., 2010). All these 
phenotypes are important in microcolonies formation, cell-cell interaction and 3D-shaped biofilm 
development (Pamp and Tolker-Nielsen, 2007; Van Gennip et al., 2009).  
Finally, the cytotoxic virulence factors, lectins LecA and LecB, has been proposed to contribute to 
biofilm development in P. aeruginosa, since LecA and LecB mutants form thin biofilms as 
compared to the wild-type bacteria (Diggle et al., 2006; Tielker et al., 2005). Both LecA and LecB 
expressions are regulated by the rhl QS system (Winzer et al., 2000).  
Concerning the third QS system, pqs, there are evidences of increased biofilm formation in presence 
of exogenous PQS, however the molecular basis of this phenomenon have been not totally 
established (Diggle et al., 2003). 
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5. RNA-based mechanisms of post-transcriptional regulation 
The dynamic and intricate regulatory network which modulates the P. aeruginosa virulence is fine-
tuned regulated at every stage in the processing of genetic information. This strategy is important to 
respond quickly and accurately to environmental cues, avoiding high energy waste which could 
affect the whole population fitness, resulting in adaptation. The adaptation process frequently 
affects the proteome profile and this mechanism is controlled by the transcriptional regulation, 
which ultimately leads to the production of different subsets of proteins, and it is enriched by post-
transcriptional regulation (Romeo et al., 2013). 
Post-transcriptional regulators are in general designated to modulate RNA decay, translation 
initiation efficiency or transcript elongation. In bacteria, these regulators include sRNAs and RNA-
binding proteins (RBPs). Other RNA regulatory elements found in bacteria include riboswitches 
encoded in untranslated regions (UTRs) of mRNAs and CRISPR elements (Breaker, 2011; 
Karginov and Hannon, 2010).  
CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) and Cas (CRISPR associated 
genes) systems, for example, exist in bacteria and archaea to provide protection from invading 
viruses and mobile elements. Specifically, CRISPR-Cas9 uses RNA-guided nucleases to cleave 
foreign genetic elements. There are three types of CRISPR-Cas systems but the main characterized 
is type II. It consists of the nuclease Cas9, which processes the CRISPR transcript in CRISPR RNA 
(crRNA). The crRNA use sequences of complementarity to guide the nuclease Cas to target DNA 
for degradation, currently used in biotechnology applications (Garneau et al., 2010; Gasiunas et al., 
2012). Interestingly, it was also revealed a role for a Cas9-based typeII CRISPR-Cas system as a 
post-transcriptional regulator (reviewed in (Sampson and Weiss, 2014) and there are example of 
CRISPR-Cas system, as Type I-F in P. aeruginosa PA14, involved in host-defence targeting 
bacterial endogenous genes. Type I-F CRISPR-Cas system degrades mRNA of the QS 
regulator LasR, thus allowing the bacteria evasion and host pro-inflammatory response (Li et al., 
2016). 
Recently, in addition to these post-transcriptional mechanisms, the specific alteration of ribosome 
function has been discovered as a novel post-transcriptional regulatory element, not completely 
explored yet (Little et al., 2016). Several ribosomal proteins are subject of modification as 
methylation and acetylation or changes in number of C-terminal amino acid residues. Although the 
physiological meaning of the ribosomal post-transcriptional modification is still unknown, it has 
 43 
 
been suggested a role in ribosomal specialization which would result in altered ribosome-mRNA 
binding or in translational efficiency, ultimately resulting in a changed protein profile (Nesterchuk 
et al., 2011). 
  
5.1 Regulation by non-coding small RNAs 
RNA-mediated regulation has been described in all kingdoms of life. In eukaryotes, microRNAs 
(miRNAs) or small interfering RNAs (siRNA) are a large class of very short (21-25 nt) non-coding 
RNAs that affect translation and degradation of target mRNAs by antisense base pairing and may 
fine-tune the expression of about 30% of all mammalian protein-encoding genes (Wahid et al., 
2010). MicroRNA genes are transcribed by RNA polymerase II as large primary transcripts (pri-
microRNA) and processed by a protein complex containing the RNase III enzyme (Drosha), in a 
shorter fragment named precursor microRNA (pre-microRNA). This precursor is subsequently 
transported to the cytoplasm where it is processed by a second RNase III enzyme, DICER, to form a 
mature microRNA of approximately 22 nucleotides. Mature microRNAs are assembled into 
ribonucleoprotein complexes known as RNA-induced silencing complex (RISC) which can 
modulate stability and/or translation of multiple target mRNAs. RISCs are composed of a variety of 
proteins such as RNA-binding proteins, RNA helicases, and nucleases (Hesse and Arenz, 2014; Lee 
et al., 2002; Shukla et al., 2011).  
The first miRNA was discovered in C. elegans in 1993 and reported in mammalian systems in 
2001. Nowadays, miRNAs are known to be pivotal regulators of processes such as cell cycle 
control, apoptosis and several developmental and physiological processes including stem cell 
differentiation, hematopoiesis, hypoxia, cardiac and skeletal muscle development, neurogenesis, 
insulin secretion, cholesterol metabolism, aging, immune responses and viral replication. In 
addition since their role in several disease, as cancers, heart and neurological disease, they are 
intensely studied as candidates for diagnostic and prognostic biomarkers and predictors of drug 
response (Hesse and Arenz, 2014; MacFarlane and Murphy, 2010). 
Bacterial sRNAs are typically defined as non-coding RNA molecules (50-500 nt), either generated 
through processing or synthesized as primary transcripts, which act as regulators that can affect 
translation initiation, transcription termination or stability of one or more target mRNAs. Although 
sRNAs are non-coding, there are some example of sRNAs that can encode for polypeptides and 
concomitantly act as riboregulators, as S. aureus RNAIII and E. coli SgrS which produce the δ-
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haemolysin and the SgrT protein, respectively (Janzon et al., 1989; Wadler and Vanderpool, 2007). 
In pathogenic bacteria, as P. aeruginosa, sRNAs are involved in regulation of virulence gene 
expression (Heurlier et al., 2004; Kay et al., 2006; Oglesby et al., 2008). 
The sRNA regulation takes place after the binding with complete or incomplete complementarity to 
the target mRNA. In addition, sRNAs can modulate protein activity, in some cases by mimicking 
other nucleic acids.  
Bacteria take advantage in using sRNAs-mediated regulation in term of reduced metabolic cost, 
multiple interconnected levels of regulation, faster regulation and unique regulatory properties 
(reviewed in (Beisel and Storz, 2010)). Furthermore the coupled transcriptional and post-
transcriptional regulation has been shown to increase the dynamics of gene expression, avoiding the 
loss of genetic information (Beisel and Storz, 2011).  
Depending on target interaction and regulation, sRNAs can be divided in two classes: i) cis-encoded 
antisense sRNAs, synthesized from the strand complementary to the mRNA target and ii) trans-
encoded antisense sRNAs, synthesized from a different genomic location respect to the mRNA 
target. The cis and trans acting sRNA regulate mRNAs with different mechanisms summarized in 
Fig. 12, as: i) blocking translation occluding the ribosome-binding site (RBS) in the 5′ untranslated 
region of target mRNAs, ii) recruiting the RNase E in order to degrade the mRNA after base-
pairing with sRNA, iii) generate the sRNA/Hfq/RNase E complex that favors RNase E attacks; this 
complex then becomes a specialized RNA decay machine, iv) binding in the 5′-UTR the inhibitory 
sequence of RBS that becomes available, allowing initiation of translation. 
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Figure 12. Small RNA-based regulatory mechanisms of mRNA expression. Inhibition of translation: (a) sRNA blocks translation of 
mRNA binding and occluding the ribosome binding site (RBS) of target mRNA. (b) sRNA occludes the RBS leading the exposition 
of the target to degradation by RNaseE. C) sRNA, Hfq and RNaseE form a complex to actively degrade the mRNA.  
Activation of translation: (d) The RBS region of mRNA is embedded in a secondary structure inhibiting the translation. The sRNA 
binding allows the opening of the structure to be available for translation. Modified from (Lalaouna et al., 2013). 
 
The majority of cis-encoded RNAs have been discovered in plasmids, phages and transposons 
(Brantl, 2002, 2007). They act as regulators base pairing with complete complementarity to the 
target mRNA and are involved in replication initiation, conjugation efficiency, suicide, 
transposition, mRNA degradation and translation initiation. Cis-RNAs encoded from plasmid and 
expressed constitutively, modulate the regulation of replication, conjugation or segregational 
stability. By contrast, chromosomally encoded antisense RNAs are expressed only under certain 
conditions, as in stationary phase (e.g. GadY (Opdyke et al., 2004) (Opdyke et al., 2004)) or under 
iron stress (e.g. IsrR (Dühring et al., 2006)).  
A widespread cis-acting RNA element in mRNAs regulation is the metabolite-sensing riboswitch, a 
portion of RNA which changes the secondary structure in response to environmental stimuli. This 
conformational arrangement modulates the expression of the coding sequence (Breaker, 2011; 
Smith et al., 2010). Typically, the riboswitch feedback regulates the associated genes, which are 
typically involved in the uptake or metabolism of the sensed metabolite (Dambach and Winkler, 
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2009; Grundy and Henkin, 2006). According to sequence and structure conservation, riboswitches 
seem underrepresented in Gram-negative pathogens but may regulate almost 2% of the genes in 
Gram-positive bacteria such as S. aureus and Listeria monocytogenes (Nudler and Mironov, 2004; 
Waters and Storz, 2009). Another major class of cis-acting regulatory RNAs is represented by 
RNA-thermosensors. In contrast to highly specific metabolite-binding riboswitches, they respond to 
a fairly global physical signal, i.e. the intracellular temperature. These RNA thermometers are 
usually characterized by irregular stem-loop structures (ROSE, FourU motifs) that sequester the 
Shine-Dalgarno (SD) region of the mRNA target (Narberhaus et al., 2006). At low temperature 
(below 30°C), these hairpins are typically stable and, hence, the ribosome binding site (RBS) is not 
accessible for translation. Increasing temperature melts the stem-loop structure to promote 
translation (Altuvia et al., 1987, 1989, 1991) 
The most studied trans-encoded sRNAs regulate the target with partially complementarity and 
usually, in Gram negative bacteria, they require a RNA-binding protein as Hfq for the mRNA 
interaction (Waters and Storz, 2009). The binding of Hfq can affect the structure of sRNA and 
target mRNAs or can modulate the local concentration of the two RNAs to facilitate the interaction. 
Furthermore Hfq protects many sRNAs from degradation, most likely by binding to RNase E 
cleavage sites within these sRNAs (Ramos et al., 2014; Soper et al., 2010). 
The interaction trans-RNA/mRNA can occur in the surroundings of the ribosome binding site 
(RBS) on the target sequence, causing a competition with the ribosome that interferes with the 
translation. However, this mode of regulation has been reconsidered, since a number of trans-RNAs 
affect the translatability of their targets binding a region not including the RBS, or modifying the 
secondary structure and changing the mRNA stability (Liu and Camilli, 2010; Storz et al., 2011).  
RNA-binding proteins play also a crucial role in post-transcriptional regulation. Some of these 
proteins and their mechanism of action are well described, as for CsrA and Hfq mentioned before. 
The presence of RBPs was reported in E. coli first, more than 20 years ago (Mu Ya Liu et al., 1995; 
Muffler et al., 1996). Recently, several studies increased the panel of information, in particular on 
the mechanism of action. Specifically, bacterial RBPs bind RNA molecules and regulate translation 
initiation, stability of their target, using mechanisms as: i) modifying the target RNAs in order to be 
more susceptible to RNases, ii) changing the accessibility of the RBS of mRNA targets and 
interfering with the ribosome binding, iii) acting as a chaperone for the interaction of the RNA 
target with other effector molecules, and iv) modulating the transcription terminator/antiterminator 
structure formation (Van Assche et al., 2015). 
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5.2 Genome-wide methodologies for investigating sRNAs regulation 
Deciphering the sRNA–target interactome is a complicate but crucial step to understanding the 
biological role of a sRNA. Computational analyses are useful to generate a list of putative target 
mRNAs, basing the prediction of sRNA-mRNA interaction on several algorithms to calculate a 
hybridization score. However, bioinformatics tools may generate biased information, and since they 
mainly focused on translational starting site, sequences in the surroundings important for the 
interaction with the sRNA could be missed. For this reason, bioinformatics data need experimental 
in vitro and in vivo validations. These combined approaches provided new insights in the 
knowledge about sRNA physiological meaning in a number of different strains (Backofen and Hess, 
2010; Pichon and Felden, 2008; Sharma and Vogel, 2009; Storz et al., 2011). 
In addition, a number of high-throughput techniques have been recently introduced to expand the 
possibilities to identify important mechanisms of sRNAs translational regulation with a more 
detailed resolution. The most recent genome-wide methodologies with a short description are 
shown in Fig. 13. 
 
 
Figure 13. Emerging genome-wide methodologies. Overview of the new technologies developed to study mechanisms of 
translational regulation. Modified from (Grenga et al., 2017) 
However, sRNAs can also change the transcriptome profile, for example in response to particular 
environmental conditions or stress response, or can modulate transcript abundance regulating the 
degradation machinery. Therefore, the experimental approaches have included also studies of 
sRNA-dependent changes in gene expression (by expression microarrays, deep sequencing, or 
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comparative protein analyses), global searches for mRNAs that bind to a particular sRNA-regulated 
protein, and genetic screens for changes in reporter gene expression or altered growth phenotypes. 
Furthermore, sRNA-mRNA interaction is also influenced by the RNA secondary structure which 
could be affected by several factors (Meyer, 2017). Thus, the plasticity of sRNA regulatory 
networks which confers both versatility and efficiency, requires a multi-omics approach, integrating 
in silico analyses, proteomic and transcriptomic approaches in a comprehensive models for bacterial 
adaptation to external challenges. An example of this combined approaches has been published in 
2013, and is based on the comparison of relative changes in total mRNA with translational changes 
(polysome fractions) and protein abundance to provide a comprehensive study of bacterial stress 
responses in Rhodobacter sphaeroides (Berghoff et al., 2013). 
 
5.3 Small RNAs in P. aeruginosa virulence 
Pseudomonas aeruginosa is one such example where sRNAs have been identified as critical 
elements of cellular adaptation and virulence. However, among the roughly 200 sRNAs discovered 
in P. aeruginosa in the past years with several high-throughput techniques, only for a few of them 
there are informations available about the physiological roles (Sonnleitner et al., 2012).  
RsmY and RsmZ are probably the most known sRNAs involved in the switch acute-chronic 
infection in P. aeruginosa. As mentioned before, these two RNAs are part of the two component 
system Gac/Rsm and they are involved in the regulation of the translational repressor protein RsmA 
which interferes with the expression of virulence and metabolic genes (Lapouge et al., 2007; 
Valverde et al., 2003). For example, the Gac/Rsm system has been described to positively regulate 
the expression of the quorum-sensing signal N-butanoyl-homoserine lactone (C4-HSL) and of 
extracellular virulence factors, such as hydrogen cyanide (HCN), pyocyanin, and elastase (Kay et 
al., 2006). 
Another interesting and well described sRNA is CrcZ, linked to carbon metabolism. CrcZ has five 
CA-motifs and it antagonizes the function of the RNA-binding protein Crc in catabolite repression. 
When preferred carbon source are not available, CrcZ binds to and sequesters Crc, allowing 
synthesis of the required catabolic enzymes for utilization of not preferred carbon source as 
mannitol or acetamide (Linares et al., 2010; Sonnleitner and Haas, 2011b). The expression of CrcZ 
is driven by CbrA/B two-component system in a σ54-dependent manner. The type of carbon source 
determines the CrcZ level, which is low in the presence of a preferred carbon source, like succinate, 
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and elevated in the presence of an intermediate substrate, like glucose, and high in the presence of a 
non-preferred carbon source such as mannitol. In addition, the CbrAB/Crc pathway is also involved 
in virulence traits as pyocyanin production and in the synthesis of porins (Linares et al., 2010).  
P. aeruginosa expresses the sRNA PhrS to connect QS to oxygen metabolism. PhrS is a 213 nt long 
sRNA, predicted by biocomputation and isolated by an RNomics approach in combination with 
Hfq-mediated co-immunopreciptation. PhrS regulates the expression of PQS and pyocyanin. In 
particular, it modulates PQS synthesis during the transition from aerobic to hypoxic conditions and 
this role has been suggested to stabilize PQS levels in fluctuating oxygen concentration (Sonnleitner 
et al., 2011). The phrS gene expression is dependent by ANR regulator and its promoter is activated 
in limited oxygen condition. Interestingly, to regulate PQS expression, PhrS binds the RBS region 
of a small coding sequence (uof) upstream pqsR which is co-translated with pqsR. Thus, PhrS 
regulates pqsR translation by modulating translation of uof (Sonnleitner et al., 2011; Sonnleitner 
and Haas, 2011b).  
In P. aeruginosa regulation of iron homeostasis is crucial to assure adaptation avoiding toxic effect 
in iron-excess environment. To achieve this fine-tuned balance, P. aeruginosa produces 
siderophores, chelators and iron storage proteins such as bacterioferritin (BfrB) and enzymes that 
neutralize oxidative stress, e.g., catalase (KatA) and iron-containing superoxide dismutase (SodB) 
(Cornelis et al., 2013; Cornelissen and Sparling, 1994; Takase et al., 2000).  
Furthermore, in most Gram-negative bacteria the ferric uptake regulator Fur complexed with Fe2+ 
ions prevents transcription of genes involved in iron acquisition and of iron-regulated genes 
involved in virulence. In E. coli Fur was characterized as a positive regulator of genes such as acnA, 
fumA, ftnA, bfr, and sodB encoding for iron-binding enzymes and Fe-superoxide dismutase (Chen et 
al., 2007; Seo et al., 2015). This Fur positive regulation is exerted through repression of a small 
regulatory RNA, RyhB, which causes degradation of these mRNAs when it is expressed (Massé et 
al., 2005b; Prévost et al., 2007).  
Two ortholog of RyhB have been bioinformatically discovered in P. aeruginosa, PrrF1 and PrrF2. 
These sRNAs are encoded in tandem, with 95% of identity, and provided with a Fur binding site 
upstream their coding sequence. In iron-limiting condition they are both synthesized since not 
repressed by Fur (Oglesby et al., 2008; Sonnleitner and Haas, 2011a). As for RyhB, PrrF1 and 
PrrF2 block the translation of sodB mRNA, occluding the RBS and leading its degradation. 
Recently other targets and regulatory mechanism have been described for PrrF1, including 
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interaction with a ‘sponge’ derived from the 3′ end of the katA transcript, thus antagonizing the 
regulatory interaction of the 5′ end of the same mRNA (Han et al., 2016; Zhang et al., 2017). 
In addition to their role in iron metabolism, PrrF represses P. aeruginosa genes involved aerobic 
and anaerobic metabolism, in anthranilate and catechol degradation (Oglesby et al., 2008). 
Anthranilate is usually converted in catechol, but PrrF sRNAs regulate this pathway channeling the 
anthranilate in the PQS biosynthetic network, affecting the expression of virulence genes (Reinhart 
et al., 2017). The expression in tandem of prrF1 and prrF2 unique in P. aeruginosa, allows the 
synthesis of a third sRNA, PrrH which is expressed in iron-deplete condition and in stationary 
phase of growth. This sRNA is involved in heme metabolism and homeostasis, and in heme-
starvation. PrrH represses achAB and sdhCDAB, which are also known to be targets of the PrrF 
sRNAs, and NirL, a protein involved in biosynthesis of heme (Reinhart et al., 2017).  
Finally, in the lab that hosted this thesis work, two novel sRNAs, ErsA (Ferrara et al., 2012, 2015) 
and ReaL (Carloni et al., 2017), have been characterized as post-transcriptional regulators in P. 
aeruginosa virulence networks as exopolysaccharides biosynthesis and quorum sensing, 
respectively. A third one, PesA (Ferrara et al., 2017), influences P. aeruginosa virulence and 
modulates pyocin S3 production. Both ErsA and PesA have been topics of this thesis work. For an 
introduction to PesA characterization, I refer you to the enclosed paper, while a brief summary of 
previous ErsA characterization is appended below. 
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5.3.1 ErsA 
ErsA is a 132 bp sRNA, encoded from the same genomic context of the well-characterized 
Escherichia coli sRNA Spot 42 (Beisel and Storz, 2011), the intergenic region between the genes 
encoding for the highly conserved proteins PolA (DNA polymerase I) and EngB (GTPase of 
unknown function). Because Spot 42 and ErsA do not share obvious sequence and structural 
similarities, it is difficult to definitively conclude that they are orthologues. Even though their genes 
are located in a highly conserved genomic context and have a comparable size and the same 
transcription direction, ErsA is not involved in carbon source catabolism like Spot 42 (Ferrara et al., 
2015). Moreover, the transcription of ErsA is strictly dependent on the envelope stress responsive 
sigma factor AlgU (σ22 /AlgT) (Ferrara et al., 2015; Potvin et al., 2008), the functional homologue 
of E. coli σE (Yu et al., 1995), that impacts P. aeruginosa pathogenesis. As mentioned above, AlgU 
is essential for the production of the exopolysaccharide alginate, whose overproduction confers a 
mucoid phenotype and provides P. aeruginosa with a selective advantage for survival in the cystic 
fibrosis lung (Jones et al., 2010). AlgU drive the expression of several transcriptional regulators 
which regulate the Pel, Psl, alginate, rhamnolipids and LPS production, the main crucial element is 
the phosphomannomutase AlgC. Interestingly, in (Ferrara et al., 2015) it has been shown that ErsA 
directly exerts a negative post-transcriptional regulation on the algC gene. ErsA-algC mRNA 
interaction was predicted bioinformatically using the web tool TargetRNA (Tjaden, 2008). Direct 
interaction was validated in vitro by electromobility shift assay and in vivo in PAO1 using the 
translational fusion algC::sfGFP with and without ErsA overexpression. Consistent with these 
results, it has been suggested that ErsA could be an additional σ 22-dependent regulation converging 
on AlgC, and the expression of AlgC is subjected to an incoherent feed-forward loop involving σ 22 
and ErsA as summarized in Fig. 14. 
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Figure 14. Model for AlgC regulation by incoherent feed forward loop. The alternative sigma factor AlgU drives the transcription of 
the algC gene and the sRNA ErsA which in turn negatively regulates algC mRNA at post-transcriptional level. Modified from 
(Ferrara et al., 2015)  
 
In addition, ErsA is responsive to envelope stress as induced by the cell wall inhibitory antibiotic D-
cycloserine and it responds to infection-relevant cues that P. aeruginosa can experience in 
mammalian host, such as oxygen availability and temperature shift (Fig. 13) (Ferrara et al., 2015). 
A large body of data support the notion that P. aeruginosa σ22 activation depends on a mechanism 
homologous to the E.coli RIP (regulated intramembrane proteolysis) modulated by σE and triggered 
by external stresses such as heat shock which lead to the accumulation of misfolded periplasmic and 
outer membrane proteins (Grigorova et al., 2004; Qiu et al., 2007; Walsh et al., 2003) and a role of 
ErsA in this response pathways could be possible.  
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Aim of the work 
P. aeruginosa small RNAs are known to be crucial regulators for the pathogenicity and virulence of 
this human pathogen. Specifically, their contribution is pivotal to have a fast and fine-tuned 
response which can integrate or antagonize transcriptional changes. Furthermore, sRNAs integrate 
and process stimuli hailing from the environment and population, and as illustrated in section 5.3, 
they play fundamental roles in the host-pathogen interaction, marking all the stages of infection 
(Repoila and Darfeuille, 2009).  
Interestingly, pioneering studies in E. coli and Salmonella revealed an important contribution of 
trans-encoded sRNAs also in antibiotic resistance and susceptibility, i.e. regulating efflux pumps 
(Acuña et al., 2016; Mathieu et al., 2016), and the expression of sRNAs in other species is affected 
in presence of antibiotics (Laureti et al., 2013; Pulido et al., 2016; Wecke and Mascher, 2011). 
Therefore, these evidences encourage considering sRNAs as promising target for valuable 
antimicrobial therapies, and raise the importance to further characterize novel sRNAs associated to 
pathogenic traits. 
The first aim of this project was to expand the knowledge about the regulatory network of the 
sRNA ErsA using a combined approach to identify and validate novel target genes, in silico, in vivo 
and in vitro. In addition, ErsA is known to regulate algC mRNA (Ferrara et al., 2012, 2015). Since 
AlgC is crucial for the EPS production which constitutes the biofilm scaffold, we focused our 
attention also on the direct involvement of ErsA in biofilm development.  
Compared to PAO1 strain, there are poor information about the regulatory role of sRNAs in PA14, 
which is known to be more virulent as usually considered the clone type of CF clinical isolate, in a 
wide set of hosts, including mice (Harrison et al., 2010a; Mikkelsen et al., 2011a). Thus, in parallel 
with the first aim of this project, we characterized the novel sRNA PesA expressed in PA14, 
discovered with the sRNA-sequencing approach which allowed us to identify ErsA (Ferrara et al., 
2012).  
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Main Results 
In the attached manuscript Falcone et al. (Part III), PAO1ΔersA has been used to analyze the 
involvement of the sRNA ErsA on biofilm formation and related phenotypes, as twitching and 
swarming motility, compared to PAO1 wild-type strain. We used the confocal laser microscopy-
flow cells technique and peg-lid microtiter biofilm assay to follow the biofilm formation at different 
stages. Our results show that the absence of ErsA determine a flat biofilm production compared to 
the wild-type which conversely develop high structures typical of 3 days-old biofilm, and a reduced 
biomass production when stained with crystal violet. These evidences suggest a positive 
contribution of ErsA on the global biofilm network, evidence that was corroborated also by motility 
assays. Indeed, with an opposite trend of regulation compared to biofilm, ErsA absence seems to 
foster the motile lifestyle, in particular the type IV pili-dependent twitching, and swarming motility. 
This result is in line with literature, since it is known that twitching and swarming motility are 
important for the early stages of biofilm formation, while the expression of flagellar genes is 
repressed in mature biofilm formation. The transition motility-to-biofilm involves two steps. In the 
short term, flagella are functionally regulated to either inhibit rotation or modulate the basal 
flagellar reversal frequency. Over the long term, flagellar gene transcription is inhibited and in the 
absence of de novo synthesis, flagella are likely diluted to extinction through growth. Both short 
term and long term control is likely important to the motility-to-biofilm transition to stabilize 
aggregates and optimize resource investment (Shrout et al., 2006). P. aeruginosa strains exhibiting 
more swarming phenotype developed a flat and uniform biofilm in flow cell experiments. 
Furthermore, twitching motility is suggested to be required for monolayer creation during the initial 
stages of biofilm development.  
Biofilm formation and motility regulation are based on complex regulatory routes at both 
transcriptional and post-transcriptional level. To visualize the impact of ErsA on the transcriptome 
profile of P. aeruginosa, and to have a global approach about the regulatory networks linked to the 
sRNA, we performed a RNA-seq experiment.  
Notably, the RNA-seq analyses revealed 168 genes differentially expressed in absence of ErsA 
compared to PAO1 wild-type. Among the 29 genes upregulated in the ErsA deletion mutant and so 
potentially repressed by ErsA, we observed genes involved in denitrification and nitrate metabolism 
(narI, narJ, nirN) and type VI and III secretion systems effectors (tssA1, tsi4, tse6). 
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The majority of genes were downregulated in absence of ErsA (139 genes); the strongest negative 
effect was observed for narK1 involved in nitrate transport. The other genes comprised well 
described genes involved in biofilm formation and motility (algD, esrC, ppyR, pelCDEFG, roeA), 
energy and carbon compound metabolism (prpD, prpC, coxA, coxB), heat-shock proteins (htpG, 
hslU, hslV, ibpA, dnaK, dnaJ) and phzS involved in pyocyanin production. 
The involvement of ErsA in biofilm architecture development emerged also from the transcriptomic 
analysis and intriguingly, the biofilm genes whose expression is altered in ErsA deletion mutant 
background are under the transcriptional control of AmrZ (Jones et al., 2014; Xu et al., 2016). 
AmrZ is a multifunctional transcriptional regulator of biofilm and motility, which takes place to the 
transition between colonizing and chronic infection and controls alginate production via activation 
of the algD promoter (Jones et al., 2013; Xu et al., 2016).  
From literature, other transcriptional regulators are known to be modulated by sRNAs in E. coli 
(Lee and Gottesman, 2016a; Majdalani et al., 2002; Massè et al., 2005a; Ottesman et al., 1998; 
Prèvost et al., 2007), therefore we hypothesized that ErsA might indirectly affect the expression 
levels of these genes, by regulating at post-transcriptional level the amrZ mRNA. To investigate the 
interaction ErsA-amrZ mRNA we employed different approaches: i) bioinformatics analysis, ii) in 
vitro electrophoretic mobility shift assays, iii) in vivo translational fusions based on the gfp reporter 
gene. From in silico analyses using the IntaRNA tool, we identified a putative interaction site for 
ErsA on amrZ mRNA, close to the translational starting site. The direct interaction has been 
validated in vitro by EMSA, and in vivo by amrZ::sfGFP translational fusion that shows reduced 
reporter activity in PAO1ΔersA compared to the reference strain, suggesting a positive regulation of 
ErsA on amrZ mRNA at the post-transcriptional level. 
Overall, our results suggest that the small RNA ErsA might represent a relevant post-transcriptional 
regulator in biofilm development at different levels, likely interacting with different target mRNAs. 
We speculate that ErsA could increase the efficiency of amrZ translation, by remodeling its 
secondary structure and this mechanism may interfere with the expression of biofilm genes which 
are transcriptionally controlled by AmrZ. However, we cannot exclude a direct role of ErsA on the 
expression of biofilm genes resulted differentially expressed in ErsA deletion mutant background.  
On the whole, we propose here a mixed regulatory pattern modulated by ErsA in biofilm formation 
and motility regulation in which the post-transcriptional regulation exerted by ErsA on AmrZ 
enforce the transcriptional influence of AmrZ on biofilm genes affecting the biofilm fitness of P. 
aeruginosa PAO1 strain.  
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In the attached paper Ferrara et al. (Part II) (Ferrara et al., 2017) we studied the novel P. aeruginosa 
sRNA PesA, transcribed from the pathogenicity island PAPI-1 in the strain PA14.  
PesA is a 260 nt non-coding RNA identified using a comparative sRNA-seq approach. It is encoded 
within the pathogenicity island PAPI-1 and pesA gene is located on the same strand and 
downstream pilM2 gene and overlaps PA14_59370 gene (unknown function).  
PesA is a processed product and it reaches the maximum expression in stationary phase. In addition, 
it is more expressed at 37°C than 20°C, and its levels are higher in anaerobic condition, with a 
progressive increment in the transition aerobic-anaerobic conditions. All these conditions recall the 
environmental stresses that P. aeruginosa experiences in the host, as the case of CF lungs. 
Following this line, we analyzed by Northern Blot and PCR-amplification the expression of PesA in 
29 clinical P. aeruginosa isolates from patients affected by chronic respiratory diseases (COPD) 
including CF, and in 5 environmental strains. Interestingly, our results show that PesA is expressed 
in 17 CF clinical isolates, in 2 COPD isolates and in 2 environmental isolates, and there is no 
difference in PesA levels at different stages of chronic infection.  
We screened in silico the PA14 genome to identify putative PesA target genes located outside 
PAPI-1. One interesting prediction by TargetRNA tool was the pyoS3A-I operon coding for pyocin 
S3. The S3 locus comprises pyoS3A and pyoS3I and specifically, PesA is predicted to bind the 
region which comprises the RBS of the pyoS3I gene, and locates within the ORF of the pyoS3A 
gene. To evaluate the regulatory role of PesA on the operon, we generated different translational 
fusions. The first one, lacZ::pyoS3A-I::sfGFP, mimics a bi-cistron controlled by the constitutive 
promoter PLtetO-1 . Analyzing the GFP activity of this translational fusion, we suggested a positive 
role of PesA on the translability of pyoS3A-I operon. To test whether translation of pyoS3A gene 
was necessary to have this PesA effects on pyoS3I, we generated a second translational fusion, 
pBBR1-pyoS3I::sfGFP containing the same region pyoS3A-I present in the first translational fusion, 
but with only pyoS3I fused in frame with sfGFP. GFP analysis confirmed the positive influence of 
PesA on pyoS3I and this effect is not dependent by pyoS3A. Thus, to evaluate the effect of PesA on 
pyoS3A translation we substituted the sequence coding for the F’LacZ domain in pBBR1-
lacZ::pyoS3A-I::sfGFP with the reporter gene mCherry, and measured simultaneously the activity 
of both mCherry and sfGFP of the translational fusion mCherry::pyoS3A-S3I::sfGFP. Our results 
confirmed the positive regulation exerted by PesA on the pyoS3I gene measuring the GFP activity. 
In addition, mCherry also showed an increase in activity when PesA was overexpressed, suggesting 
that PesA also exerts a positive regulation on the upstream gene pyoS3A. Thus, PesA seems to be a 
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positive regulator of the whole pyoS3 operon, specifically affecting its translatability without 
influencing stability of the pyoS3A-I mRNA as confirmed by Real time PCR. 
These evidences are supported also by the observation that ΔpesA results in strong reduction of 
pyocin S3 production compared to PA14 wild-type. Pyocins are bacteriocins synthesized by more 
than 90% of P. aeruginosa strains and are suggested to play a role in niche establishment and 
protection in mixed populations. The pyocin genes are usually located on the P. aeruginosa 
chromosome and induced by mutagenic agents that cause DNA damage such as mitomycin C and 
UV irradiations. In this paper, we suggest that PesA is involved in niche establishment mechanisms 
enhancing the production of pyocin S3. PesA was in fact also detected in environmental isolates and 
its expression from PAPI-1 might confer a selective advantage that favours PAPI-1 maintenance in 
the environment due to its regulation of pyocin S3.  
We evaluated also the virulence potency of PA14ΔpesA compared to PA14 wildtype on the CF 
bronchial epithelial cell line IB3-1. Measuring the viable cell number evaluating the intact 
mitochondria, we observed that PA14ΔpesA is less virulent than wildtype strain, suggesting a role 
for the sRNA in P. aeruginosa acute phase of infection. 
In addition, the PA14 mutant strain ΔpesA shows an increased sensitivity to ciprofloxacin and UV 
irradiation, introducing an interesting link for PesA in coordinating antibiotic resistance, DNA 
damage repair and DNase activity producing pyocins.  
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Conclusions and future Prospects 
In this PhD work, we focused on the regulatory function of two sRNAs in P. aeruginosa, ErsA and 
PesA, in PAO1 and PA14 strains, respectively.  
ErsA, whose expression is modulated by the alternative sigma factor AlgU, was previously 
suggested to work as the repressor arm of AlgU, regulating at post-transcriptional level AlgC to 
fine-tune the exopolysaccharides production in P. aeruginosa PAO1 (Ferrara et al., 2015). The 
results collected in this thesis expanded this framework of information assessing the positive 
contribution of ErsA in PAO1 biofilm development, likely by direct binding to amrZ mRNA, 
encoding for one of the most important regulators involved in this complicated process.  
Interestingly, ErsA seems to retrace the role played by AmrZ in the conversion of a motile and 
acute-infection lifestyle in a more settled, adaptable and resistant P. aeruginosa strain and we 
propose here a mixed regulatory circuits modulated by ErsA in biofilm formation and motility 
regulation (Fig.1), in which the post-transcriptional regulation exerted by ErsA on AmrZ would 
enforce the transcriptional influence of AmrZ on biofilm genes affecting the biofilm architecture of 
P. aeruginosa PAO1.  
To achieve our goals, we used a set of in vivo and in vitro assays surrounded by the high throughput 
RNA-seq approach. The dataset obtained by the whole transcriptome of PAO1 ΔersA not only 
corroborated the phenotypic results revealing interesting genes involved in biofilm formation and 
motility regulation, but it also represents a useful starting point for future ErsA target validations 
and regulatory networks identification. Indeed, the transcriptomic profile of PAO1 ΔersA lead us to 
glimpse novel regulatory routes in which ErsA could be directly or indirectly involved. For 
example, ErsA deletion affects the transcriptional levels of multiple heat shock response operons as 
dnaK-grpE, dnaJ-dapB, htpG-PA1597, hslV-hslU and this strongly suggest a contribution of ErsA, 
likely modulated by AlgU. Likewise stress response, type III and VI secretion systems and nitrate 
metabolism operons are also affected in absence of ErsA. A combinatorial approach similar to the 
one used to reach the aims of this PhD project has to be settled to identify ErsA direct target genes 
connected to these important pathways.  
In addition, all the data collected by our analyses will be integrated in the future by a proteomic 
profile of PAO1Δ ersA, in order to identify target genes previously revealed by RNA-seq which are 
also affected at translational level. We also expected to highlight novel genes whose products are 
affected in absence of ErsA but not at mRNA level. To this purpose ribosome profiling or ribo-seq 
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technique (Ingolia, 2014) might be employed to monitor in vivo translation of PAO1 ΔersA 
compared to the reference strain. 
Similarly to ErsA, in this work we characterized another sRNA associate to P. aeruginosa 
virulence, named PesA. It is the first sRNA characterized to date which is encoded in a 
pathogenicity island in P. aeruginosa PA14, and our results suggest its involvement in virulence 
targeting genes crucial for niche establishment, virulence and stress resistance. Interestingly, our 
analysis revealed that PesA is expressed in several clinical isolates from patients affected by chronic 
respiratory diseases, including CF. PA14 ΔpesA is less virulent than wild-type strain as revealed by 
infecting the CF bronchial epithelial cell line IB3-1, suggesting also role for the sRNA in P. 
aeruginosa acute phase of infection. In addition the deletion of PesA resulted in PA14 more 
sensitive to ciprofloxacin treatment, one of the most common antibiotics used to treat P. aeruginosa 
infections in CF patients. On the whole, the panel of results collected by this study suggests an 
interesting role of both ErsA and PesA in P. aeruginosa virulence and pathogenesis. These 
observations raise the possibility to consider these two sRNAs as target for non-conventional 
antibacterial therapy as the case of RNA-based drugs or antibiotics targeting RNAs (Melnikova, 
2007). In the last years, indeed, the increasing antibiotic resistance among the most widespread 
human pathogens, urged to design novel class of drugs and expand the number of their targets. 
Several classes of molecules have been investigated for RNA therapeutics including antisense 
RNA, ribozymes, RNA decoys, aptamers, small interfering RNA (siRNA) and microRNA 
(miRNA) in order to overcome the limited number of proteins and small molecules currently used 
as target for therapeutics (Dersch et al., 2017; Hong et al., 2014; Kaczmarek et al., 2017). However, 
target selectivity, stability, delivery and long-term safety have to be fine-tuned for RNA drugs to 
become a successful therapeutic category. Another possibility to target sRNAs is employing PNA 
(Peptide Nucleic Acid) oligomers, which can recognize complementary DNA/RNA sequences, and 
are characterized by a changeable peptide-like backbone (Nielsen, 2010). PNAs might be designed 
for example to target PesA in order to interfere with its regulatory activity and increase P. 
aeruginosa ciprofloxacin sensitivity and PNAs designed to target ErsA could affect the proper 
biofilm shaping and this may contribute to the anti-biofilm compound activity. 
Furthermore, in the future, mouse models are required to test the involvement of ErsA and PesA in 
acute and chronic infection and eventually test the RNA-based therapy against the two sRNAs in 
vivo. 
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In conclusion, our results expanded the knowledge about sRNAs in P. aeruginosa, adding novel 
regulatory elements to well-known networks and we believe that detailed understanding of target 
genes of small RNAs may help to expand the frontiers on novel therapies against P. aeruginosa 
infections. 
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Abstract
Small non-coding RNAs (sRNAs) are post-transcriptional regulators of gene expression that
have been recognized as key contributors to bacterial virulence and pathogenic mecha-
nisms. In this study, we characterized the sRNA PesA of the opportunistic human pathogen
Pseudomonas aeruginosa. We show that PesA, which is transcribed within the pathogenic-
ity island PAPI-1 of P. aeruginosa strain PA14, contributes to P. aeruginosa PA14 virulence.
In fact, pesA gene deletion resulted in a less pathogenic strain, showing higher survival of
cystic fibrosis human bronchial epithelial cells after infection. Moreover, we show that PesA
influences positively the expression of pyocin S3 whose genetic locus comprises two struc-
tural genes, pyoS3A and pyoS3I, encoding the killing S3A and the immunity S3I proteins,
respectively. Interestingly, the deletion of pesA gene results in increased sensitivity to UV
irradiation and to the fluoroquinolone antibiotic ciprofloxacin. The degree of UV sensitivity
displayed by the PA14 strain lacking PesA is comparable to that of a strain deleted for
pyoS3A-I. These results suggest an involvement of pyocin S3 in DNA damage repair and a
regulatory role of PesA on this function.
Introduction
Bacterial small RNAs (sRNAs) have been recognized as key contributors to regulatory net-
works, and have been shown to play critical roles in many intra- and extracellular processes,
and in pathogenesis [1–3]. Most sRNAs exert their regulatory function post-transcriptionally,
acting by base pairing with the mRNA of their target genes ultimately modulating mRNA
translation and/or stability. sRNAs can share extended base complementarity when they are
cis-encoded on the opposite strand of the target mRNA, or they can interact with the target
mRNA via short and imperfect base pairing, as in the case of trans-encoded sRNAs. The
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expression of most sRNAs is responsive to environmental stress conditions spanning from
iron and oxygen limitation, to oxidative, metabolic/nutrient, pH and cell envelope stresses [4].
In the opportunistic human pathogen Pseudomonas aeruginosa the use of transcriptomics
approaches has recently led to the identification of numerous new sRNAs, mostly in the atten-
uated strain PAO1 and some also in the virulent one PA14 [5–7]. The bacterium P. aeruginosa
is known as a major cause of both acute and chronic lung infections in patients belonging to
all age groups who are immunocompromised, or who have defective mucociliary clearance,
previous epithelial injury or foreign body placement [8]. Lung infections caused by P. aerugi-
nosa can appear as a spectrum of clinical entities ranging from a rapidly fatal pneumonia in a
neutropenic patient to a multi-decade bronchitis in patients with cystic fibrosis (CF). The
expression of virulence traits in P. aeruginosa is fine-tuned by a dynamic and intricate regula-
tory network [9],that leads the expression of P. aeruginosa pathogenic functions with a sharp
timing. In this scenario, sRNAs can finely contribute to P. aeruginosa ability to quickly adapt
to a new environment and manage to persist.
Previously, bioinformatics and approaches such as the pull-down with the RNA chaperone
Hfq have been used for identifying novel P. aeruginosa sRNAs but only a small number of
them have been characterized functionally, and even less described as being implicated in the
regulation of P. aeruginosa virulence [10–17]. Moreover, most of the studies have been per-
formed using the reference strain PAO1, while very little is known about the biological effects
of the sRNA mediated regulation in virulent P. aeruginosa strains, such as PA14. Compared to
PAO1, the clinical isolate PA14 is significantly more virulent in a wide range of hosts, includ-
ing mice, the nematode Caenorhabditis elegans, the insect Galleria mellonella, and the plant
Arabidopsis thaliana, and has thus become an important reference strain because of its
enhanced virulence [18–20]. Generally, PAO1 and PA14 strains share highly conserved
genomes, although PA14 possesses a slightly larger one, likely due to horizontal gene transfer
resulting in the acquisition of pathogenicity islands (PAIs) [21].
This study focuses on a P. aeruginosa sRNA observed for the first time by a sRNA-sequenc-
ing approach [5], in which unique and conserved sRNAs in the P. aeruginosa strains PAO1
and PA14 were revealed. Here, we validated the sRNA with the operative name SPA0021,
renamed PesA, as being transcribed from the pathogenicity island PAPI-1, present in PA14
strain, but not in PAO1. In addition, our results display that PesA is expressed in several P. aer-
uginosa isolates, including environmental and clinical ones isolated from CF patients. More-
over, we show that PesA operates a post-transcriptional regulation of genes involved in S-type
pyocin production. Pyocins are narrow-spectrum bacteriocins synthesized by more than 90%
of P. aeruginosa strains and presumed to play a role in niche establishment and protection in
mixed populations. The pyocin genes are usually located on the P. aeruginosa chromosome
and induced by mutagenic agents that cause DNA damage such as mitomycin C and UV irra-
diations. P. aeruginosa pyocins can be subdivided into insoluble R and F pyocins and soluble S
pyocins. S-type pyocins AP41, S1, S2, and S3 are constituted of two components in which the
large component carries an endonuclease C-terminal domain responsible for the killing activ-
ity that causes cell death by DNA cleavage [22–27], while pyocins S4 and S5 have tRNAse and
pore-forming activities, respectively [28, 29]. More recently, also the new S-type pyocin S6,
with rRNase activity, has been described functionally [30]. In our study, we show that PesA
deletion leads to decreased expression of pyocin S3, associated to increased sensitivity to UV
irradiation and to the fluoroquinolone antibiotic ciprofloxacin. Furthermore, PesA is induced
by host-environment stimuli such as low oxygen availability and body temperature, suggesting
a key role in P. aeruginosa adaptability to different environmental stresses. Finally, we also
found that PesA is involved in the regulation of P. aeruginosa PA14 virulence in CF human
bronchial epithelial cells. Our results suggest that a PAPI-1-encoded sRNA can contribute to
PesA, a PAPI-1 encoded small RNA of P. aeruginosa
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the modulation of the expression of genes outside PAPI-1, and to different aspects of P. aerugi-
nosa pathogenesis during infection.
Materials and methods
Ethics Statement
Study on human P. aeruginosa isolates from Hannover has been approved by the Ethics Com-
mission of Hannover Medical School, Germany [31]. The patients and parents gave oral
informed consent before the sample collection. Approval for storing of biological materials
was obtained by the Ethics Commission of Hannover Medical School, Germany. The study on
human P. aeruginosa isolates from the Regional CF Center of Lombardia (S1 Table) was
approved by the Ethical Committees of San Raffaele Scientific Institute and Fondazione
IRCCS Ca’ Granda, Ospedale Maggiore Policlinico, Milan, Italy, and written informed consent
was obtained from patients enrolled or their parents according to the Ethical Committees
rules, in accordance with the laws of the Italian Ministero della Salute (approval #1874/12 and
1084/14).
Bacterial strains and culture conditions
Bacterial strains and plasmids used in this study are listed in S2 Table. E. coli strains were rou-
tinely grown in Luria-Bertani broth (LB) at 37˚C. P. aeruginosa strains were grown at 37˚C in
Brain Heart Infusion (BHI) rich medium or in LB at 120 rpm unless otherwise indicated. Car-
benicillin and gentamicin were added at 300 and 20 μg/ml, respectively, unless otherwise indi-
cated. For PBAD induction in vector plasmid pGM931, arabinose was added to a final
concentration of 10 mM. Anaerobic batch cultivations of P. aeruginosa and the shift from aer-
obic to anaerobic conditions were performed in a 800 ml-Biostat-Q system bioreactor
(B-Braun) as described previously [17].
Plasmid constructions and mutant generations
Oligonucleotides used in this study are listed in S3 Table. To construct plasmid pGM-pesA, the
pesA gene was PCR-amplified from PA14 genomic DNA with oligos 9/10, digested with NcoI-
PstI and cloned into the pHERD20T derivative vector pGM931 carrying a transcriptional ter-
minator downstream the multicloning site [32, 33].
Plasmids pBBR1-pyoS3I::sfGFP, pBBR1-leader-pyoS3A::sfGFP, pBBR1-lacZ::pyoS3A-I::
sfGFP, and pBBR1-mCherry::pyoS3A-I::sfGFP expressing pyoS3I::sfGFP, pyoS3A::sfGFP, lacZ::
pyos3A-I::sfGFP, ormCherry::pyos3A-I::sfGFP translational fusions, respectively under the
PLtetO-1 constitutive promoter were constructed as follows. A DNA fragment including the last
39 codons of the open reading frame of Pyos3A and 36 first codons of PyoS3I was amplified by
PCR with oligos 11/12, digested with NsiI-NheI and cloned into the sfGFP reporter vectors
pXG10-SF and pXG30-SF [34] giving rise to plasmid pXG10-pyoS3I::sfGFP and pXG30-lacZ::
pyoS3A-I::sfGFP, respectively. A DNA fragment including the 278-nt UTR and the first 37
codons of the pyos3A open reading frame was amplified with oligos 13/14 digested with NsiI-
NheI and cloned into the sfGFP reporter vectors pXG10-SF giving rise to plasmid pXG10-
leader-pyoS3A::sfGFP.
The DNA fragments spanning from the PLtetO-1 promoter to the end of the GFP reporter
gene were amplified by PCR respectively from pXG10-pyo-S3I::sfGFP, pXG30-lacZ::pyoS3A-I::
sfGFP and pXG10-leader-pyoS3A::sfGFP with oligos 18/19, digested with ClaI-XbaI and cloned
into the low-copy number shuttle vector pBBR1-MCS5 giving rise to constructs pBBR1-
pyoS3I::sfGFP, pBBR1-lacZ::pyoS3A-I::sfGFP and pBBR1-leader-pyoS3A::sfGFP, respectively.
PesA, a PAPI-1 encoded small RNA of P. aeruginosa
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mCherry gene was amplified by PCR from the pMMR plasmid [35] using primers 15/16, (in
which forward primer contained the Shine-Dalgarno sequence, and reverse primer lacked
mCherry stop codon sequence), digested with NsiI and cloned into the pXG10-pyoS3I::sfGFP
previously digested with NsiI, giving rise to plasmid pXG10-mCherry::pyoS3A-I::sfGFP. The
DNA fragment spanning from the PLtetO-1 promoter to the end of the GFP reporter gene was
amplified by PCR using oligos 18/19 digested with ClaI-XbaI and cloned in the pBBR1-MCS5
vector, giving rise to plasmid pBBR1-mCherry::pyoS3A-I::sfGFP. Plasmid pBBR1-mCherry
expressing mCherry reporter gene under PLtetO-1was constructed as follows. The DNA frag-
ment including the PLtetO-1 promoter and the mCherry reporter gene was amplified from
pBBR1-mCherry::pyoS3A-I::sfGFP using oligos 17/18 (in which reverse primer contained
mCherry stop codon). The PCR product was digested with ClaI-XbaI and cloned in the
pBBR1-MCS5 vector.
P. aeruginosamutant in pesA gene was generated by an enhanced method of markeless
gene replacement described previously [36] with some modifications to adapt it to P. aerugi-
nosa as described previuosly [17]. PA14 mutant in pesA gene was obtained by allelic exchange
with a deletion from—34 to + 140 positions with respect to pesA transcription start site as fol-
lows. TS1 region spanning left 533 bp flanking sequence of pesA gene was amplified by PCR
with oligos 23/24. TS2 region spanning last 127 nt and right 368 bp flanking sequence of pesA
was amplified by PCR with oligos 25/26. PCR amplifications were performed from PA14 geno-
mic DNA. Overlap extension (SOE)-PCR with oligos 23/26 was used to join TS1 and TS2 that
carried end complementary regions introduced by 25/26, respectively during their separate
PCR amplification [37]. Joined TS1-TS2 DNA fragments were digested with EcoRI-PstI and
cloned in CC118 λpir into the poly-linker site of pSEVA612S giving rise to pSEVApa14-ΔpesA.
The TS1-TS2–inserted pSEVApa14-ΔpesA was transferred from E. coli CC118 λpir to
PA14, with the assistance of the helper E. coli strain HB101(pRK600) in a conjugative triparen-
tal mating. Exconjugant P. aeruginosa clones were selected on M9-citrate with 60 μg ml−1 of
gentamicin. Since pSEVA612S derivatives cannot replicate in P. aeruginosa, GmR exconjugant
clones could appear only by co-integration of the construct in the genome of the recipient
strain by homologous recombination between joined TS1-TS2 fragments borne by pSE-
VA612S and the recipient chromosome. Plasmid pSW-1 was transferred from E. coli DH5α to
P. aeruginosa clones bearing genomic co-integrates of pSEVApa14-ΔpesA by triparental mat-
ing as above, and pSW-1-recipient P. aeruginosa clones were selected on M9-citrate with
300 μg ml−1 of carbenicillin. Cultures of resulting P. aeruginosa clones carrying pSW-I were
grown overnight in LB with 300 μg ml−1 of carbenicillin and then plated on the same medium.
Single colonies were screened for loss of gentamicin resistance. Gentamicin-sensitive clones
carrying the deleted alleles were then screened by PCR with oligo pairs 27/28 for pesA.
All plasmid constructs and deletion mutant were checked by sequencing with oligos indi-
cated in S3 Table.
RNA isolation and analysis
Total RNA was prepared as described previously [5] from 2–10 ml of bacterial cell cultures.
Quality and concentration of the RNA extracted were assessed by a Biospectrometer (Eppen-
dorf). Northern blot analyses were performed as described previously [5]. DNA oligonucleo-
tide probes were 5’-end labeled with [γ-32P]ATP (PerkinElmer, NEG502A) and T4
polynucleotide kinase (Promega, M4103) according to manufacturer’s instruction. Oligo 1
and 2 were used to probe PesA and 5S RNA, respectively. Treatment with terminator-5’-phos-
phate-dependent exonuclease was performed in terminator reaction buffer A (Epicentre,
TER51020) as described in detail previously [17].
PesA, a PAPI-1 encoded small RNA of P. aeruginosa
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Radioactive bands were acquired after exposure to phosphor screens using a Typhoon™
8600 variable mode Imager scanner (GE Healthcare BioSciences) and visualized with image-
Quant software (Molecular Dynamics).
Quantitative RT-PCR analysis was performed on total RNA extracted from P. aeruginosa
PA14 wild-type and ΔpesA at mid-, late-exponential and stationary phase (OD600 of 0.8, 1.6
and 2.7, respectively). cDNA synthesis was performed from 1 μg of total purified RNA using
QuantiTect Reverse Transcription Kit (Qiagen). RT-PCRs were performed using QuantiTect
SYBR1 Green PCR Kit (Qiagen) and oligo pairs 30/31, 32/33, 34/35 for 16S, pyoS3A and
pyoS3I amplification, respectively. The reaction procedure involved incubation at 95˚C for 15s
and 40 cycles of amplification at 94˚C for 15 s, 60˚C for 30 s and 72˚C for 30s. 16S ribosomal
RNA was used as reference.
In vitro and vivo assays of sRNA/mRNA interactions
Electrophoretic Mobility Shift Assay (EMSA) to analyze sRNA/mRNA interactions were per-
formed as described previously [17].
Experiments with fluorescent reporters were carried out as described previously [17].
Fluorescence polarization FP485/535, fluorescence intensity FI590/635 and Abs595 were measured
in a Tecan Infinity PRO 200 reader, using Magellan as data analysis software (Tecan). GFP
and mCherry activities were expressed in Arbitrary Units (AU) as ratio FP485/535/Abs595 and
FI590/635/Abs595, respectively.
RNA synthesis
RNAs for RNA/RNA interaction assays were prepared by T7 RNA polymerase transcription of
gel-purified DNA fragments obtained by PCR as described previously [17]. DNA fragments
for PesA RNA and pyoS3A-ImRNA preparations were amplified from P. aeruginosa PA14
genomic DNA with oligo pairs 3/4 and 5/6, respectively. The DNA fragment for RseX RNA
was amplified from E. coli C1a genomic DNA with oligos 7/8.
Pyocin S3 spotting assay
Pyocin killing assay was performed using the spotting method as indicated previously [38]
with some modifications. 10 μl of filter-sterilized supernatants from cell cultures with OD600 of
1 were spotted onto LB 1.5% agar plates. A lawn of the pyocin S3 sensitive P. aeruginosa strain
ATCC 27853 containing 5 × 106 cells ml−1 was plated by inclusion into 0.3% soft agar over the
dried spots. Plates were incubated overnight at 37˚C and checked for the formation of the
clearing zone on the spotting site, which is indicative of the pyocin S3 activity.
Antibiotic disk diffusion
Susceptibilities of P. aeruginosa strains to antimicrobial agents were analyzed by disk diffusion
measurement. Filter disks (Oxoid, CT0425B, CT0013B, CT0207B, CT0052B, CT0058,
CT0010B) were placed on a lawn of 106 CFU/ml bacterial cells plated by inclusion into 0.3%
LB agar. Plates were incubated overnight at 37˚C and the diameters of the clear zones around
the disks were measured.
UV sensitivity assay
UV treatment was performed using a Stratalinker 1800 UV Crosslinker (Stratagene). Cell cul-
tures with an OD600 of 1 (corresponding to 8 x 10
8 CFU/ml) were serially diluted until 10−7;
3 μl of each dilution were spotted in triplicate onto LB-agar plates, dried, and exposed to
PesA, a PAPI-1 encoded small RNA of P. aeruginosa
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increasing amounts of UV radiation, from 0 to 100 J/m2. Plates were incubated overnight at
37˚C.
Cytotoxicity assays in human CF respiratory cells
IB3-1 cells, an adeno-associated virus-transformed human bronchial epithelial cell line derived
from a CF patient (ΔF508/W1282X) and obtained from LGC Promochem, were grown as
described previously [39]. Cells were infected with P. aeruginosa strains at a multiplicity of
infection (MOI) of 100. Cell viability was evaluated using the CellTiter 961Non-Radioactive
Cell Proliferation Assay (MTT) kit (Promega, G4000), according to manufacturer’s
instructions.
Bacterial isolates analysis
Bacterial isolates were plated on 1.5% BHI-agar plates and grown overnight at 37˚C. Culture
samples were taken and processed for genomic DNA and total RNA extraction. PAO1 and
PA14 strains treated in the same conditions were used as controls. Oligos 9/10 and 37/38 were
used for PCR-amplification of the genomic region containing the pesA and 16S (as positive
PCR-control) loci, respectively.
Results
The sRNA PesA is encoded in the PAPI-1 and is a processed transcript
The SPA0021 sRNA was identified using a comparative sRNA-seq approach in which 52 P.
aeruginosa novel sRNAs have been identified either in the attenuated strain PAO1 or in the
virulent one PA14. SPA0021 was validated to be⇡ 260 nt in lengths, and one of the 12 sRNAs
whose genetic locus is unique to the PA14 strain [5]. Moreover, SPA0021 was found to be
encoded within the pathogenicity island PAPI-1, and because of this property, we renamed it
as pathogenicity island-encoded sRNA A (PesA). The pesA gene locates downstream and on
the same strand of pilM2 gene (belonging to the type IV B pilus operon pil2), and overlaps the
3’ of PA14_59370 (gene with unknown function) (Fig 1A and 1B). Since a rho-independent
transcription terminator was predicted within the PA14_59370 sequence [40]. The cluster of
the sRNA-seq reads that mapped upstream the predicted terminator was considered as the 3’
of the pesA gene [5]. The 5’-end was also mapped by the sRNA-seq read-clustering and was in
perfect agreement with the size validated by Northern blot [5].
We evaluated PesA expression along the growth-curve in the rich medium BHI (Fig 1C).
Northern blot analyses showed a main band of the expected product size of⇡ 260 nt (black
arrow) at each analyzed time point, and multiple bands with higher molecular weight (white
arrows) especially at early exponential phase (OD600 = 0.2). The main band of PesA showed to
accumulate in late stationary phase. The presence of high molecular weight multiple bands,
and the absence of rho-independent transcription terminators downstream pilM2, suggested
that the main band of⇡ 260 nt could derive from the processing of a longer transcript. Sensi-
tivity to treatment with terminator 50-phosphate-dependent exonuclease (Fig 1D), which pref-
erentially degrades monophosphate processed transcripts confirmed that the⇡ 260 nt RNA is
indeed a processed product.
PesA is widespread expressed in clinical and environmental isolates
To assess the clinical impact of PesA, we validated its presence and expression levels through-
out a collection of 29 clinical P. aeruginosa isolates derived from respiratory samples of patients
with chronic respiratory diseases, including CF and chronic obstructive pulmonary disease
PesA, a PAPI-1 encoded small RNA of P. aeruginosa
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(COPD), and 5 isolates from environmental habitats. In particular, the clinical isolates were
recovered both during intermittent infections and at different stages of chronic lung infection.
Part of them was previously characterized both in vitro and in vivo [31, 41]. We also included
in this study the Liverpool epidemic strain LESB58 [42] and PAO1 and PA14 as controls.
In Fig 2, results on pesA-gene amplification and Northern blot analysis show that the pesA
gene is present in 17 out of the 27 CF clinical isolates, in the 2 COPD isolates and in 2 out of 5
environmental isolates. Notably, there was no association between the presence/expression of
pesA gene and the P. aeruginosa status (chronic vs intermittent). In addition, no differences
were observed between clonal isolates recovered from the same patients at different stages of
Fig 1. Genomic context and transcriptional features of P. aeruginosa pesA gene. A) Schematic overview of the PAPI-1 region of
PA14. The pesA gene is indicated as white arrowhead. B) Sequence of the pilM2–PA14_59370 intergenic region of PA14. The pesA
sequence is in bold. The 50-end of PesA is indicated with +1. A predicted Rho-independent transcription terminator is highlighted in black.
The predicted stop codons of pilM2 and PA14_59370 are highlighted in gray. C) PesA expression is induced in stationary phase. Wild-type
PA14 was inoculated in BHI at an OD600 of 0.2 and grown for 20 h at 37˚C with agitation. At the indicated OD600, culture samples were taken
and processed for total RNA extraction and analysis by Northern blot. Black arrow indicates the main band of pesA of⇡ 260 nt; white arrows
indicate bands of higher molecular weight of pesA present especially at early exponential phase (OD600 = 0.2). D) Northern blot analysis of
PesA on 10 μg of total RNA extracted at the end of the exponential growth phase, treated (+) or untreated (−) with terminator 50-phosphate-
dependent exonuclease (T-ex).
https://doi.org/10.1371/journal.pone.0180386.g001
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chronic infection (e.g. AA2-early, AA43-late, AA44-late or TR1-early, TR66-late, TR67-late).
In the BHI-plate aerobic growth conditions of these experiments, the majority of the pesA-har-
boring isolates showed levels of expression similar to those of the PA14 strain or even higher
(panel A, lanes 5–7, 11 and 12; panel B, lanes 1, 2, 4, 5, 9, 10; panel C, lanes 2–5, 8 and 10),
while 5 isolates showed lower or no expression levels with respect to the PA14 (panel B, lanes 6
and 12; panel C, lanes 1, 6 and 11). In the case of PAO1 and LESB58 strains, no gene amplifica-
tion was observed (panel A, lanes 4 and 13).
PesA is induced in anaerobic growth and at 37˚C
We analyzed the transcriptional responsiveness of PesA RNA to environmental or body tem-
perature, and reduced oxygen availability. Temperature sensitivity was tested by probing PesA
in early- (OD600 = 0.8) and mid-exponential phase (OD600 = 1.8) at both 20 and 37˚C and after
20 min of acclimation following a shift from 20 to 37˚C, as described in detail previously [17].
As shown in Fig 3A, the growth at 37˚C caused an up-regulation of PesA if compared to the
growth at 20˚C; no increase of PesA RNA accumulation was observed during the 20 min of
acclimation. PesA showed also to be responsive to oxygen availability. PesA was probed at
mid- and late-exponential phase (OD600 of 0.8 and 2, respectively) under anaerobic conditions
in BHI with nitrate to sustain anaerobic respiration, as described previously [17]. In addition,
bacterial cells were grown in BHI with aeration until mid-exponential phase (OD600 = 0.8);
then, oxygen was excluded from cultures. PesA levels were assessed immediately before oxygen
exclusion and 20 (OD600 = 0.9) and 150 min (OD600 = 1.3) from the start of anaerobic condi-
tions, as described previously [17]. PesA levels were higher in anaerobic than aerobic condi-
tions both in mid- and late-exponential phase (Fig 3B). In addition, the shift from aerobic to
anaerobic conditions caused a progressive increase of PesA levels.
PesA is involved in ciprofloxacin and UV-resistance
To explore the involvement of PesA in the regulation of cellular mechanisms, also linked to P.
aeruginosa virulence, we constructed the knock-out mutant strain PA14 ΔpesA and the plas-
mid vector pGM-pesA carrying the pesA gene under the arabinose inducible PBAD promoter
with the aim to measure the effects of perturbing PesA levels on phenotypic traits of the PA14
strain. Deletion of the pesA gene and overexpression from the pGM-pesA vector in the wild-
type background were ensured by Northern blot (S1 Fig).
Fig 2. PesA gene dissemination and expression levels among environmental, CF and COPD clinical isolates. Assays on
environmental, CF and COPD isolates are shown in three panels, A, B and C, respectively. The strain-collection was plated on BHI-agar
plates. After overnight growth at 37˚C, culture samples were taken and processed for total RNA extraction and analysis by Northern blot, and
for genomic DNA extraction. Positive or negative PCR-amplification outcomes are indicated as “+” or “-” in the “pesA gene amplification”
row, below each Northern Blot. PAO1 and PA14 were used as controls of Northern Blot analysis and for negative or positive gene
amplification, respectively.
https://doi.org/10.1371/journal.pone.0180386.g002
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We performed different types of phenotype evaluations. The most evident effects of PesA
deletion were on UV and ciprofloxacin susceptibility. In particular, PesA deletion resulted in
an enhanced sensitivity to the antibiotic ciprofloxacin and to UV irradiation. In fact, the sus-
ceptibility of wild-type PA14 and ΔpesAmutant cells to antimicrobials was analyzed by
Fig 3. PesA expression is induced by temperature and low availability of oxygen. Levels of PesA RNA
in: A) Wild-type PA14 grown in BHI at 20˚C (lanes 1 and 4), 37˚C (lanes 3 and 6) or following 20 min of
acclimation (AC) from 20 to 37˚C (lanes 2 and 5). Culture samples were taken at middle (OD600 of 0.8) and
late (OD600 of 1.8) exponential growth phase. B) Wild-type PA14 grown in BHI anaerobically (NO3−; lanes 1
and 2), aerobically (O2, lane 6) and aerobically until an OD600 of 0.8 and then shifted to anaerobic conditions
(O2 ! NO3−; lanes 3, 4 and 5). Samples were taken 20 and 150 min after the shift to anaerobic conditions (t20
and t150). After sampling, cell cultures were processed for total RNA extraction and analysis by Northern blot.
Intensities of the bands of PesA were quantified and normalized to those of 5S RNA in the same lane. Values
are expressed as arbitrary units (AU) in the histograms below each Northern blot and represent the
mean ± Standard Deviation (SD) of three independent experiments.
https://doi.org/10.1371/journal.pone.0180386.g003
PesA, a PAPI-1 encoded small RNA of P. aeruginosa
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antibiotic disk diffusion on agar plates. The diameters of the inhibitory zones were measured
after overnight incubation at 37˚C. As shown in Fig 4, the diameter of the clear zone around
ciprofloxacin was higher for mutant ΔpesA (46.33 ±0.58 mm) in comparison to that of wild-
type strain (40.33 ± 0.58 mm) thus suggesting a contribution of PesA in the ciprofloxacin resis-
tance mechanism. In addition, we noticed an incremented sensitivity of the ΔpesAmutant
strain to UV light, showing a decrease in CFUs with respect to the wild-type starting from
treatment with 30 J/m2 (Fig 5). This suggested the involvement of PesA in improving survival
under conditions of genotoxic stress, such as UV irradiation treatment. Intriguingly, the dele-
tion of pyoS3A-I operon, that is positively regulated by PesA (see below), gave rise to same lev-
els of UV sensitivity as pesA deletion (Fig 5).
We did not observe significant differences for other phenotypes analyzed, including
growth-curves analysis on rich and minimal media, susceptibility to other antimicrobial agents
of different structural families, hemolytic activity, flagellum-mediated motility, pyocyanin and
pyoverdine secretion.
PesA is involved in P. aeruginosa pathogenicity in human CF respiratory
cells
We evaluated the virulence of P. aeruginosa PA14 strains on the CF bronchial epithelial cell
line IB3-1. In particular, we assessed the killing capacity of PA14 ΔpesAmutant compared to
the wild-type strain by the MTT assay, which provides a method of determining viable cell
number measuring the conversion of 3-(4,5-dimethylthiazol)-2,5-diphenyltetrazolium bro-
mide (MTT) to insoluble formazan by dehydrogenase enzymes of the intact mitochondria of
living cells. Our results (Fig 6) showed that cells infected with P. aeruginosa PA14 ΔpesA
mutant were more viable with respect to those infected by the wild-type strain, thus indicating
that pesAmay contribute to P. aeruginosa PA14 acute virulence.
PesA targets pyoS3A-I operon
As mentioned previously, PesA is encoded in cis to the 3’ of the gene PA14_59370 with
unknown function, which makes the study of such putative target difficult to perform. There-
fore, we managed to identify direct targets of PesA RNA by the use of the bioinformatics tool
TargetRNA [43]. This tool predicted, as a high-scored output, an interaction in the region
from -30 to -8 nt upstream the gene pyoS3I of the pyoS3 operon (Fig 7A and S4 Table), pre-
dicted to encode pyocin S3 in the PA14 strain. The pyocin S3 genetic locus comprises two
structural genes, pyoS3A (PA14_49520) and pyoS3I (PA14_49510), annotated to encode the
killing S3A and the immunity S3I proteins, respectively. To confirm this annotation in PA14,
we deleted the pyoS3 operon and tested the pyocin S3 production by the killing assay of the
sensitive ATCC 27853 P. aeruginosa strain [27]. As shown in Fig 8, deletion of pyoS3A-I
completely abolished the production of pyocin S3 by PA14 strain. Remarkably, PesA deletion
resulted in strong reduction of pyocin S3 production, thus suggesting a positive role of PesA
on the pyocin S3 production.
The predicted region of the pyoS3A-I operon targeted by PesA comprises the Ribosome
Binding Site (RBS) of the pyoS3I gene, and locates within the ORF of the pyoS3A gene. To
assess this predicted PesA-pyoS3mRNA interaction, PesA RNA and the pyoS3mRNA region
spanning –116 to +108 from pyoS3I translational start site were produced in vitro, mixed and
analyzed on native polyacrylamide gels. As shown in Fig 7B, the two RNAs specifically formed
a complex.
We generated distinct types of translational fusions to test the effects of PesA on the pyoS3I
gene alone and on the pyoS3A-ImRNA. A first reporter plasmid, named pBBR1-lacZ::
PesA, a PAPI-1 encoded small RNA of P. aeruginosa
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pyoS3A-I::sfGFP, mimics a bi-cistron under the control of the heterologous constitutive pro-
moter PLtetO-1. It was obtained by cloning a region of 224 nt, comprehensive of the last 117 nt
of the pyos3A gene and the first 108 nt of pyoS3I thus generating a first translational fusion of
the reporter F’lacZ with the last 39 codons of pyoS3A, and a second translational fusion of the
first 36 codons of pyoS3I gene with sfGFP. GFP activity was assayed in PA14 wild-type and
PA14 ΔpesA in the absence and presence of PesA overexpression from pGM-pesA. As shown
in Fig 9A, there was an approximately 25% reduction in GFP activity in the PA14 ΔpesA back-
ground. In the presence of pGM-pesA overexpressing PesA, in wild-type background, GFP
activity increased approximately 30%. These results suggested that PesA positively regulates
pyoS3I expression. To test whether translation of pyos3A gene was necessary to have this PesA
effects on pyos3I, we generated a second mono-cistronic reporter derivative, pBBR1-pyoS3I::
Fig 4. PesA deletion enhances sensitivity to ciprofloxacin. Antibiotic disk diffusion was performed on LB-
agar plates spread with 106 CFU bacterial cells of wild-type PA14 and ΔpesA mutant strains. The diameters of
the inhibitory zones were measured after overnight incubation at 37˚C. Data derive from three independent
experiments. Values represent the mean ± SD. Statistical significance by Student’s t-Test is indicated: **p<
0.01.
https://doi.org/10.1371/journal.pone.0180386.g004
PesA, a PAPI-1 encoded small RNA of P. aeruginosa
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sfGFP, carrying the same pyoS3A-I region as pBBR1-lacZ::pyoS3A-I::sfGFP in which only the
pyoS3I gene was translationally fused with sfGFP. GFP analyses confirmed that PesA influence
in a positive manner the regulation of pyoS3I in the mono-cistronic construct, with a ~20%
increment in GFP activity in the presence of PesA overexpression in the wild-type back-
ground, and a ~40% decrease in the PA14 ΔpesA background (Fig 9B). This suggested that the
translation of the two genes is not merely and solely coupled and that the effect of PesA on
pyoS3I do not require the translation of pyoS3A.
To assess the influence of PesA also on the pyoS3A gene, we substituted the sequence coding
for the F’LacZ domain in pBBR1-lacZ::pyoS3A-I::sfGFP with the one of the reporter gene
mCherry, and monitored simultaneously the activity of both mCherry and sfGFP of the trans-
lational fusionmCherry::pyoS3A-S3I::sfGFP. As shown in Fig 9C, the ~50% increase in sfGFP
activity followed by PesA overexpression, and the ~25% decrease in the PA14 ΔpesA back-
ground reconfirmed the positive regulation exerted by PesA on the pyoS3I gene. mCherry also
showed an increase in activity when PesA was overexpressed, suggesting that PesA also exerts
a positive regulation on the upstream gene pyoS3A. Thus, PesA seems to be a positive regulator
of the whole pyoS3 operon.
Quantitative RT-PCR on total mRNA of wild-type and ΔpesA strains was also performed to
check whether PesA influenced pyoS3mRNA levels. Samples were taken at mid-, late-expo-
nential and stationary phase (OD600 of 0.8, 1.6 and 2.7, respectively) and both genes, pyoS3A
and pyoS3I, were analyzed for their expression levels. No significant differences were observed
either for pyoS3A or pyoS3I in wild-type and ΔpesA backgrounds at any time-point. Notably,
the expression levels of the two genes were comparable at every time-point and seemed not to
be influenced by the growth phase, being constant along the growth curve (S5 Table). We con-
clude that PesA exerts positive regulation on pyoS3A-ImRNA by modulating mRNA translat-
ability and without influencing its stability.
Fig 5. PesA deletion enhances UV sensitivity similarly to pyoS3 operon deletion. 3 μl of cultures of
PA14 wt, ΔpesA and ΔpyoS3, serially diluted 10-fold, were spotted onto LB-agar plates, and treated with UV
light at the indicated doses. Surviving CFUs were observed after overnight incubation at 37˚C.
https://doi.org/10.1371/journal.pone.0180386.g005
PesA, a PAPI-1 encoded small RNA of P. aeruginosa
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By the use of the IntaRNA web tool [44, 45], we also detected a putative interacting region
between PesA and the leader sequence of the pyoS3 operon, from -76 to -42 from the TTG
start codon of the pyoS3A gene. To evaluate whether PesA was also able to influence the
S3-operon translation by acting on its leader sequence, we generated the translational fusion
leader-pyoS3A::sfGFP, by cloning the whole leader region of the pyoS3 operon and the
sequence encoding the first 37 aminoacids of pyos3A gene, in frame with the sfGFP reporter.
The comparison of the fluorescence activity of the leader-pyoS3A::sfGFP translational fusion
between the wild-type and ΔpesA genetic background did not show any significant difference,
not even in presence of PesA overexpression from pGM-pesA in wild-type (S2 Fig). Spurious
outside interactions of PesA with sfGFP and mCherry open reading frame were ruled out
using alternative reporter plasmids carrying the sfGFP andmCherry genes alone (S2 Fig).
Discussion
We studied the novel P. aeruginosa sRNA PesA, which was originally identified as being tran-
scribed from the horizontally acquired pathogenicity island PAPI-1 in the strain PA14. Our
analysis revealed that PesA is widespread in clinical isolates from patients affected by chronic
respiratory diseases, such as CF, being expressed in 55% of the cases tested. Moreover, PesA
expression is responsive to low oxygen conditions, a hallmark of CF and COPD, and impacts
P. aeruginosa pathogenicity in CF bronchial cells. These results suggest that PesA could be rele-
vant during P. aeruginosa infection in chronic respiratory diseases.
Fig 6. Time course of cell viability of IB3-1 cells following bacterial infection with P. aeruginosa PA14
wild-type andΔpesA. Cell viability, assessed as a reduction of MTT salt, was quantified by the optical
density (OD) at 490 nm. IB3-1 cells were seeded at a density of 5 × 104 cells/well into 96-well microplates, and
infected with 5 × 106 bacterial cells (MOI 1:100). At every time point, data are shown as the difference in
OD490 between the PA14 wild-type strain and the sRNA-deleted mutant ΔpesA. Uninfected cells were used
as positive control of cell viability. Data derive from three independent experiments. Results are shown as the
difference in the OD490 reached at the different time points by IB3-1 cells infected by the mutant strain or non-
infected, subtracted of the OD490 reached by IB3-cells infected with the wild-type strain. Values represent the
mean ± standard error of the mean (SEM). Statistical significance between wild-type and ΔpesA strains by
Student’s t-Test is indicated: *p< 0.05.
https://doi.org/10.1371/journal.pone.0180386.g006
PesA, a PAPI-1 encoded small RNA of P. aeruginosa
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Fig 7. Interaction of PesA with pyoS3A-I mRNA. A) Prediction by TargetRNA software of the base-pairing
interactions between PesA and pyoS3A-I mRNA. B) In vitro interaction between PesA RNA and pyoS3A-I
mRNA by an electrophoretic mobility shift assay. Increasing amounts of PesA RNA (0, 0.08, 0.15, and 0.25
pmol; lanes 1–4) or, as a negative control, E. coli RseX RNA (0.25 and 2.5 pmol; lanes 5 and 6) were
incubated at 37˚C for 20 min with 0.15 pmol radiolabeled pyoS3A-I mRNA and loaded onto a native 6%
polyacrylamide gel.
https://doi.org/10.1371/journal.pone.0180386.g007
Fig 8. PesA deletion impairs the production of pyocin S3. Plate showing the effects of pyocin S3 present
in the filtered supernatants of PA14 wild-type, ΔpesA and ΔpyoS3A-I on the killing of the indicator strain P.
aeruginosa ATCC 27853. Drops of 5 μl of filtered supernatants from PA14 wild-type, ΔpesA and ΔpyoS3A-I
cultures at OD600 = 1 were deposited on Luria-Bertani agar plates. A layer of the indicator strain P. aeruginosa
ATCC 27853 was plated over the dried drops by inclusion in 0.7% agar. Plates were incubated overnight at
37˚C. Clearer haloes represent inhibition (killing) of the indicator strain by pyocin S3 present in the sedimented
supernatants.
https://doi.org/10.1371/journal.pone.0180386.g008
PesA, a PAPI-1 encoded small RNA of P. aeruginosa
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We speculated that PesA had the potential to act as a trans-encoded base-pairing sRNA
involved also in the post-transcriptional regulation of genes located outside PAPI-1 and thus
performed genome-wide bioinformatics screenings for target genes. One predicted target was
the pyoS3A-I operon coding for pyocin S3. We then confirmed that both pyoS3A and pyoS3I
genes are positively influenced by PesA. The interaction of PesA with the bicistronic pyoS3A-I
mRNA is suggested to simultaneously stimulate translation initiation and termination of
pyoS3I and pyoS3A, respectively, without influencing stability of the pyoS3A-ImRNA. Interest-
ingly, PesA could impact a putative mechanism of translation coupling between pyoS3I and
Fig 9. PesA positively regulates the expression of both the pyoS3A and pyoS3I translational fusions in
PA14. Comparison of the sfGFP and mCherry activities expressed in arbitrary units (AU) resulting from the
translational fusion of (A) lacZ::pyos3A-I::sfGFP, (B) pyoS3I::sfGFP and (C) Cherry::pyoS3A-I::sfGFP
combined with the control vector (pGM931) or the plasmid overexpressing PesA (pGM-pesA), in PA14 wild-
type and PA14 ΔpesA. The strains were grown to an OD600 of 1.8 in LB medium supplemented with gentamicin
and carbenicillin, to maintain pBBR1- and pGM- plasmids, respectively, and arabinose, to induce PesA
overexpression. Cells were harvested and treated for sfGFP and mCherry activity determination by measuring
fluorescence polarization FP485/535 and fluorescence intensity FI590/635, respectively. sfGFP and mCherry
activities are expressed as ratio FP485/535/Abs595 and FI590/635/Abs595, respectively. Data derive from three
independent experiments. Values represent the mean ± SD. Statistical significance by Student’s t-Test is
indicated: *p<0.05; **p< 0.01.
https://doi.org/10.1371/journal.pone.0180386.g009
PesA, a PAPI-1 encoded small RNA of P. aeruginosa
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pyoS3A [22] that remains to be elucidated. However, in this paper we demonstrate that stimu-
lation of pyoS3I by PesA does not require translation of the upstream pyoS3A thus suggesting
that the two genes are not strictly translationally coupled. This scenario, as a whole, is compati-
ble with the role of PesA in assuring balanced expression of toxin S3A and antitoxin S3I to pre-
vent deleterious effects on the producing host. Overall, these data obtained with the reporter
genes are consistent with the observation that PesA deletion results in strong reduction of pyo-
cin S3 production (Fig 8).
It is conceivable that PesA can be involved in mechanisms of niche establishment via pyocin
S3. PesA was in fact also detected in environmental isolates and its expression from PAPI-1
might confer a selective advantage that favours PAPI-1 maintenance in the environment due
to its regulation of pyocin S3.
It is likely that PesA has a broad set of target genes whose functions go beyond the niche
establishment. The observation that PesA deletion induces less killing in infected CF bronchial
epithelial cells suggests that PesA could modulate, directly or indirectly, virulence factors of P.
aeruginosa. It was previously shown that pyocin S2 is endowed with cytotoxic activity on
human cell lines [46]. It can be argued that pyocin S3 has similar effects and can act as viru-
lence factor whose regulation is under the control of PesA.
Furthermore, PesA could regulate the expression of genes involved in DNA damage
repair as suggested by the increased sensitivity of ΔpesAmutant to fluoroquinolone antibiotic
ciprofloxacin and to UV irradiation. Intriguingly, the degree of UV sensitivity displayed by
the ΔpesAmutant is comparable to that of a strain deleted for pyoS3A-I. These results imply a
potential involvement of the DNase activity of pyocin S3 in DNA damage repair, and intro-
duce an intriguing network among sRNAs, pyocins and DNA damage repair that will require
additional experiments to be elucidated. To our knowledge this is the first work characteriz-
ing a sRNA encoded in a pathogenicity island in P. aeruginosa. In addition, our results indi-
cate that PesA is able to modulate key genes located outside the PAPI-1. In summary, the
horizontal acquisition of PAPI-1 could provide the new host with a regulatory function that
can switch the expression of genes involved in niche establishment, virulence and stress
resistance.
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for total RNA extraction and analysis by Northern blot. B) PA14 strains harbouring pGM-
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S2 Fig. Fluorescence activity to check PesA regulation on the leader of pyoS3A gene, and
spurious outside interactions of PesA with sfGFP andmCherry open reading frames. A)
Comparison of the sfGFP activity resulting from the translational fusion leader-pyoS3A::sfGFP
in PA14 wild-type and PA14 ΔpesA (-), and combined with the control vector (pGM931) or
the plasmid overexpressing PesA (pGM-pesA) in PA14 wild-type. B) Comparison of the fluo-
rescence activity of the reporter gene sfGFP combined with the control vector (pGM931) or
the plasmid overexpressing PesA (pGM-pesA), in PA14 wild-type and PA14 ΔpesA. C)
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Abstract 
The small RNA ErsA of Pseudomonas aeruginosa was previously suggested to be involved in 
biofilm formation via negative post-transcriptional regulation of the algC gene that encodes the 
virulence-associated enzyme AlgC, which provides sugar precursors for the synthesis of several 
polysaccharides. In this study, we show that a knock-out ersA mutant strain form a flat and uniform 
biofilm, not characterized by mushroom-multicellular structures typical of mature biofilm. 
Conversely, the knock-out mutant strain showed enhanced swarming and twitching motilities. To 
assess the influence of ErsA on the P. aeruginosa transcriptome, we performed RNA-seq 
experiments comparing the knock-out mutant with the wild-type. More than 160 genes were found 
differentially expressed in the knock-out mutant. Parts of these genes, important for biofilm 
formation and motility regulation, are known to belong also to the AmrZ transcriptional regulator 
regulon. Here, we show that ErsA binds in vitro and positively regulates amrZ mRNA at post-
transcriptional level in vivo suggesting an interesting contribution of the ErsA-amrZ mRNA 
interaction in biofilm development at several regulatory levels.  
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Introduction 
Biofilm formation is considered to be an adaptive strategy of the human pathogen Pseudomonas 
aeruginosa, and the switch from the motile to a sessile mode of growth represents an important step 
in the virulence of this pathogen (Costerton et al., 1999).  
Biofilms are microbial communities assembled in a self-produced matrix of exopolysaccharides, 
proteins and DNA (Ma et al., 2006), generating conditions that confer resistance and protection 
against antimicrobial agents and the immune system. The biofilm lifestyle cycle of P. aeruginosa 
PAO1 develops through coordinated stages. Adhesion to a surface is the first step in the 
colonization of P. aeruginosa and is followed by cell-to-cell agglutination. Attachment is an 
irreversible condition characterized by formation of microcolonies that confluence in more 
structured and three-dimensional clusters. During these two stages, the bacterial cells display three 
types of motility, swimming movement in liquid or low-viscosity conditions, swarming on 
semisolid surface and twitching on a solid surface. Swarming motility is based on flagella and type 
IV pili as well as on biosurfactants, swimming is flagella-dependent, and twitching relies on 
extension and retraction of type IV pili (Kohler et al., 2000; O’Toole and Kolter, 1998; Wang et al., 
2014). The final stage of biofilm development is bacterial dispersion, in which the bacteria re-enter 
the planktonic state of spreading and colonizing other surfaces (Flemming et al., 2007; Wang et al., 
2014).  
As summarized in Fig. 1, intertwined regulatory pathways and numerous regulators control 
transcriptionally and post-transcriptionally biofilm development. Most of these regulators are 
coordinated by the alternative sigma factor AlgT/U (σ22) (Potvin et al., 2008), a mediator of stress 
response and a functional homologue of E. coli σE (Yu et al., 1995). AlgU regulates the alginate 
production driving the expression of algD operon, and activating two transcriptional regulators, 
AlgR and AmrZ, both required for alginate production in multiple mucoid strains (Mohr et al., 
1991, 1992; Yu et al., 1995). AmrZ, besides the interaction with algD, also directly affects the P. 
aeruginosa exopolysaccharides profile. In fact, as shown in Fig.1, AmrZ triggers the expression of 
the exopolysaccharide Pel interacting with a member of the pel operon (pelB), represses the 
expression of the exopolysaccharide Psl binding to the pslA promoter. In addition, AmrZ affects the 
intracellular levels of the signaling molecule bis (3’-5’)-cyclic diguanylic monophosphate (c-di-
GMP) (Jones et al., 2014; Petrova et al., 2014; Xu et al., 2016). Pel and Psl exopolysaccharides are 
the major contributors to P. aeruginosa biofilm structure and development. Psl supports the cell-to-
cell interactions during the initial attachment and adhesion phase, forming a fiber web to constitute 
a scaffold for the biofilm shaping, and Pel provides structural stability to the global configuration 
(Jennings et al., 2015; Ma et al., 2006, 2007; Yang et al., 2011).  
Biosynthesis of Pel, Psl and LPS uses common sugar precursors supplied by the AlgU-induced 
AlgC enzyme, which coordinates the levels of exopolysaccharides in the cell, catalyzing the 
conversion of Man-6-P and glucose-6-P (Glc-6-P) to Man-1-P and Glc-1-P, respectively (Coyne et 
al., 1994; Ma et al., 2012). AlgC is positively regulated by AlgR at the transcriptional level, and 
negatively regulated by the small RNA (sRNA) ErsA at the post-transcriptional level (Ferrara et al., 
2015; Wozniak and Ohman, 1994; Zielinski et al, 1991). ErsA is a novel sRNA recently 
characterized in P. aeruginosa whose expression responds to several infection cues such as limited 
iron availability, temperature shifts from environmental to body temperature and reduced oxygen 
conditions. The incoherent feed-forward loop settled by ErsA and AlgU to fine-regulate AlgC was 
supposed to be an additional regulatory route in the complex process of biofilm shaping, in 
particular balancing the sugar precursors production in the exopolysaccharides biosynthesis (Ferrara 
et al., 2015). 
In a recent study (Zhang et al., 2017), ErsA has been described to bind and regulate at the post-
transcriptional level oprD mRNA, coding for a porin which highly contributes to carbapenems 
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sensitivity. The overexpression of ErsA negatively affects translation of oprD mRNA and 
consequently the OprD protein level, reducing susceptibility to meropenem treatment. These 
findings contribute to enforce the role of ErsA in P. aeruginosa pathogenesis by regulating different 
virulence traits. 
sRNAs can regulate multiple targets, allowing the cells to have a faster response to stress conditions 
and adapt in a short time frame to environmental changes (Beisel and Storz, 2010).  
ErsA provides a relevant regulatory contribution balancing metabolism and virulence routes by 
regulating the checkpoint enzyme AlgC and it was conceivable to hypothesize novel ErsA targets in 
the large landscape of regulatory routes connected to exopolysaccharides production and biofilm 
formation. 
In this study, we scrutinized for the first time the regulatory pattern of ErsA in P. aeruginosa 
biofilm formation revealing a positive contribution of the sRNA in biofilm maturation and 
shaping. An RNA-seq approach allowed us to identify several genes involved in this process, 
whose expression was deregulated in an ErsA deletion mutant. Most of these genes belong to 
AmrZ regulon, which was shown to be a novel direct target for ErsA (Fig. 1). 
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MATERIALS AND METHODS 
Bacterial strains and media. Bacteria and plasmids used in this study are listed in Table S1. 
Escherichia coli strains were grown 37°C in Lysogeny Broth (LB). P. aeruginosa strains were 
grown at 37°C in LB or in Brain Heart Infusion Broth (BHI) or Artificial Sputum Medium 
(ASM) in flasks at 200 r.p.m.. When required, for E.coli strains the media were supplemented 
with 10 ug/ml gentamycin, 100 ug/ml ampicillin, 25 ug/ml kanamycin, and for P. aeruginosa 
strains with 50 ug/ml gentamycin and 300 ug/ml carbenicillin. For monitoring biofilm 
development in flow-chambers conditions, PAO1 wild-type and PAO1 ΔersA (Ferrara et al., 
2015) were chromosomally tagged with green fluorescent protein (GFP) and grown in modified 
FAB medium (Heydorn et al., 2000) supplemented with 0.3 mM glucose.  
ErsA overexpression was obtained from pGM-ersA plasmid (Ferrara et al., 2015) using arabinose 
0.2% when required.  
Plasmid construction and mutant generation. Oligonucleotides used in this study are listed in 
Table S2. Translational fusions pBBR1 amrZ::sfGFP, amrZCIS1::sfGFP, amrZΔIS2::sfGFP and 
amrZCIS1ΔIS2::sfGFP under the PLtetO-1 constitutive promoter were generated as follows. A 
DNA fragment of 161 bp including 56 nt of UTR-region and 35 codons of the open reading 
frame (ORF) of amrZ was amplified by PCR with oligos 1/2 (Table S2), digested with NsiI-NheI 
and cloned into the sfGFP reporter vectors pXG10-SF resulting in the plasmid pXG10-
amrZ::sfGFP. Likewise for amrZ::sfGFP, 161 bp including 56 nt of UTR-region and 35 codons 
of the open reading frame (ORF) of amrZ were amplified by PCR with oligos 1/2 (Table S2) 
from pUCIDT amrZCIS plasmid, carrying the synthetic and modified sequence of amrZ, 
digested with NsiI-NheI and cloned into pXG10-SF to generate the translational fusion pXG10-
amrZCIS1::sfGFP. The translational fusion pXG10-amrZΔIS2::sfGFP was generated amplifying 
a fragment of 119 bp including 56 nt of UTR-region and 21 codons of the amrZ ORF with oligos 
1/3 (Table S2) digested with NsiI-NheI and cloned into pXG10-SF. AmrZCIS1ΔIS2::sfGFP was 
constructed amplifying a fragment of 119 bp including 56 nt of UTR-region and 21 codons of 
the amrZ ORF with oligos 1/3 (Table S2) from pUCIDT amrZCIS plasmid. All the fragments 
from the PLtetO-1 promoter to the end of the GFP reporter gene, including the different versions of 
amrZ, were amplified from pXG10-amrZ::sfGF, amrZCIS1::sfGFP, amrZΔIS2::sfGFP and 
amrZCIS1ΔIS2::sfGFP, using oligos 9/10, digested with ClaI-XbaI and cloned into the low-copy 
number shuttle vector pBBR1-MCS5 generating the pBBR1-amrZ::sfGFP, amrZCIS1::sfGFP, 
amrZΔIS2::sfGFP and amrZCIS1ΔIS2::sfGFP, respectively. All the plasmids were then 
transformed into P. aeruginosa strains as reported previously (Ferrara et al., 2015). 
Mini-Tn7- gfp strain construction. A PrrB1-gfp-a transposon cassette was inserted into the 
chromosome of PAO1 wild-type and ΔersA by conjugation using pBK-miniTn7-ΩGm as a 
delivery plasmid carrying the cassette inserted into NotI site as reported previously (Lambertsen 
et al., 2004). 
Biofilm adhesion in 96-wells peg-lid microtiter. A quantity of 200 ul of overnight bacterial 
cultures grown in BHI or ASM and diluted to OD600= 0.01, with the addition of carbenicillin 300 
ug/ml and arabinose 0.2% when required, was aliquoted into 96-well peg-lid microtiter plates 
(Nunclon Delta Surface Cat. No.167008, Nunc TSP Cat. No.445497, Thermo Scientific) as 
reported previously (Harrison et al., 2010). The plates were incubated at 37°C in aerobic 
conditions with 100 r.p.m. stirring. After 20 hrs of incubation, growth was monitored by 
measuring the OD600, and the ability of the P. aeruginosa strains to adhere to the polystyrene 
peg-lid was tested by crystal violet staining. Briefly, the peg-lid was washed twice with saline 
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solution and then stained with 0.1% crystal violet for 20 min (O´Toole, 2011). Excess of stain 
was rinsed off by placing the peg-lid in saline solution before to solubilize the dye in absolute 
ethanol per well. The optical density of each well was measured at 590 nm. Biofilm formation 
was expressed in adhesion units as the result of the OD590/OD600 ratio and statistical analysis 
were performed using T-Test. 
Biofilm development in flow-cells system. Biofilms were grown at 30°C in flow chambers 
composed by three individual channels as described previously (Møller et al., 1998). PAO1 wild-
type and ΔersA overnight cultures diluted to OD600 = 0.01 were inoculated into each flow 
channel with a small syringe. After 1 hr without flow, each channel was supplied with a flow of 
3 ml/h of FAB medium with glucose 0.3 mM, using a Watson Marlow 205S peristaltic pump. 
The mean flow velocity in the flow cells was 0.2 mm/s.  
Confocal laser scanning microscopy and image processing. The microscopic analyses were 
performed using a Zeiss LSM510 confocal laser scanning microscope (CLSM; Carl Zeiss, Jena, 
Germany) equipped with an Ar/Kr laser and filter sets for GFP detection (excitation, 488 nm; 
emission, 517 nm). Images were obtained using a 40×/1.3 Plan-Neofluar oil objective.  
Simulated shadow projection images and cross sections were generated using the IMARIS 
software package (Bitplane AG, Zürich, Switzerland). 
The experiment was performed in triplicate for each strain acquiring 7 random images for each 
channel every day for 3 days. Thus, 21 images for each time point were employed for the 
statistical analyses using COMSTAT 2.1 software (Heydorn et al., 2000; Vorregaard, 2008, 
www.comstat.dk) 
 
Co-twitching and co-swarming motility assays. Swarming assays were performed using 
Nutrient Broth (Nutrient Broth n°2 Oxoid) medium plates supplemented with 0.5% glucose and 
0.5% Bacto-agar (Difco). Overnight cultures normalized at the same OD600 of PAO1 wildtype 
and ΔersA were spotted on the same plate suitably spaced each other and placed at both 28°C 
and 37°C for 24 hrs.  
Twitching was performed on LB plates supplemented with 1% Bacto-agar (Difco). The 
inoculation was performed with a sterile toothpick dipped in the overnight cultures and followed 
at 37°C for 24 hrs. Statistical analysis was performed on 3 independent replicates with GraphPad 
Prism software. 
 
RNA sequencing and data analysis. For RNA-Seq, cultures of wild-type PAO1 and ∆ersA 
strains were grown to early stationary phase (OD600 = 2.7) in BHI medium. For each strain, total 
RNA was extracted from at least two independent biological replicates using Trizol reagent 
(Thermo Fisher Scientific Inc.) followed by RNA clean & concentrator kit (Zymo Research, 
Irvin, USA) accordingly to vendors’ protocols. RNA quality was checked using RNA Nano kit 
on an Agilent Bioanalyzer 2100 machine. Samples with an RNA integrity number (RIN) greater 
than 9 were used in downstream analysis. Strand-specific sequencing libraries were prepared 
using 50 ng of mRNA-enriched samples as input for TruSeq stranded mRNA library preparation 
kit (Illumina) following vendor’s recommendations. Sequencing was performed on an Illumina 
NextSeq 500 to a depth of 15-20 million reads per sample. After quality filtering, raw reads were 
aligned using BWA aligner against P. aeruginosa PAO1 genome (NC_002516.2). Read count 
for gene relative abundance was obtained using HTSeq-count tool from HTSeq package (Anders 
et al., 2015), while differential expression analysis and statistical analysis were performed as 
previously described (Peano et al., 2014). RNA-seq data have been deposited in the 
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ArrayExpress database at EMBL-EBI (www.ebi.ac.uk/arrayexpress) under accession number E-
MTAB-6247.  
 
RNA isolation and synthesis. Total RNA was extracted as reported previously (Ferrara et al., 
2012). RNA for RNA/RNA interaction assays was prepared by T7 RNA polymerase 
transcription of gel-purified DNA fragments. DNA fragments for ErsA RNA and amrZ mRNAs 
(amrZ, amrZCIS1, amrZΔIS2, amrZCIS1ΔIS2) preparations were amplified from P. aeruginosa 
PAO1 genomic DNA with oligo pairs 4/5 or 4/6 and 7/8, respectively. The transcription 
reactions were performed using the Riboprobe® System-T7 (Promega) with 300 ng of DNA 
template. DNA probe was 5′-end–labelled with (γ-32P) ATP and T4 polynucleotide kinase 
(Promega) according to manufacturer's instruction. Synthesized RNA was precipitated and 
resuspended in diethylpyrocarbonate-treated water. Purified RNA was checked by denaturing 
polyacrylamide gel electrophoresis and quantified using a Qubit Fluorometer.  
In vitro and in vivo assays of sRNA/mRNA interactions. To assess the ErsA/amrZ mRNA 
interactions in vitro, the binding reactions were set up as described previously (Ferrara et al., 
2015). After the electrophoresis, the membrane was UV-crosslinked and hybridized with a [32P]-
labelled oligo and the radioactive bands were acquired using a TyphoonTM 8600 variable mode 
imager scanner (GE Healthcare BioSciences) and visualized with ImageQuant software 
(Molecular Dynamics). 
Non-radioactive EMSA were performed using Mini-Protean® Electrophoresis System (BioRad) 
at 4°C and 150 V for 45 min. The gel was stained in SYBR™ Gold Nucleic Acid Gel Stain 
diluted in 0.5 × TBE. Images were acquired by Gel Doc™ XR+ (BioRad) imaging system.  
Fluoresence measurements of P. aeruginosa strains carrying the reporters pBBR1-amrZ::gfp 
were carried out as previously reported (Ferrara et al., 2015). Abs595 and fluorescence 
polarization FP485/535 were measured in a Tecan Infinity PRO 200 reader, using Magellan as data 
analysis software (Tecan). GFP activities were expressed in Arbitrary Units (AU) as ratio 
FP485/535/Abs595. Statistical analysis performed on three individual clones per strain using T-test. 
Results 
ErsA is required for biofilm adhesion and development  
We investigated the effects of deleting the ersA gene on biofilm formation using a semi-quantitative 
microtiter “peg-lid” assay in Brain Heart Infusion medium (BHI). As shown in Fig. 2A, the ErsA 
deletion resulted in decreased biofilm formation in BHI compared to PAO1 wild-type strain, and 
the complemented strain carrying the plasmid pGM-ersA produces more biofilm than the ersA 
deletion mutant strain carrying the pGM931 empty vector (Fig. 2B). 
To examine the role of ErsA in P. aeruginosa biofilm architecture development, we cultivated the 
PAO1 wild-type and the ΔersA GFP-tagged strain, in flow-chambers continuously supplied with 
modified FAB medium supplemented with glucose. Biofilm development stages were followed and 
visualized daily for 3 days by Confocal Laser Microscopy (CLSM). In agreement with biofilm 
formation in the microtiter “peg-lid” assays in BHI medium, the PAO1 ΔersA strain developed less 
biofilm biomass than the wild-type, which showed the mushroom-like structures typical of 3-days 
old P. aeruginosa biofilms in flow-cells system (Fig. 2C). The statistically significant differences in 
biomass and spatial structure between PAO1 wild-type and ΔersA biofilms were determined by the 
COMSTAT 2.1 software (Heydorn et al., 2000; Vorregaard, 2008) as represented in Fig. 2C. We 
further noticed the positive influence of ErsA on adhesion and biofilm formation when 
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overexpressed in PAO1 wild-type and ΔersA strains, grown in artificial sputum medium (ASM) 
(Fig. S1), which is defined to reflect the chemical environment of CF lungs (Haley et al., 2012; 
Sriramulu and Shre, 1999). 
ErsA negatively regulates swarming and twitching motility  
Motility is crucial in cell-to-cell adherence and attachment in early biofilm stages and it has been 
suggested an inverse regulation of motility and biofilm during biofilm development (Caiazza et al., 
2007; Wang et al., 2014). Several transcriptional and post-transcriptional regulators are involved in 
these pathways and some of them coordinate both sessile and motile lifestyles (Gloag et al., 2013; 
O’Toole and Kolter, 1998; Ramsey and Whiteley, 2004; Shrout et al., 2006). To further investigate 
the involvement of ErsA on these biofilm-related phenotypes, we performed co-swarming, 
swimming and co-twitching experiments comparing PAO1 wild-type with ΔersA strain. Our results 
reveal a negative influence of ErsA on both swarming and twitching motility (Fig. 3) and the 
temperature conditions do not affect ErsA regulation on swarming motility (Fig. 3A). No 
differences between PAO1 wild-type and ΔersA mutant strain were observed for swimming motility 
(Fig. S2). 
ErsA deletion affects the transcriptional levels of 168 genes in P. aeruginosa PAO1 
Small RNAs are usually involved in post-transcriptional regulation, and the role of ErsA in biofilm 
development and motility shown in this study, suggested interference with the translation of 
transcriptional regulators. Thus, to expand the panel of ErsA targets in P. aeruginosa PAO1, and to 
have a better view of the effect of ErsA activity on the genome-wide gene expression, we 
performed an RNA-seq experiment comparing PAO1 wild-type to ErsA deletion mutant strains, 
grown to late exponential phase (OD600 of 2.7) in BHI medium. We observed 168 genes (Table S3 
and the most representative genes listed in Table 1) differentially expressed in the ersA deletion 
mutant when compared to the wild-type strain. Among the 29 genes upregulated in the ersA 
deletion mutant we identified genes involved in denitrification and nitrate metabolism (narI, narJ, 
nirN) as well as type VI and III secretion systems effectors (tssA1, tsi4, tse6). 
The majority of genes were downregulated in absence of ErsA (139 genes); the strongest negative 
effect was observed for narK1 involved in nitrate transport. The other hits with a change of 
Log2(FC) ≤ -1.5, comprise well described genes involved in biofilm formation and motility (algD, 
esrC, ppyR, pelCDEFG, roeA), energy metabolism and carbon metabolism (prpD, prpC, coxA, 
coxB), heat-shock proteins (htpG, hslU, hslV, ibpA, dnaK, dnaJ) and phzS involved in pyocyanin 
production. 
ErsA binds in vitro and positively regulates in vivo amrZ mRNA at the post-transcriptional 
level 
In order to investigate the possibility that ErsA regulates expression of AmrZ at the post-
transcriptional level through direct binding of ErsA to the amrZ mRNA, we used a plasmid based 
GFP-reporter system and an electromobility-shift assay for the in vivo and in vitro validation, 
respectively. Before this, however, we used the full-length ErsA RNA sequence and the amrZ 
mRNA (including the 5′ untranslated region, 5’-UTR), as inputs in the web tool IntaRNA (Wright et 
al., 2014) to predict ErsA-amrZ mRNA interactions. This tool identified two putative interaction 
sites for ErsA on the amrZ mRNA. The interaction site 1 (IS1) involves part of the ErsA U-rich 
unstructured region, from nt 41 to 52 and is predicted to bind to amrZ mRNA in the region 
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spanning +5 to +14 from the translational starting site AUG (Fig. 4A). The ErsA interaction site 2 
(IS2) on amrZ mRNA is predicted at positions +65 to +89 and covers a longer region on ErsA 
unstructured structure, from nt 26 to 56 (Fig. 4A).  
To test the ErsA post-transcriptional regulation on amrZ mRNA, we generated a translational fusion 
between the 5’-UTR along with the first 35 codons of amrZ mRNA and the superfolder variant gene 
of the green fluorescent protein (sfGFP) under the control of the heterologous constitutive promoter 
PLtetO-1. This GFP reporter fusion was transformed into P. aeruginosa PAO1 wild-type and ΔersA 
strains, respectively. As shown in Fig. 4B, the ErsA deletion caused a reduction in GFP activity of 
the amrZ::sfGFP translational fusion compared to the wild-type and it was possible to increase the 
amrZ::sfGFP translational levels in ΔersA mutant strain by inducing with arabinose the expression 
of ersA from the pGM-ersA plasmid (Fig.S3), suggesting a direct effect of ErsA on amrZ translation 
efficiency. The lack of a full genetic complementation could be explained by the fact that we 
observed by Northern blot that the ErsA levels expressed by pGM-ersA in a ΔersA strain are lower 
than those expressed by the chromosomal copy of ersA gene (data not shown). This scenario is 
different from that observed for the expression of ErsA from pGM-ersA in a wt background where 
the ErsA levels resulted to be 5-6 fold higher than those expressed by the chromosomal copy of 
ersA gene (Ferrara et al., 2015). This would suggest a higher ErsA degradation in a ΔersA 
background. 
Interactions of ErsA with the GFP open reading frame were previously controlled using a plasmid 
carrying exclusively the gfp gene (Ferrara et al., 2015). These results strongly suggested positive 
regulation by ErsA on translation of the amrZ gene. This regulation does not depend on Hfq (data 
not shown). Furthermore, to document the predicted ErsA–amrZ mRNA interaction also in vitro, 
ErsA RNA and amrZ mRNA were synthesized, mixed and analyzed by electrophoresis on native 
polyacrylamide gels. As shown in Fig. 4C, ErsA specifically formed a complex with the amrZ 
mRNA. 
To further document the specific ErsA-amrZ mRNA interactions, we generated three amrZ mRNA 
fragments, i) amrZCIS1, in which the interaction site 1 has been substituted with its complementary 
sequence, ii) amrZΔIS2 characterized by the deletion of the interaction site 2 and iii) amrZ 
CIS1ΔIS2 containing both the modifications present in amrZCIS1 and in amrZΔIS2. The in vitro 
analysis showed that ErsA forms a complex with both amrZCIS1 and amrZΔIS2 (Fig. 5A and B), 
and it does not bind to amrZ CIS1ΔIS2 mRNA (Fig. 5C). This suggested that both interaction 
sequences are involved in ErsA-amrZ binding (Fig. S4). In vitro results were corroborated by in 
vivo experiments, measuring the translational levels of amrZCIS1::sfGFP, amrZΔIS2::sfGFP and 
amrZCIS1ΔIS2::sfGFP in PAO1 wild-type and ΔersA strains. The absence of the interaction sites 
for ErsA causes a reduction of translational fusions activity in both genetic backgrounds (Fig.5D), 
associated also to a transcriptional instability (data not shown).  
Discussion 
ErsA is a 132 nt long sRNA expressed in P. aeruginosa in concert with other stress-induced genes. 
We have previously reported that ErsA regulates exopolysaccharide production, negatively 
affecting at the post-transcriptional level algC mRNA translation in an incoherent feed-forward 
loop driven by the alternative sigma factor σ22 (Ferrara et al., 2015). Several sRNAs can regulate 
broad spectra of mRNA targets, usually governing similar or correlated cellular processes (Storz et 
al., 2011). In this work, we expanded the target spectrum of ErsA, validating its direct interactions 
with the transcriptional regulator AmrZ, which is involved in biofilm and motility, in particular 
promoting multicellular colony formation and repressing swarming and twitching motility.  
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P. aeruginosa strains exhibiting increased swarming phenotype generally develop flat and uniform 
biofilm in flow cell experiments (Shrout et al., 2006). Likewise, twitching motility is suggested to 
be required for monolayer creation during the initial stages of biofilm development (Guttenplan and 
Kearns, 2013; Shrout et al., 2006). In addition, in gram-negative bacteria, biofilm formation and 
cellular motility are inversely regulated (O’Toole and Kolter, 1998; Wang et al., 2014). According 
to these observations, inactivation of ersA gene results in increased twitching and swarming motility 
leading to a less structured biofilm matrix resulting in development of homogeneous monolayers 
with high surface to volume ratios to the wild-type strain. 
These phenotypes were supported by genome-wide expression analysis, showing that inactivation 
of ErsA affects expression of several genes involved in biofilm development and motility 
regulation, such as pelCDEFG, algD, ppyR and roeA. All these genes are known to be directly or 
indirectly regulated by the transcriptional regulator AmrZ (Jones et al., 2014; Xu et al., 2016).  
Small RNAs can positively or negatively affect translation of transcriptional regulators. For 
example, three sRNAs, DsrA, MicF and GcvB, inhibit translation of the lrp gene, coding for a 
transcriptional regulator involved in amino acid transport and use (Majdalani et al., 2002; Massè et 
al., 2005a; Ottesman et al., 1998; Prèvost et al., 2007). The results of this work strongly suggest that 
ErsA positively affects amrZ translation through direct binding to amrZ mRNA at two different 
segments located on the mRNA, IS1 and IS2, with the former positioned close to the translational 
starting site. ErsA binds to these two regions with the same segment as involved in the algC 
interaction (Ferrara et al., 2015). Likewise ErsA, other sRNAs are known to regulate target 
expression via multiple interactions. SgrS, a regulator of the manXYZ operon binds two different 
sites, both involved in RNaseE-dependent degradation of the mRNA (Rice et al., 2012); the 
aforementioned GcvB sRNA, interacts with two independent regions on the lrp mRNA (Lee and 
Gottesman, 2016); and RyhB is suggested to repress expression of msrB, a methionine oxidase 
gene, interacting with two sites on the same mRNA (Bos et al., 2013).  
It is possible that concomitant binding of two ErsA RNAs to the amrZ mRNA, is required to 
remodel amrZ mRNA secondary structure in order to release the AUG from the interaction with the 
anti-AUG sequence present in amrZ mRNA in its unbound form (Fig. S4). These interactions 
would expose the translational starting site and improve the efficiency of translation of amrZ 
transcript, thus explaining the positive contribution of ErsA at the post-transcriptional level. 
Even though we identified biofilm genes being part of the AmrZ regulon and therefore differentially 
expressed in the absence of ErsA, the transcriptomics data does not reflect in all cases the known 
regulation exerted by AmrZ. For example, the roeA and ppyR genes, suggested to be positively 
regulated by ErsA, are known to be repressed by AmrZ (Jones et al., 2014; Merritt et al., 2010; 
Sternberg et al., 2008). We cannot exclude that ErsA may also stabilize directly these transcripts, 
for instance protecting them from degradation, or that these effects depend on the activity of other 
regulators affecting roeA and ppyR expression. Therefore, ErsA seems to overlap with the AmrZ 
regulon in guiding the switch from a motile life-style into the biofilm mode, extending our previous 
findings of its involvement in extracellular matrix production (Ferrara et al., 2015). ErsA thus 
stimulates indirectly exopolysaccharide production through its control of AmrZ translation; acting 
on AlgC, it may redirect the sugar precursor fluxes providing more building blocks for extracellular 
polysaccharides biosynthesis (Fig. 1). ErsA, in this sense, may be part of a mixed-regulatory circuit, 
like that involved in high osmolarity response in E.coli (Guillier et al., 2006).  
A P. aeruginosa mixed-regulatory circuit could be used to take advantage of ErsA to have a more 
rapid and enhanced response compared to transcriptional regulators, in particular in stress 
conditions (Shimoni et al., 2007) or for niche-competition in case of mixed‐species biofilms. 
Indeed, ErsA has recently been described to be overexpressed in P. aeruginosa biofilm grown with 
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Staphylococcus aureus. However, the role of ErsA in neutralizing S. aereus agents has to be 
investigated (Miller et al., 2017). 
Thus, ErsA may be employed as a “fast switcher” in the regulation of biofilm development at 
multiple stages and regulatory levels, fine-tuning the main routes controlled by the alternative sigma 
factor σ22 in the transition between acute and chronic infection of P. aeruginosa. 
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Figure 1. Schematic representation of different levels of AlgU-dependent regulatory routes in 
Pseudomonas aeruginosa. AlgU drives the expression of the alginate biosynthetic operon by 
activating the expression of algD promoter and it modulates exopolysaccharides (Pel and Psl) 
production by inducing the expression of transcriptional regulators, as AmrZ and AlgR, and the 
small RNA ErsA, which regulates algC at the post-transcriptional level. Green arrows represent 
positive regulations, red arrows negative regulations.  
Figure 2. Biofilm formation of PAO1 wild-type, ΔersA, wild-type/pGM931, ΔersA/pGM931 and 
ΔersA/pGM-ersA strains. A. PAO1 ersA mutant strain produces less biofilm in BHI medium when 
compared to the wild-type strain. B. The phenotype is rescued when the ersA mutation is 
complemented by the pGM-ersA plasmid (4 replicates for each strain, 24 hrs at 37°C. Adhesion 
units are expressed as the ratio of biofilm formation optical density OD590 normalized for the 
bacterial growth OD600). T.Test p.value < 0.001 ***, < 0.01 **, < 0.1 *. C. Spatial distribution of 3 
days-old flow-chamber-grown biofilms of PAO1 wild-type and ΔersA GFP-tagged strains. The 
larger central plots are simulated fluorescence projections, in which long shadows indicate large, 
high micro-colonies. The scale bars shown are also valid for the right and lower frames. Surface to 
volume ratio, thickness distribution and biomass of PAO1 wild-type and ΔersA values are means of 
data from 21 image stacks (seven image stacks from three channels). The statistical analysis was 
performed using GraphPad Prism software (p.value < 0.01 **; < 0.001 ****).  
Figure 3. PAO1 and PAO1 ΔersA motility. ErsA deletion results in more swarming motility 
compared to the PAO1 wild-type on 0.5% Nutrient Broth agar plates supplemented with 0.5% 
glucose at 37°C and 28°C (A), and twitching motility at the plastic-1.0% LB agar interface stained 
with 0.1% crystal violet (B). Statistical analysis was performed on 3 independent replicates with 
GraphPad Prism software (p.value < 0.05 *; < 0.01 **). The best representative pictures are 
displayed. 
Figure 4. Interaction of ErsA with amrZ mRNA. A. Prediction by IntaRNA software of the two 
base-pairing interactions between ErsA and amrZ mRNA. ErsA is predicted to bind to amrZ mRNA 
at two different sites in the ORF; the interaction sequence 1 is close to the ATG (highlighted in 
gray). B. Comparison of the fluorescence polarization expressed in arbitrary units (AU) resulting 
from the translational fusion amrZ::sfGFP in PAO1 and PAO1 ΔersA. The absence of ErsA results 
in a reduction of the reporter activity compared to the reference strain (statistical analysis performed 
on three individual clones per strain using T-test, p.value < 0,01 **). C. In vitro interaction between 
ErsA RNA and amrZ mRNA by electrophoretic mobility shift assay. Increasing amounts of ErsA 
RNA (0.15, 0.3, 0.6, 1.2 pmol; lanes 3–6) or, as a negative control, yeast tRNA (0.89 and 8.9 pmol; 
lanes 7 and 8) were incubated with 0.3 pmol of amrZ mRNA at 37°C for 20 min and loaded onto a 
native 6% polyacrylamide gel. Nucleic acids were transferred onto Hybond N+ nylon membranes. 
After blots, the ErsA-mRNA interactions were tested using oligonucleotide probes for the mRNA 
target. Free target mRNA is indicated with open arrowheads, sRNA/mRNA complex with filled 
arrowheads. 
Figure 5. In vitro (non-radioactive EMSA) and in vivo analysis of ErsA interactions with amrZ and 
amrZ modified transcripts. A. Interactions between ErsA-amrZ mRNA and ErsA- amrZCIS1 
mRNA generated by substitution of IS1 with its complement sequence. B. Interactions between 
ErsA-amrZ mRNA and ErsA- amrZΔIS2 mRNA carrying the deletion of IS2. C. Interactions 
between ErsA-amrZ mRNA and ErsA- amrZCIS1ΔIS2 mRNA characterized by both the 
modifications present in amrZCIS1 and amrZΔIS2. ErsA specifically binds amrZ, amrZCIS1 and 
 120 
 
amrZΔIS2 mRNAs (black arrows) but no complex is formed when combined to amrZCIS1ΔIS2 
mRNA. Binding reactions were performed mixing the amrZ mRNAs forms (5 pmol) with 
increasing amount of ErsA RNA (ratio 1:0.5, 1:1, 1:2). ErsA RNA free form 10 pmol (A lane 9, B 
lane 9, C lane 5), amrZ mRNA free form 5 pmol (A lane 1, B lane 1, C lane 6). D. Comparison of 
the fluorescence intensity expressed in arbitrary units (AU) deriving from amrZ::sfGFP, 
amrZCIS1::sfGFP, amrZΔIS2::sfGFP and amrZCIS1ΔIS2::sfGFP in PAO1 wild-type and ΔersA 
strains. Modification in ErsA interaction site IS1 and/or IS2 causes a reduction in the translational 
levels of amrZ mRNA in PAO1 wild-type, comparable to those measured in ersA deleted strain. T-
test p.value < 0.001 ***. 
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Table 1 Selection of the most representative genes differentially expressed in PAO1 ErsA deletion 
mutant with Log2 (FC) ≤ -1 or Log2 (FC) ≥ 1. 
† Log2 (FC) = log2 of fold change calculated as ratio between gene expression of PAO1 wildtype 
versus PAO1 ΔersA. 
‡ Genes involved in biofilm formation and motility regulation. 
Locus Tag Name and description Log2(FC)† Fold Change 
 
Down-regulated in PAO1∆ersA strain 
  
PA0105 coxB -1,70889 -3,269092 
PA0106 coxA -1,82114 -3,5336031 
PA0792 prpD, propionate catabolism -3,035 -8,1964546 
PA0795 prpC, citrate synthase 2 -2,68584 -6,4345978 
PA1107‡ roeA, RoeA -1,57126 -2,9716413 
PA1596 htpG, heat shock protein HtpG -1,69763 -3,2436766 
PA2663‡ ppyR, Psl and pyoverdine operon regulator, PpyR -2,18138 -4,5358722 
PA3058‡ pelG, PelG -1,4459 -2,7243272 
PA3059‡ pelF, PelF -2,06261 -4,1774136 
PA3060‡ pelE, PelE -1,89954 -3,7309422 
PA3061‡ pelD, PelD -1,54687 -2,9218255 
PA3062‡ pelC, PelC -1,75174 -3,3676448 
PA3126 ibpA, heat-shock protein IbpA -2,64174 -6,240839 
PA3540‡ algD, GDP-mannose 6-dehydrogenase AlgD -1,5095 -2,8471135 
PA3877 narK1,nitrite extrusion protein 1 -3,06065 -8,3434844 
PA3879 narL, two-component response regulator NarL -1,67047 -3,1831828 
PA4217 phzS, flavin-containing monooxygenase -1,60294 -3,037617 
PA4596 esrC, EsrC -2,53876 -5,8108934 
PA4760 dnaJ, DnaJ protein -1,23304 -2,3506178 
PA4761 dnaK, DnaK protein -1,72393 -3,3033504 
PA5053 hslV, heat shock protein HslV -1,52351 -2,87491619 
PA5054 hslU, heat shock protein HslU 
 
-2,14174 -4,4129396 
Up-regulated in PAO1∆ersA strain   
PA0082 tssA1, TssA1 1,424308 2,6838574 
PA0093 tse6, Tse6 1,500855 2,8301039 
PA0509 nirN, NirN 2,22837 4,6860424 
PA2775 tsi4, Tsi4 1,314079 2,4864355 
PA3872 narI, respiratory nitrate reductase gamma chain 3,080462 8,4588527 
PA3873 narJ, respiratory nitrate reductase delta chain 2,190598 4,5649467 
PA3874 narH, respiratory nitrate reductase beta chain 1,653484 3,1459244 
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Figure 5. 
 
 
 
 Figure S1. Biofilm assay in peg-lid microtiter. PAO1wild-type (WT) and ΔersA background strains 
were grown in ASM at 37°C and 100 rpm shaking for 20h in presence of arabinose 0.2% to induce 
the ersA overexpression. The overexpression of ErsA induces an increment of biomass attached to 
the abiotic surface as quantified by crystal violet staining. The statistical analysis was performed 
using GraphPad Prism software (p.value < 0,01 **; < 0,001 ****). 
 
 Figure S2. Swimming motility of PAO1 wild-type and ΔersA strains performed in LB medium 
supplemented with agarose 0.3%, at 37°C for 18 hrs. 
 Figure S3. Comparison of fluorescence intensity of amrZ::sfGFP translational fusion combined 
with the control vector pGM931 and pGM-ersA in PAO1 wild-type and ΔersA strains, in presence 
of arabinose 0.2% to induce ersA expression. Fluorescence intensity was measured after 6 and 24 
hrs from induction with arabinose. 
 
  
 
Figure S4. A. amrZ (from -56 to +105) secondary structure predicted by RNAfold software. B. 
Proposed model for ErsA-amrZ interaction. Two molecules of ErsA are suggested to bind amrZ 
mRNA in IS1 and IS2, remodeling the amrZ secondary structure and exposing the AUG. 
 
Table S1. Bacterial strains and plasmids used in this study 
Strains  Description Construction Reference 
Pseudomonas aeruginosa     
PAO1 Wild-type  (Olson et al., 
2000) 
PAO1ΔersA Markerless ΔersA  (Ferrara et al., 
2015) 
PAO1 miniTn7(Gm)PrrnB1-gfp-a Gmr, Cmr PAO1 wild-type 
containing the 
chromosomal 
insertion 
miniTn7(Gm)PrrnB1-
gfp located just 
downstream of the 
coding region of 
glmS gene. 
This study 
PAO1ΔersA miniTn7(Gm)PrrnB1-gfp a Gmr, Cmr PAO1 ΔersA 
containing the 
chromosomal 
insertion 
miniTn7(Gm)PrrnB1-
gfp located just 
downstream of the 
coding region of 
glmS gene. 
This study 
Escherichia coli    
TOP10 mcrA Δ(mrr-hsdRMS-
mcrBC) φ80lacZDM15 
∆lacX74 deoR recA1 
araD139 ∆(ara-leu)7697 
galU galK rpsL endA1 
nupG 
 Invitrogen 
DH5α fhuA2 lac(del)U169 phoA 
glnV44 Φ80' lacZ(del)M15 
gyrA96 recA1 relA1 endA1 
thi-1 hsdR17 
 Invitrogen 
Plasmids Description Construction Reference 
pXG10-SF sfGFP reporter plasmid; 
lacZ::gfp under PLtetO‐1, 
Cmr 
 (Corcoran et 
al., 2012) 
pXG10-amrZ::sfGFP pXG10-SF derivative; 
PLtetO‐1 -amrZ::sfGFP, Cmr 
contains PCR 
product using 
oligos #1 and #2 
This study 
pXG10-amrZCIS1::sfGFP pXG10-SF derivative; 
PLtetO‐1 -amrZ 
CIS1::sfGFP, Cmr 
contains PCR 
product from 
pUCIDT-amrZ 
CIS1 using oligos 
This study 
#1 and #2  
pXG10-amrZΔIS2::sfGFP pXG10-SF derivative; 
PLtetO‐1 -amrZΔIS2::sfGFP, 
Cmr 
contains PCR 
product using 
oligos #1 and #3 
This study 
pXG10-amrZCIS1ΔIS2::sfGFP pXG10-SF derivative; 
PLtetO‐1 -
amrZCIS1ΔIS2::sfGFP, 
Cmr 
contains PCR 
product from 
pUCIDT-amrZ 
CIS1 using oligos 
#1 and #3  
This study 
pBBR1-MCS5 lacZα, Gmr  (Kovach et 
al., 1995) 
pBBR1-amrZ::sfGFP pBBR1-MCS5 derivative; 
PLtetO‐1-amrZ::sfGFP, Gmr 
contains PCR 
product using 
oligos #9 and #10 
This study 
pBBR1-amrZCIS1::sfGFP pBBR1-MCS5 derivative; 
PLtetO‐1-amrZCIS1::sfGFP, 
Gmr 
contains PCR 
product using 
oligos #9 and #10 
This study 
pBBR1-amrZΔIS2::sfGFP pBBR1-MCS5 derivative; 
PLtetO‐1-amrZΔIS2::sfGFP, 
Gmr 
contains PCR 
product using 
oligos #9 and #10 
This study 
pBBR1-amrZCIS1ΔIS2::sfGFP pBBR1-MCS5 derivative; 
PLtetO‐1-amrZ 
CIS1ΔIS2::sfGFP, Gmr 
contains PCR 
product using 
oligos #9 and #10 
This study 
pUCIDT-amrZ CIS1  Plasmid cloning vector 
containing the synthetic 
gene amrZ CIS1. Ampr 
Generated by IDT 
(integrated DNA 
technologies)  
This study 
pBK-miniTn7(Gm)PrrnB1-gfp-a PrrnB1, Ampr, Gmr, Cmr  (Lambertsen 
et al., 2004) 
pRK600 Helper plasmid, 
RP4/RK2 conjugation 
system, ColE1, Cmr 
 (Christensen 
et al., 1998) 
pUX-BF13 R6K, RP4 mob, Ampr  (Bao et al., 
1991) 
pGM931 pHERD20T derivative, 
araC/PBAD - tΩ, Ampr  
 
 (Ferrara et al., 
2015) 
pGM-ersA pGM931 derivative, ersA 
under PBAD, Ampr  
 
 (Ferrara et al., 
2015) 
 
Bao, Y., Lies, D. P., Fu, H., and Roberts, G. P. (1991). An improved Tn7-based system for the 
single-copy insertion of cloned genes into chromosomes of gram-negative bacteria. Gene 109, 167–
168. doi:10.1016/0378-1119(91)90604-A.  
Christensen, B. B., Sternberg, C., Andersen, J. B., Eberl, L., Møller, S., Givskov, M., et al. (1998). 
Establishment of new genetic traits in a microbial biofilm community. Appl. Environ. Microbiol. 
64, 2247–2255. doi:10.1128/IAI.68.6.3140-3146.2000.  
Corcoran, C. P., Podkaminski, D., Papenfort, K., Urban, J. H., Hinton, J. C. D., and Vogel, J. 
(2012). Superfolder GFP reporters validate diverse new mRNA targets of the classic porin 
regulator, MicF RNA. Mol. Microbiol. 84, 428–445. doi:10.1111/j.1365-2958.2012.08031.x.  
Ferrara, S., Carloni, S., Fulco, R., Falcone, M., Macchi, R., and Bertoni, G. (2015). Post-
transcriptional regulation of the virulence-associated enzyme AlgC by the σ(22) -dependent small 
RNA ErsA of Pseudomonas aeruginosa. Environ. Microbiol. 17, 199–214. doi:10.1111/1462-
2920.12590.  
Kovach, M. E., Elzer, P. H., Hill, D. S., Robertson, G. T., Farris, M. A., Roop, R. M., et al. (1995). 
Four new derivatives of the broad-host-range cloning vector pBBR1MCS, carrying different 
antibiotic-resistance cassettes. Gene 166, 175–6.  
Lambertsen, L., Sternberg, C., and Molin, S. (2004). Mini-Tn7 transposons for site-specific tagging 
of bacteria with fluorescent proteins. Environ. Microbiol. 6, 726–732. doi:10.1111/j.1462-
2920.2004.00605.x.  
Olson, M. V., Stover, C. K., Pham, X. Q., Erwin, A. L., Mizoguchi, S. D., Warrener, P., et al. 
(2000). Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen. 
Nature 406, 959–964. doi:10.1038/35023079. 
Table S2. Oligonucleotides used in this study. Lowercase: sites for restriction enzymes. Bold: T7 
promoter sequence. 
Oligo 
# 
Oligo name  Sequence (5´ 3´) Application 
1 AmrZ_NsiI_Fw GTTTTatgcatGAGAACAATGAACGCTT
C 
Amplification 
of part of the 5' 
UTR and 35 
codons of amrZ 
ORF with 
NsiI/NheI ends 
for cloning in 
frame with 
sfGFP in 
pXG10-SF 
vector 
2 AmrZ_NheI_Rv GTTTTgctagcAGCGACTTCTGCGATCT
G 
3 AmrZ ΔIS2_NheI_Rv GTTTTgctagcAACGACGAATTTGTCAG
CGGT 
Amplification 
of part of the 5' 
UTR and 21 
codons of amrZ 
ORF to 
generate amrZ 
ΔIS2 with 
NsiI/NheI ends 
for cloning in 
frame with 
sfGFP in 
pXG10-SF 
vector 
4 T7_AmrZ_Fw CTAATCGACTCACTATAGGGGAGA
ACAATGAACG 
Amplification 
of amrZ in 
fusion with 
RNA 
polymerase T7 
promoter for in 
vitro 
transcription 
5 AmrZ_Rv_EMSA AGCGACTTCTGCGATCTG 
6 AmrZ ΔIS2_Rv_EMSA AACGACGAATTTGTCAGCGGT Combined to 
primer number 
3 for 
amplification of 
amrZ ΔIS2 in 
fusion with 
RNA 
polymerase T7 
promoter for in 
vitro 
transcription 
7 T7_ErsA_Fw CTAATACGACTCACTATAGGGCGA
ATGGCTTCTTGAGCC 
Amplification 
of ErsA in 
fusion with 
RNA 
polymerase T7 
promoter for in 
vitro 
transcription 
8 ErsA_Rv_EMSA AAAAAAAACCCCGAGCTTCGTATGG
GGAG 
 
9 Ptet-O1_ClaI_Fw GTTTTatgcatTCCCTATCAGTGATAGAG Amplification 
of the fragment 
spanning from 
the PLtetO‐1 
promoter to the 
stop codon of 
gfp of pXG10-
amrZ::sfgfp 
with ClaI/XbaI 
ends for 
cloning in 
pBBR1-MCS5 
10 sfGFP_TAA_XbaI_Rv TGATGCCtctagaTTATTTGTAGAGCTC 
11 sfGFP_+96_r TTGTGCCCATTAACATCACCATC Reverse primer 
on gfp for 
verification of 
constructs 
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